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SUMMARY Claudia Mirian de Godoy Marques 
TISSUE ENGINEERED HUMAN SKIN MODELS TO STUDY THE EFFECT OF 
INFLAMMATION ON MELANOMA INVASION 
Increasing evidence suggests inflammation is associated with progreSSIOn of a range of 
cancers. The phenomenon of local recurrence after surgical excision of melanoma also merits 
investigation - post-excision there is both wounding and inflammation. Following on from 
this the overall aim of this work was to investigate whether anti-inflammatories could help 
reduce melanoma cell migration, invasion and survival in vitro. 
The first objective of this work was to investigate the effects of NSAIDS (ibuprofen released 
from a hydrogel or capsaicin) in reducing melanoma cell migration. The second objective 
was to investigate the role of NSAIDS in reducing melanoma invasion in a 3D wounded and 
inflamed tissue engineered skin model. This was designed to imitate the physiological 
conditions of an inflamed wound bed post-excision of primary melanoma. The third objective 
was to investigate the effects of a combined therapy of capsaicin and HA 14-1 in inducing 
apoptosis in melanoma cells and normal skin cells as an alternative treatment for malignant 
melanoma. 
Three melanoma cell lines of increasing metastatic potential were used - HBL, A375SM and 
C8161. Both ibuprofen and capsaicin reduced melanoma cell migration and opposed the 
inflammatory effects of the major pro-inflammatory cytokine TNF-a in stimulating cell 
migration. 
A 3D skin model which was wounded and subjected to an inflammatory environment was 
established. Investigation of invasion of A375SM cells in this model showed that the addition 
of ibuprofen released from a hydrogel reduced melanoma cell invasion. Fibroblasts were also 
found to retard invasion in 2 out of 3 melanoma cells in this model. 
Finally, a combined therapy of capsaicin and HAI4-1, an apoptotic inducer, was shown to be 
a promising alternative in inducing apoptosis in all three tumours. Effects of the two agents 
were additive for HBL and A375SM cells and synergistic for the C8161 cells. 
In summary this data suggests both NSAIDS and NSAIDS combined with a pro-apoptotic 
inducer could be useful approaches for reducing melanoma metastases and inducing 
apoptosis for patients suffering from primary and metastatic melanoma. 
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CHAPTER 1 
INTRODUCTION 
1 
1.1. CANCER - ORIGIN AND HISTORY 
Continuous advances in science and technology, and developments in clinical 
and public health are leading to improvements in the quality of life and longevity. Many 
diseases have been found to be curable or controlled very well by treatments. However, 
there are still some diseases which are not treatable or are age-related degenerative 
diseases such as heart disease and cancer. Cancer is a disease of complex aetiology and 
there is still much to be studied and understood. 
In this study the impact of inflammation on melanoma migration, invasion and 
survival was studied in a simple 2D model and in an engineered human skin model. 
Therefore, to start with, some background to the origin and history of cancer is 
described. 
Cancer can be found in historical Roman documents by Aulus Cornelius Celsus 
(2SBC-SO) who translated the word carcinos into the Latin word cancer, meaning crab 
(Broxmeyer, 2004), as he described a solid mass which could resemble a crab-like form 
having the main body and the roots of cancer invading into other organs and tissues. 
Nowadays the word cancer can be understood as a degenerative disease in which a 
nonnal cell suffers many consecutive alterations in its DNA (Deoxyribonucleic Acid) 
and the cell itself loses its capability of being a "normal" and become a variant forn1. 
This can result in a cell which is highly proliferative, invasive and has an endless cell 
division cycle. 
Cancer cells can be capable of invading blood and/or lymphatic vessels and 
implanting in other tissues/organs distant from their original location; this process is 
known as metastasis. There are many types of cancer and it can affect people at any age 
however, it tends to be more common with increasing age as the probability of DNA 
alteration and damage is higher. 
Cancer can also be associated with genetic (inherited) factors (Norman and Chin, 
2006), family history or immune surveillance failure as well as environmental factors 
such as long-term exposure to carcinogens such as radiation, alcohol, tobacco and 
vIruses. 
Neoplasia is the accurate term for defining abnormal cell growth or tumour 
formation. Basically there are two forms of tumours: 1) Benign tumours which 
demonstrate uncontrolled cell growth but maintain a similar phenotype to the original 
source of cells. Generally benign cancers are encapsulated and surrounded by a normal 
fibrous tissue which is induced by compression as the tumour expands. This capsule 
may prevent tumour cells leaking or spreading. The capsule also demarcates the tumour 
from normal tissue, making removal by surgical procedures feasable. A benign cancer 
may however transform into a malignant form of cancer. 2) Tumours are also 
characterised by an uncontrolled cell proliferation and growth, however, unlike benign 
tumours, these cells are able to invade and produce a metastasis. This infiltrating 
property of tumour cells can cause normal tissue destruction. As metastases occur, 
tumour removal only proceeds at sites where surgical resection is possible to remove the 
neoplastic cells with a wide margin of normal tissue. The presence of metastases 
distinguishes malignant tumours from benign tumours. 
Tumours may be discovered as a swelling or lump associated with neoplasia or 
inflammation. However, not all forms of cancer appear as a solid tumour as there can be 
cases of circulating immune cells which give a range of forms of leukemia. 
Cancer was not really treated until the improvement of microscopy and the 
realisation that the human body is made of living cells, making it possible to better 
understand the disease. At that time only rudimentary forms of treatments were made 
with poor outcomes from surgical procedures. Fundamental advances in the treatment 
of cancer only appeared at the end of the 19th century when Marie Curie and Pierre 
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Curie implemented radiation as the first non-surgical treatment for cancer (Goodman et 
al., 1984). Nowadays, radiotherapy and chemotherapy are commonly used in cancer 
patients to improve survival rates. Nevertheless much more investigation and research 
work is still needed to improve the pharmacological agents used to hopefully target the 
malignant cells without compromising healthy living tissue. The use of many anti-
cancer drugs and treatments is still limited and associated with many unwanted side 
effects. 
A significant contribution to understanding the causes of cancer occurred in 
1953 when Francis Crick and James Watson unravelled the structure of the DNA. Since 
then many studies have been able to investigate the causes of cancer at a cellular and 
molecular level and hence better understand the fundamentals of the disease. In addition 
to this, the knowledge of the biochemical structure of the cell plasma membrane and 
cell physiology made it possible to get a closer look at the development of the disease 
and devise better treatments. 
This study focuses on melanoma skin cancer and therefore a review on human 
skin physiology is required before discussing melanoma as a cancer. 
1.2. HUMAN SKIN STRUCTURE 
Skin is the largest human organ. It covers an area of approximately 1.5 to 2 m2 , 
and represents about one sixth of total body weight. It is estimated that each square inch 
of skin has 4.6 m of blood vessels, 3.6 m of ncrves, 350 sweat glands. 100 sebaceous 
glands and, 1500 nervous receptors (Marieb and Hoehn, 2007a). 
Skin has many physiological functions .. such as serving as a barrier to the 
environment; protection from water loss and light mechanical shock; production of 
specialized pigment cells to form a shield against ultraviolet rays of the sun; producticn 
of vitamin D in the epidermal layer; regulation of body temperature through sweat 
glands and provision of anti-infective properties by sebaceous gland which also helps it 
to regulate body metabolism. 
A diagram of human skin structure can be seen in Figure 1.1. 
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Figure 1.1. Structure of Human Skin (Shier et aL, 1999). 
Skin is a heterogeneous structure consisting of various types of tissue and cells. 
The skin is organised in three overlapping layers: the epidermis, dermis- and hypodermis 
(or subcutaneous fat tissue), (see Figure 1.1). Between the epidermis and the dermis 
there is a thin layer known as the basement membrane (BM). The BM is a structure of 2 
layers of basal lamina, which consists of type IV collagen, glycoproteins and 
proteoglycans (Junqueira and Carneiro, 2005). The structural and molecular 
composition of the BM varies between tissues. 
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1.2.1. Epidermis 
The epidermis survIves through a self-renewal process. Clonogenic basal 
keratinocytes forming the innermost epidermal basal layer regularly undergo mitosis, 
differentiation and upward migration to replace terminally differentiated cornified cells 
that are continuously shed into the environment. As a result, human epidermis is 
completely renewed approximately every month. To accomplish this process and to face 
the emergency of wound healing, the epidermis relies on the presencc of stem cells and 
transient amplifying cells which arc located in thc basal layer of the epidermis. The 
basic and essential characteristics of a stcm cell is its capacity for extensive sc1f-
maintenance with proliferative self-renewal potential extending for at least one life-span 
of the organism irrespective of whether the cell is multipotent (as for the haematopoietic 
stem cell) or unipotent (as for epidermal stem cells) in nature. Conversely, the transient 
amplifying cell population, which arises from stem cells and will eventually generate 
terminally differentiated cells, has a high proliferative rate for only a limited period of 
time before becoming committed to terminal differentiation (Harris, 1996). 
There are some factors associated with the conversion from stem cell to transient 
amplifying cell. Some studies suggest that the transcription factor p63 (a homologue of 
p53) is known to be expressed in epithelial stem cells of skin keratinocytes in vitro 
(Pellegrini et at., 200 I) and the proto-oncogene c-myc, a transcriptional regulator of 
proliferation in a large variety of cell types, including skin keratinocytes (Wong et al., 
2008). 
The epidclmis is composcd of five layers, from the BM to the surfacc: 1-
germinative layer (stratum basale): 2- spinous or pricklc-ceiliayer (stratum spinosllm); 
3- granular layer (stratum granulosum); 4- clear layer (stratum lucidllll1); and 5- horny 
layer (stratum corneum) (Marieb and Hoehn, 2007a: Junqueira and Carneiro, 2005). 
Figure 1.2 illustrates the stratification of the epidermis. 
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Figure 1.2. Cells of the epidermis. 
The germinative layer is the lowest layer of the epidermis and lies on the BM. 
The BM separates the epidermis from the dermis. The keratinocytes are the 
predominant cell type. 
When a basal epidermal cell undergoes a commitment to terminally differentiate, 
it ceases to divide and begins to migrate outwards towards the surface of the skin. 
Dramatic changes in its cytoskeletal architecture take place, accompanied by numerous 
changes in the expression of keratin and filaggrin (Smith and Dale, 1986). Keratins are a 
group of water-insoluble proteins (molecular weight range 40-70kD) that form 10-nm 
tonofilaments in a wide variety of epithelial cells. Monoclonal antibodies (AE1, AE2 
and AE3) recognize all known keratin species. These keratins can be divided into two 
families according to their reactivity to AE 1 and AE3 antibodies. Keratins of AE 1 
family are in general more acidic than those of the AE3 family. Keratin can be further 
divided, according to their molecular size into keratin classes: 50kD and 58kD keratins 
are present in all cell layers (which is a characteristic of all stratified squamous 
epithelia), whereas the 56.5kD and 65-67kD keratins are associated only with the more 
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differentiated cells above the basal layer (related to the keratinized epidermis) (Sun et 
al., 1983; Woodcock-Mitchell et af., 1982). Thus, the expression of specific keratin 
classes appeared to correlate with different types of epithelial differentiation (simple 
versus stratified; keratinized versus nonkeratinized) (Sun et ai., 1983; Tseng et al .. 
1982). 
As basal cells enter the spinous layer. they strengthen their cytoskeletal and 
intercellular connections. Once this task is completed the cells enter the granular layer, 
where they produce the epidermal barrier becoming corneocytes. The major constituents 
of the corneocytes are keratin intermediate filaments, which fill the inside of the 
corneocytes, and contribute to the mechanical stiffness of the stratum corneum 
architecture. 
This makes up the epidermal barrier (localized primarily in the stratum corneum) 
which consists of protein-enriched cells (corneocytes with cornified envelope and 
cytoskcletal elements, as well as corneodesmosomes) and lipid-enriched intercellular 
domains. The nucleated cells in the epidennis have gap and adherens junctions, 
additional desmosomes and cytoskeletal elements which also contribute to the barrier. 
As keratinocytes differentiate, lipids are synthesized are extruded into the extracellular 
domains, where they form lipid-enriched extracellular layers. The cornified cell 
envelope, a robust protein/lipid polymer structure, is located below the plasma 
membrane of terminally differentiated keratinocytes (Hohl, 1990). Filaggrin, as 
mentioned before, is a cross-linked protein to the cornified envelope and aggregates 
keratin filaments into macrofibrils. Cytokines, cAMP and calcium influence the 
formation and maintenance of barrier function (Jensen and Proksch, 2009). 
Involucrin plays a role in forming the cornified layer. It is a 66kD protein with a 
rod-like shape, which was the first cornified envelope precursor protein to be identified 
and it is localised in the outmost region of the cornified envelope (Vanhoutteghem et al.. 
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2008). It has extensive tandem repeated of specific amino acid sequence in which the 
glutamine/glutamine residues are used for extensive cross-links (Vanhoutteghem et al. 
2008). 
Filaggrin and trichohyalin are multifunctional proteins known to play an 
important role during cornification. Mutations in the genes encoding for filaggrin have 
been identified in patients with ichthyosis vulgaris and atopic dermatitis (such as 
eczema). Profiiaggrin, which is processes to functional fiiaggrin monomers, and 
keratohyalin granules in the epidermis and hair follicle respectively (Markova et al., 
1993). 
Filaggrin and trichohyalin also combine sequence repeats, similar to cornified 
envelope precursors, with two calcium binding EF-hand domains (a calcium-binding 
motif named after the E- and F-helices of parvalbumin), which are typical features of 
the S 100 proteins. S 100 proteins function as regulatory protein that are inyolved in 
different steps of the calcium signalling, following cell morphology, cell cycle and 
differentiation (Sun et al., 2000). Calcium concentration increases as keratinocytes 
migrate to the stratum corneum and differentiate. 
The human epidermis is renewed every 15-30 days, depending on many factors 
such as age and body location. 
Around 10-25% of the cells in the germinative layer are melanocytes. 
Melanocytes are derived from neural erest cells. They appear as rounded-like cells with 
long irregular dendritic extensions into the epidermis reaching the cells of the 
germinative layer and prickle-cell layer. Mclanocytes synthesise melanin granules 
(pigment) and transfer them into the cytoplasm of keratinocytes. Stimulation of melanin 
production by mclanocytes is caused by increased exposure to UV (ultra-violet) 
radiation. This is an attempt to form a shield of protection in the supranuclear region of 
the eells against the deleterious effects of UV radiation, such as DNA damage. Longer 
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UV radiation exposure produces darkening or tanning of the skin caused by further 
synthesis of melanin transferred to keratinocytes. 
Other cells found in the germinative layer are the Merkel's cells which are the 
neuroendocrine cells of the skin. Their highest density is within the epithelial mucosa, 
lips, palate, palms and fingertips. It is suggested that these cells are specialised in slow-
adapting tactile mechanoreceptors. 
In the prickle-cell layer, keratinocytes appear irregular (spiny) in shape, 
therefore they are called prickle cells. Keratinocytes are attached to one another by 
numerous intermediate intercellular filaments which span from their cytosol to attach to 
the desmosomes. This prevents the intercellular spaces from becoming markedly dilated 
and therefore helps to keep cells firmly attached one to another. During inflammation, 
these intercellular junctions may be damaged causing them to rupture and allowing the 
intercellular spaces to enlarge. Inflammatory cells and mediator factors often occupy 
these enlarged intercellular spaces. Other cells found in the prickle-cell layer are 
Langerhans cells which derive from precursors in the bone marrow. These cells have a 
star-like shape and are localised in the supra-basal epidermal layer among keratinocytes. 
Their function is to take up the antigens that reach the epidermis, process them and 
migrate to regional lymph node and present antigens to immunocompetent T cells. 
Therefore accordingly they appear to playa key role in cutaneous immunosurveillance. 
The granular layer is a thin layer of three to five layers of keratinocytes with 
changes in appearance as they flatten and their organelles and nuclei disintegrate. These 
cells produce and accumulatc two forms of granules: the keratohyaline granules which 
form keratin in thc upper layers of epidermis and lamellatcd granules containing a 
waterproof glycolipid substance which is transfcrred to thc extracellular space slowing 
down the water loss in the epidennis. Above the granular layer, cell nutrition is reduced 
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as these cells are far from the dermal capillaries. Accordingly the cells die producing 
clear horny layers. 
The clear layer is so called as it is highly refractive. This layer is made of a few 
rows of clear flat dead keratinocytes. The cytoplasm is mostly made of keratin filaments. 
This layer of the epidermis is only seen in thick skin. 
The horny layer is the uppermost layer of the epidermis. It is made of 20-30 
flattened epithelial cells layers. This accounts for up to % of the epithelial thickness. 
These layers are called keratinized layers because of the build-up of the protein keratin 
in these cells. This serves as a barrier against hostile exogenous factors and also 
prevents water loss. 
Other specialised cell junctions to keep the epithelium impermeable are the tight 
junctions which form a seal between adjacent cells and also define the apical and basal 
sides of an epithelial cell. Just below the tight junctions are the adhesion junctions that 
hold cells in a fixed position and help to keep cells tightly united together in response to 
skin shear stress. Among adjacent cells are the communications junctions (or gap 
junctions) providing cell attachment as well as cell-to-cell communication of small 
molecules and signals. Therefore, keratinocytes work together to provide a barrier, 
keeping foreign and harn1ful substances out of the body, preventing water and other 
physiological substances from escaping the body as well as forming a network of 
communication between cells (Marieb and Hoehn, 2007a; Junqueira and Carneiro, 
2005). 
Changes in lipid composition and epidermal differentiation lead to a disturbed 
skin barrier, which allows the entry of environmental allergens, immunological reaction 
and inflammation in atopic dermatitis. A disturbed skin barrier is an important 
component in the pathogenesis of contact dermatitis, ichthyosis. psoriasis, and atopic 
dermatitis (Jensen and Proksch 2009). 
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Although the epidermis has a rich innervated network, its stratified layers of 
cel1s are non-vascular. Hence, epithelium metabolic exchange occurs by diffusion from 
the capil1aries in the dermal papillae layer of connective tissue. The thickness of the 
epidennis varies between 0.04 to 1.6 mm. 
1.2.2. Dermis 
The dermis is an important tissue as it provides mechanical protection to the 
underlying body parts and serves as an interface and filling tissue to bind together all 
the superficial structures. The dermis is a specialised connective tissue made of cells, 
fibres and extracellular matrix. The cell types found in the dermis are typical of those 
found in any connective tissue proper such as fibroblasts, macrophages and occasional 
mast cells and white blood cells. This strong and flexible connective tissue layer is 
composed of a gel-like matrix heavily embedded with water collagen, elastin and 
reticular fibres. Collagen fibres and glycosaminoglycans (GAGs), can bind large 
amounts of water and collagen to determine the high intrinsic tension of skin. As 
proteins are synthesized in the rough endoplasmic reticulum, glycosaminoglycans bind 
to proteins in the Golgi Apparaus to fonn proteoglycans. Proteoglycans are exported in 
secretory vesicles to the extracellular matrix. Proteoglycans, collagen and water form a 
gel-like mass that can absorb and expel water like a sponge. This gel-like mass may also 
act as a physical barrier to foreign particles (Marieb and Hoehn, 2007a). 
Differently, hyaluroran (a non-sulfated glycosaminoglycan), IS synthesized 
without a protein core and is released at cell surface directly into the extracellular matrix. 
Hyaluronan contributcs significantly to cell proliferation and migration, and may also 
be involved in the progression of some malignant tumours (Edward et at., 2005). 
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Embedded in this layer are systems and structures common to other organs and 
tissues such as lymphatic and blood vessels, nerve fibres, and muscle cells. The main 
cell types are fibroblasts which are responsible for the synthesis of collagen and elastin. 
There are about 20 different types of collagen, but adult collagen consists mainly of 
types I and III, whereas type IV is a major constituent of the basal lamina. Other cell 
types include mast cells which are capable of producing potent inflammatory mediators; 
macrophages which are derived from blood monocytes and have phagocytic properties; 
and plasma cells which express immunoglobulin receptors on their surface and once 
activated, are able to synthesise immunoglobulins. There are also some types of 
leukocytes that can move from the circulation into the dermis through extravasation. 
These include: neutrophils, a phagocytic cell, eosinophils which recognise parasites and, 
lymphocytes that are cells capable of triggering an immune reaction. The dennis also 
contains a multitude of nerve endings that act as tactile and thermo receptors. 
The dermis has two major layers, the papillary layer (or stratum papillare) and 
the reticular layer (or stratum reticulare). 
The thin superficial papillary layer is made up of loose connective tissue clearly 
demarcated from the epidermis by the BM border. Its superior surface is thrown into 
projections called dermal papillae that indent into the epidermis 3bovc 3!ld ':C!:!J!!1S 
small blood vessels that nourish the epidermis. Within the papillary layer are thin fibres 
of collagen which provide strength and flexibility and, contains receptors which 
communicate with the Central Nervous System - these include touch, pressure, hot, cold 
and pain receptors. 
The thick reticular layer lying below the papillary layer is much denser. It 
contains bundles of interlocking collagen fibres that run in various planes parallel to the 
skin surface, elastin and reticular fibres which give the skin its stretch and recoil 
properties. It also houses hair follicles, nerves and certain glands. The lower part of the 
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reticular dennis shows a continuous transition to its lower adjacent layer, the 
hypodennis. 
The hypodennis or subcutaneous fat tissue consists of a spongy connective 
tissue interspersed with energy-storing adipocytes (fat cells). The hypodennis is hea\-ily 
interlaced with blood vessels, ensuring a quick delivery of stored energy and nutrients 
as needed. Other functions of the subcutaneous fatty tissue include the insulation of the 
body from cold and shock absorption like on the palms of the hands and soles of the feet 
(Marieb and Hoehn, 2007a). Skin appendices are hair follicles, sebaceous and sweat 
glands. 
1.3. EPIDEMIOLOGY OF CANCER 
It is estimated that one in three people in the United Kingdom will develop a 
malignancy by thc time they reach the age of 70, with the incidence increasing with age. 
Unf011unately, the UK incidence of cancer is expected to increase by 2025 (Gabriel, 
2004). This may however be applicable to any developed or developing region of the 
world as cancer is an age and degenerative disease, common where longevity is 
increased. 
The incidence of cancer is a worldwide phenomenon. For example in Brazil, 
breast and prostate cancer in 2006 were estimated as the highest in the southern and 
northern regions respectively (Menezes et at., 2007). 
In the USA (United States of America), overall incidence of cancer and cancer 
deaths dropped. according to the trends based on data from 1975 through 2005 (lemal et 
at., 2009). This was due to largely decreases in the most common cancers: breasts, 
prostate, lung and colorectal cancers. However. there are more new cases of skin cancer 
(more than one million) diagnosed annual1y (America Cancer Society. Cancer Facts & 
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Figures, 2009). In addition to this, the incidence of melanoma continues to fIse 
significantly fast. The US Skin Cancer Facts (2009) reported some data that should be 
carefully considered: 1) melanoma accounts for about 3 percent of skin cancer, but it 
causes more than 75 percent of skin cancer deaths; 2) although survival with melanoma 
increased from 49 percent between 1950 and 1954 to 92 percent between 1996 and 2003, 
one person dies of melanoma almost every hour (every 62 minutes): and, 3) about 65 
percent of melanoma cases can be attributed to ultraviolet (UV) radiation from the sun. 
In the United Kingdom (Westlake, 2008) breast cancer is the most common 
cancer for women (42,000 new cases a year). The most common type of cancer in men 
is prostate cancer with over 31,900 new cases a year. Lung cancer is the second most 
common form and men are more likely to be affected (37,200 new cases a year). 
Colorectal cancer is the third most common cancer in men (about 18,700 new cases a 
year) and the second most common cancer in women (nearly 16,200 cases a year). 
However an analysis of 1.6 million cases of cancer in people aged up to 79 in England, 
in an eight year period, showed that cancers of the bone and specific types of ovarian 
and testicular cancers disproportionately affected young people aged between 13 and 24 
(O'Dowd, 2006). As for childhood cancer, whIle statistics show that over 160,000 
children worldwide are newly diagnosed with cancer each year, the exact number of 
new cases is not known as cancer registers do not exist in many countries. Leukemia is 
the most common childhood cancer in Europe, America and East Asia. Other tumour 
types are more frequent in developing countries, such as lymphomas, Kaposi's sarcoma 
and retinoblastoma (International Union against Cancer, 2006). 
Melanoma, the most serious form of skin cancer accounts for almost three per 
cent of all newly diagnoscd cancers each year. There are about 3,500 new cases of 
melanoma in men and over 4,500 new cases in women each year in the UK (Westlake, 
2008). 
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As melanoma is the skin cancer investigated in this study, it is discussed in more 
detail as follows. 
1.4. SKIN CANCER - MELANOMA 
There are two main types of skin cancer, melanoma and non-melanoma skin 
cancer. Melanoma is the most serious form of skin cancer as it grows and spreads 
rapidly in the body. 
1.4.1. History of Melanoma 
As described in "Texbook of Melanoma" (Thompson et aI., 2004), the first case 
of a patient with melanoma was published by John Hunter in 1787. His patient had a 
recurrent mass behind the angle of the lower jaw. Hunter's original specimen is still 
preserved in the Hunterian Museum of the Royal College of Surgeons of England. In 
1968, Bodenham reported that microscopic examination of the specimen confirmed that 
it was a melanoma. However, in 1806 Rene Laennec was the first to describe melanoma 
as a disease entity and in 1812, used the term 'melanosis'. The tirst case in England was 
reported by William Norris in 1820. He referred to it as a case of fungoid disease but 
later described a patient who died from disseminated melanoma. Many other 
descriptions have been made, including "superficial spreading" melanoma by David 
Williams and, the first excision of metastasis in the lymph nodes in 1851. In the early 
20th century Frederick Eve remarked that 'it is generally stated that melanomas are the 
most malignant form of tumours'. He also recommended the removal of a primary 
tumour and the nearest chain of lymphatic glands. At this time, melanoma was usually 
very advanced when diagnosed and the prognosis was very poor. From 1970 to the 
present day, the management of melanoma went through a series of changes. Many 
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countries adopted rapid treatment for patients with melanomas presenting a tumour 
thickness of> I mm in an attempt to increase the survival rate. However, melanoma still 
causes many deaths worldwide as it produces metastasis very rapidly making treatment 
difficult. 
1.4.2. Epidemiology of melanoma 
The earliest descriptions of skin cancer were of slow inexorable growths 
destroying their entire path. The Latin term - noli me tangere (touch me not) was given 
because they were thought to be incurable and therefore not to be treated (Colver, 2002). 
In fact it is now known that melanoma if diagnosed at an early stage may be curable. 
The incidence of invasive cutaneous malignant melanoma is increasing rapidly 
and mortality trends are increasing steadily upwards. Some authors state that there is an 
urgent need for better therapy of cutaneous malignant melanoma (MacKie, 1996). 
Although melanoma is not a common source of cancer, in the United Kingdom, 
the incidence of melanoma has increased over three fold in the last 25 years to age-
standardized rates of 11.1 per 1000,000 in men and 12.6 per 100,000 in women in 2003. 
As incidence rates have increased faster than any other major cancer melanoma is a 
public health concern as it is the eighth most common malignancy in the UK (Newton-
Bishop, 2008). 
Later stage melanoma incidences are particularly high in lower socioeconomic 
groups than in higher socioeconomic groups. This may be explained as individuals in 
low socioeconomic areas have less access to educational campaigns and screening 
examinations and effective treatments when compared to individuals from higher 
socioeconomic areas (Ortiz et at., 2005). 
Considering the increasing incidence of melanoma in both USA and UK, it can 
be assumed that melanoma incidence may be increasing world wide. 
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1.4.3. Skin types and skin cancer 
Skin types can be referred to the different skin colours. Three pigments 
contribute to skin colour: melanin, carotene and haemoglobin. Melanin, a polymer made 
up of tyrosine amino acids, ranges in colour from yellow to orange to brown. As 
described before, melanin is transferred from melanocytes to keratinocytes. The 
melanocytes of black- and brown-skinned people produce much darker melanin than 
those of fair-skinned individuals. Melanocytes are stimulated to greater activity when 
the skin is exposed to sunlight. Prolonged sun exposure causes a substantial melanin 
build up, which helps to protect viable skin cells from ultraviolet radiation and in fair-
skinned people causes visible darkening of the skin. Despite of melanin's protective 
effects, excessive sun exposure eventually damages the skin. It depresses the immune 
system and can alter the DNA of skin cells and may lead to skin cancer. 
Carotene is a yellow to orange pigment found primary in the stratum corneum 
and in adipose tissue. Carotene is particularly abundant in the skin of Oriental people. 
Together with melanin, it accounts for the yellowish tinge of their skin. 
Haemoglobin - the pinkish hue of Caucasian skin reflects the crimson colour of 
oxygenated haemoglobin in the red blood cells circulating through the dermal 
capillaries. Since Caucassian skin contains only small amounts of melanin, the 
epidermis is quite transparent and allows haemoglobin'S red colour to show through. 
(Marieb, 2000). 
Skin cancer IS uncommon ill skin colour people compared to Caucasians. 
However, skin cancer prevention and screening practices historically have been lower 
among Hispanics, Blacks and Asians (Bradford, 2009). On the other hand, white-
skinned people living in sunny areas seem to be morc aware of the need to protect skin 
against UV radiation. 
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1.5. IDENTIFICATION OF MELANOl\IA 
Melanoma can be caused by ultraviolet (UV) radiation, genetic factors and 
ageing. Melanoma, also known as malignant melanoma, is a cancer that develops from 
melanocytes. As mentioned before, these cells produce melanin, a pigment that is 
passed into adjacent keratinocytes where it accumulates over the cell nucleus, forming a 
shield to protect the skin from the harmful effects of the UV radiation. Melanoma may 
develop in moles as well as elsewhere on the skin. It can also occur in the eyes, under 
the finger nails or on other body parts not usually exposed to the sun such as the palms 
of hands or the soles of feet. Approximately one third of melanomas develop from 
normal moles. The earlier melanoma is detected the better the chance of being curable. 
Despite the majority of melanomas arising in the skin, it may also arise on mucosal 
surfaces or at other sites to which neural crest cells migrate. Melanoma occurs more 
commonly in adults and more than 50 % of the cases arise in apparently normal exposed 
areas of the skin. Early signs in a nevus that suggest malignant change include a dark 
patch that is getting larger, a mole with a ragged edge, a mole with a mixture of 
different shades of brown and black colours, development of satellites, inflamed moles, 
bleeding or crusting of a mole and an itching mole. In suspected skin lesions an excision 
biopsy is processed by conyentional histology and examined. 
1.5.1. Cell"s own mechanisms of protection 
Both UV A (ultra-violet - longer wavelength) and UVB (ultra-violet - medium 
wavelength) rays cause damage, including genetic injury, wrinkles, lower immunity 
against infection, aging skin disorders, and cancer. The mechanisms inducing such 
changes are not yet fully understood. In order to counteract to these deleterious effects, 
the body takes some defensive mechanisms against DNA damage, as follows: 
19 
• 
• 
Production of anti-oxidants to fight against oxidants (also called free radicals) . 
These are unstable molecules produced by normal chemicals during metabolic 
process. High levels of oxidants may alter the genetic component, contributing 
to ageing and cancer. The large surface area of the skin makes this organ a prime 
target for oxidants. 
Repair of defective DNA. Cells can produce protective enzymes (such as DNA 
polymerases (Kunkel and Bebenek, 2000)) which help to repair damaged DNA. 
Melanoma and other skin cancers may be caused by a breakdown in this 
mechanism. 
• Apoptosis. It is a natural process of cell self-destruction, which occurs when 
cells are severely damaged. Some genetic mutations or other factors inhibit 
apoptosis. Once this occurs, cells continue to proliferatc in an uncontrolled 
manner and may result in clones of modified cells. 
• Immune response against a non-recognizable or altered cell within the system. 
This is a very complex process which may include innate immune and/or 
specific responses, activating cells and soluble factors. 
The initiation of cancer may occur therefore if one or more mechanisms of 
protection fail to destroy or eliminate an altered cell. 
1.5.1.1. Cancer development 
The multiplication of cells is carefully regulated and responsive to specific needs 
of the body. Very occasionally the mechanism of protection fails and the exquisite 
controls that regulate cell multiplication break down. A cell in which this occurs begins 
to grow and divide in an unregulated fashion, without regard to the body's need for 
further cells of its type. This results in a clone of cells able to expand indefinitely and 
tumour formation takes place. Some tumours do not have serious consequences but 
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tumours composed of cells that spread throughout the body usually cause the disease. 
Cancer therefore is caused by accumulation of mutations of the somatic cells. 
Approximately half of all cases of human cancer may be attributed to a defective p53 
protein, caused by mutation s in the p53 gene, changing one amino acid in the protein to 
another. This may alter the binding of the protein to DNA or the transcription factors, 
corrupting the signal from p53 to the cellular machinery or it may unnaturally increase 
the stability of the protein, disrupting the delicate balance of synthesis and degradation 
that controls the level of p53 in the cell. Either way, p53 is unable to open the gates to 
cell cycle arrest or apoptosis, and cancerous cells are allowed to proliferate without 
control (Goodsell, 1999). The p53 tumour suppressor has been termed "The guardian of 
the cell". It is not essential for life but it is essential in its role protecting an organism. 
Tumour progression is initially dependent on other cells, and the rate of tumour 
growth is determined by comparing the excess of cell production with cell loss. For 
tumour expansion to occur, vascularization (or angiogenesis) develop to "feed" tumour 
cells. With further progression, tumour become more independent (and aggressive) 
(Anderson et at., 2009) and may generate blood vessels as they develop the ability to 
synthesize growth factors that stimulate formation of vessels. Further steps are the 
detachlnent to cells from solid tumours and metastasis formation. 
1.5.2. Histopathological Detection of Melanoma 
Malignant melanoma originates from altered melanocytes of the basal and 
spinous layers of the epidermis. Histopathological examination demonstrated that 
abnormal melanocytes proliferate (by mitosis) and spread into both the epidermis and 
the dermis. Superficial spreading of melanoma is represented by abnormal melanocytes 
growing radially within the epidelmis and is known as Pagetoid spread (Figure 1.3 A). 
If only this horizontal spread occurs no metastasis are formed. Therefore this is a pre-
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invasive form of melanoma. This type of melanoma can be surgically removed with a 
high success rate. 
On the other hand, melanoma cells may also proliferate and invade in a vertical 
way, reaching deeper in the dermal layer (Figure 1.3 B). This type of vertical invasion is 
highly likely to develop into a metastatic form of melanoma with a poor clinical 
prognoSIs. 
Melanoma cells 
Melanoma cells 
Dermis 
A B 
Figure 1.3. Melanoma cell invasion occurring in two different ways. Horizontal cell 
proliferation (A); vertical cell proliferation and invasion (B). 
1.5.3. Clinical classification of melanoma 
Clinical classification of melanoma is based on tumour spread from its place of 
origin to regional lymph nodes or distant sites. For tumours at the primary site, the 
greater the thickness and depth of local invasion of the melanoma, the higher the chance 
of lymph node or systemic metastasis and, therefore the worse the prognosis. Melanoma 
may spread into local lymphaticlblood vessels and to distant places via lymphlblood 
circulation. At this point, the lesion can be classed as an invasive malignant melanoma 
capable of producing distant metastases. Melanoma also varies in terms of pigmentation 
and size. 
According to some authors (Buchan and Roberts, 2000), four main types of 
cutaneous melanoma are classified for clinical identification: 1) superficial spreading 
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melanoma; 2) nodular melanoma; 3) lentigo maligna melanoma; 4) acral lentiginous 
melanoma. 
1. Superficial spreading melanoma. These include over half of the melanomas 
presenting on white skinned people. They are more common in women than in men. 
Lesions are pigmented with irregular borders and are slightly raised. Normal skin 
margins are lost and there may be evidence of inflammation. Superficial and spreading 
growth may last months. A change in thickness or the growth of nodules indicates a 
vertical invasion of the tumour and its growth indicates a worsening in prognosis. 
Crusting and bleeding can occur if the lesion is ignored. This type of melanoma can 
occur in normal skin, however it frequently arises in a pre-existing mole. 
2. Nodular Melanoma. Malignant nodular melanomas are more common in men, 
later in life. This type comprises 20-25% of all melanomas. They occur on the trunk, 
head and neck. There is no horizontal growth. The tumour invades vertically and rapidly 
from the skin surface and, has a poor prognosis. The colour varies between reddish to 
brown or black. This type of melanoma may present as an elevated dome-shaped or, 
even tag-like lesion. It is common to find it as a red raised central lesion with a 
peripheral brown ring or crescent of melanin. This type of melanoma bleeds at an early 
stage and therefore is easily confused with a vascular lesion. The absence of horizontal 
invasion of cells around a nodular melanoma distinguishes it from other forms of 
melanoma. 
3. Lentigo maligna melanoma. This type of melanoma is common in people oyer 
60 years of age and those who have had long periods of sun exposure. Therefore it is 
often found in normally exposed body areas such as face, hands and legs. It may have a 
long pre-invasive phase of several years. During this phase. the lesion has a slow 
growth and flat brown even appearance. However, with time, the pigmentation becomes 
irregular with areas of dark, brown, blue or black. Red or purple dark areas are less 
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frequent. The development of an elevated nodule indicates a vertical invasive growth 
phase. If ignored, bleeding, oozing and ulceration may occur. 
4. Acral lentiginous melanoma. These comprise 10 % of melanomas in the white 
skinned popUlation and their common sites are palms, soles and around the nail bed. 
These lesions appear as a large flat pigmented area around a focus of a raised melanoma 
and may bleed or ooze. Lesions around the nail bed are often mistaken for old blood. 
1.5.4. The Clark level of invasion and Breslow thickness 
Both techniques are a measurement of the depth of invasion as an important 
prognostic factor in the pathology. Clark (Clark et aI., 1975) recognised that there was a 
relationship between the level of invasion of the tumour and the clinical prognosis. The 
higher the level of Clark's classification the deeper the invasion. Five levels of 
classification are used (See Table 1.1). 
Table 1.1. Clark's classification level (Clark et al., 1975). 
Level Description 
1 Lesions involving only the epidermis (in situ melanoma) 
2 Invasion of the papillary dermis by single cells 
3 Invasion fills and expands the papillary dermis 
4 Invasion into the reticular dermis 
5 Invasion through the reticular dermis into the subcutaneous tissue 
Breslow (1970) refined the above classification and demonstrated that the direct 
measurement of the tumour thickness (in millimetres), from granular layer to the 
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deepest abnormal tumour cell along with a safe margin of excision provides a more 
precise and reproducible prognosis for patient survival and, the likelihood of metastatic 
spread (Figure 1.4). Therefore, according to the Breslow thickness, the thicker the 
tumour the lower the rate of survival. 
Epidermis 
Dermis 
Subcutaneous fat 
Breslow 
$1mm 
2-4m 
Wider 5-year 
excision survival 
margins rates (%) 
1 em· ···· ' 90-
3 em····· ' 65-
> 4 mm .... 3 em····· ' 45-
Figure 1.4. Breslow thickness and determination of the size of margins required for 
excision and prediction of 5 year survival rates. Adapted from Rajpar and Marsden 
(2008a). 
1.5.5. Treatments for melanoma 
As survival from pnmary melanoma is determined by Breslow thickness, 
treatments for melanoma can be described from early stages from surgical removal of 
superficial melanoma to the more intensive treatments and palliative care (Rajpar and 
Marsden,2008a). 
1.5.5.1. Treatment for early stage melanoma 
Melanoma in situ IS the very early stage ill which abnormal 
melanocytes/melanoma cells are found in the basal layer and to a lesser extent in the 
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spinous layer of the epidennis. Treatment is by surgical removal of melanoma cells and 
a margin of healthy tissue around it. It can be totally curable if it is removed at an early 
stage. 
Early melanoma, in its pre-invasive fonn is classified as a tumour of less than I 
mm in thickness. Treatment is by surgical excision and no further treatment is necessary 
as it has a high chance of being completely cured. 
1.5.5.2. Treatment of stage 2 and 3 melanoma 
Stage 2 is considered to be when a melanoma is more than 2 mm thick or more 
than I mm thick and ulcerated. Stage 3 is when melanoma cells have already invaded 
into the body and are found in one or more lymph nodes. Both stages 2 and 3 involve 
further tests to check for metastasis fonnation and, further treatment may be necessary. 
Post-surgery treatments need to be more effective and stronger in an attempt to 
reduce recurrence in the lymph nodes and to prevent metastatic invasion of the 
melanoma. This makes metastasis treatment completely different when compared to the 
pre-invasive stage of the disease. Successful treatment is more likely if the melanoma is 
fully surgically removed, including a small area of nomlal surroundillg skin or, ~f it 
remains localised around the original scar or when only regional lymph nodes are 
involved (Cancer Research UK, 2009; Rajpar and Marsden, 2008b). 
Chemotherapy is used only in cases of advanced melanoma, including a 
combination of drugs and sometimes immunotherapy (where the patient's own immune 
system is activated). Interferon and interleukin 2 are the commonest approaches used 
for immunotherapy. 
Treatments are thercfore: surgcry. isolated limb perfusion. laser treatments, 
chemotherapy. radiotherapy, interferon, vaccines and palliative care. 
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Some of the latest treatments and co-adjuvant drug therapies include some basic 
anti-inflammatory agents. This reflects the recent knowledge that inflammation seems 
to play a role in cancer development. Accordingly, a summary of inflammation is 
described next. 
1.6. INFLAMMATION 
Inflammation is a process in which immune cells and a cascade of cytokines and 
chemokines are stimulated in response to tissue trauma such as cuts or other mechanical 
trauma, e.g. bums, infection, autoimmune responses and toxic agents. 
With acute inflammation (Playfair and Chain, 2005a; Playfair and Chain, 2005b; 
Kang et al .. 2006; Marieb and Hoehn, 2007b), mast cells and macrophages release 
chemical mediators such as histamine and heparin into the surrounding area. As a result, 
phospholipids, one of the main substances released, are converted to arachidonic acid by 
the enzyme phospholipase A2. In the next stage, the arachidonic acid may enter two 
different inflammatory pathways. One is the cyclic peroxides in which cyclooxygenase 
enzymes (COXl and COX2) convert the arachidonic acid into prostaglandins. 
Prostaglandins mediate vasodilation and inhibit platelet aggregation. This leads to 
increased vascular permeability which allows serum and protein to accumulate in the 
tissue around the wound. The result of this is redness, swelling and heat apparent in and 
around the wound site. 
If Arachidonic acid enters the lipoxygenase pathway, it is converted into 
leukotrienes. Leukotrienes are responsible for recruiting leukocytes to the inflamed area. 
This involves a complex specific immune response and may damage the surrounding 
tissue if inflammation is uncontrolled. 
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Thromboxanes are also produced by the release of phospholipids and mediate 
platelet aggregation and vasoconstriction which opposes the effects of inflammation. 
Therefore a balance between the production of prostaglandins and thromboxanes may 
control inflammation. See Figure 1.5. 
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Phospholipase A2 
Arachidonic Acid 
COX1 +COX2 
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(vasod~ation and inhibits 
platelet aggregation) 
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(leukocytes and specific 
immune response) 
Thromboxanes 
Opposes the effects of 
inflammation 
Figure 1.5. Flow chart of acute inflammation. 
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During intlammation, monocytes, macrophages and other cell types produce 
cytokines such as Tumour Necrosis Factor (TNF) and Interleukins (lLs), mainly IL-l 
and IL-6. These cytokines initiate many of the changes in the vascular endothelium 
promoting leukocyte entry to the inflammatory site, as well as inducing tissue repair. 
The beginning of inflammation involves' some hemodynamic changes to slow 
down the blood flow through the smaller blood vessels. This is achieved by the 
vasoconstriction of nearby larger blood vessels. The slower blood flow facilitates 
adherence of activated leukocytes to the capillary walls. The increase in capillary 
permeability (or vasodilation) increases the spaces between endothelial cells. As blood 
flow is slower, adhesion molecules are activated on the surface of the endothelial cells 
on the inner wall of capillaries. Activation of integrins on the leukocyte enables surface 
attachment to adhesion molecules on the endothelial cell surface. This makes it easy for 
leukocytes to flatten and squeeze through the space between the endothelial cells, a 
process called diapedesis, extravasation (Ransohoff et aI., 2003) or transmigration 
(Figure 1.6). 
Although there are many leukocytes in the circulating blood, neutrophils are the 
first responder to inflammation. 
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Figure 1.6. Inflammation and diapedesis. Stages of leukocytes attraction to the site of 
inflammation: Cell activation, rolling, adhesion and diapedesis. (Adapted from Ransohoff 
et aL, 2003). 
This process is explained further in Figure 1.6 which shows the actions of 
neutrophils in an acute inflammatory response. This is divided into 5 subsequent phases: 
margination (the process in which free-flowing leukocytes exit the central blood stream, 
and adhere onto the internal surface of the vessel walls), rolling, adhesion, diapedesis 
and chemotaxis. These series of events are mediated by many biochemical changes such 
as: 
1. The internal surface of endothelial cells express selectins (E-Selectin), integrins 
ligands, such as ICAM-l (Intercellular Adhesion Molecule-I) and chemokines. 
Leukocytes express chemokines receptors, selectins ligands (L-Selectins) and 
integrins. 
2. Leukocytes selectins ligands, and endothelium selectins (E-selectin) act as receptors 
to provide binding for rolling. 
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3. Engagement of the chemokine receptor on the leukocyte surface to the immobilised 
chemokines on the endothelial cell surface provides further rolling, adhesion and 
integrin activation. 
4. Leukocytes integrin association with integrin ligand on endothelial cell surface 
promote diapedesis. 
In acute inflammation chemotaxis is aided by C5a component from complement 
activation, along with the lipoxygenase pathway to attract phagocytes (such as 
macrophages which can engulf and destroy substantial numbers of bacteria, other cells 
or microorganisms) and induce specific immune responses. 
These events are stimulated and enhanced by a variety of chemical inflammatory 
mediators, produced by leukocytes and macrophages. These include proinflammatory 
cytokines such as TNF-alpha, IL-l and IL-6. As a result of these proinflammatory 
cytokines, IL-8, a type of chemokine is released. Chemokines play a key role 111 
chemotaxis and regulation of leukocyte mobilization. The entire process results III 
redness, swelling, heat and pain. As inflammation finishes, the healing process begins to 
restore and repair the damaged tissue. Inflammation and wound healing process begin to 
restore and repair the damaged tissue. This is helped by the production of a clotting 
system in a form of a matrix into which fibroblasts migrate and initiate healing. This 
occurs by the production of a clotting system fom1ing a matrix into which fibroblasts 
migrate and initiate healing. 
In this study, reconstructed human skin models have been used to inYestigate 
melanoma invasion in an inflamed wound bed. Therefore some background on skin 
wound healing has been included. 
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1.7. SKIN WOUND HEALING 
Wound healing is a complex and essential process in all damaged human tissues. 
Skin wound healing involves a collaborative effort of many different tissues and cells 
lineages during the phases of proliferation, migration, matrix synthesis and contraction. 
Growth factors and matrix signal also present at wound site also playa role in wound 
healing. 
As skin is the barrier from the external environment any breakage must be 
rapidly and perfectly healed. Adult skin wound healing results in a scar that is neither 
aesthetically nor functionally similar to the same previous intact tissue. The same 
principles underlie the healing of physical damage such as cuts as well as other 
mechanical or chemical damages, such as ulcers and bums. 
When the skin is wounded, the remaining healthy living tissue activates the 
healing process, which overlaps with the inflammatory response. The body immediately 
releases chemical mediators of inflammation which play an important role in cleaning 
the damaged tissue area and, growth factors which help a wound to heal. Healing 
involves the release of fibrinogen and thrombin to react and form a gel-form of fibrin 
which clots to fill in the empty wound space. This is important as scaling the open 
wound helps avoid possible contamination or infection. It also serves as a provisional 
scaffold for cells that proliferate and migrate in from the wound edges towards the 
centre of the wound. Healing itself occurs as fibroblasts proliferate and migrate in the 
fibrin clot produced within the wound. As fibroblasts proliferate and migrate, a new 
extracellular matrix is produced, including collagen and elastin. The proliferation of 
keratinocytes from the wound edges closes the epidermal gap over the new dermal 
tissue and. within a few days the tissue is healed and gradually returns to normal 
function. 
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There are important factors for the fast and healthy healing of wounds. such as 
adequate supply of nutrients and oxygen (importantly vitamin C an essential cofactor 
for collagen synthesis by dennal fibroblasts, and zinc for helping in wound healing 
(Lansdown et al., 2007); and an aseptic wound bed (Lippincott Williams & Wilkins, 
2003). On the other hand, congenital disorders 'may contribute to a delay in wound 
healing, such as disorders of plasma fibrinogen synthesis (Flute, 1977) and diabetes 
(Lioupis, 2005). 
A sequence of overlapping events about the skin wound healing process has 
been described by some authors (Marks, 2003; Lippincott Williams & Wilkins, 2003; 
Martin, 1997). Hence the steps of skin wound healing can be enumerated as follows: 
1. Within seconds of tissue damage, release of serotonin, histamine and 
prostaglandins from the blood circulation enter the injured site. 
2. In the initial few minutes, the small blood vessels constrict and platelets plug 
the endothelial gaps. However. as the wounded skin previously caused leakage of blood 
from damaged blood vessels, the fonnation of a clot servcs as a temporary shield of the 
unprotected wound tissues and provides a provisional matrix for cell migration during 
the healing process. This clot is fonned by platelets embedded in a mesh of cross-linked 
fibrin fibres provided by thrombin cleavage of fibrinogen. The clot acts as a reservoir of 
cytokines and growth factors that are released as activated platelets degranulate. This 
start of wound closure provides chemotaxis for recruitment of circulating inflammatory 
cells to wound site, initiates the tissue movements of reepithelialization, connective 
tissue contraction and wound angiogenic response. The wound edges swell. Leukocytes 
from surrounding vessels move in and digest cellular debris and digest bacteria, 
gradually demolishing the clot. Redness, wannth. swelling. and pain may occur. 
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3. Adjacent healthy tissue supplies blood, fibroblasts, and other building 
materials such as proteins. These form a highly vascular tissue known as granulation 
tissue, which begins to bridge the wounded area. At this stage, in a non-infected site, 
inflammation may decrease. 
4. Fibroblasts in the granulation tissue secrete collagen which criss-crosses the 
area forming scar tissue. 
5. Meanwhile (after 18-24 hours), epithelial cell at the wound edge multiply and 
migrate toward the wound centre forming a new layer of surface cells. For this to 
happen the leading-edge keratinocytes have to dissolve the fibrin clot barrier and move 
through or along the interface between clot and healthy dermis. The major fibrinolytic 
enzyme is plasmin derived from plasminogen within the clot itself and can be activated 
either by tissue-type plasminogen activator (tPA) or urokinase-type plasminogen 
activator (uPA). Both of these PA's activators and receptors are upregulated in the 
migrating keratinocytes. In addition to this, various members of the matrix 
metalloproteinases (MMPs) family, can cleave an specific subset of matrix proteins and 
these are also upregulated by wound-edge keratinocytes. This may inclue MMP 1, 
MMP2 and MMP 1 0 which were detected by the high levels of proteolytic activity in 
chronic wound fluid. Keratinocytes that are' normally basally restricted appear 
suprabasally at the wound margin. This is important for cell and tissue strength during 
reepithelialization of the wound. After 2-4 days, new capillaries develop in the wound 
cavity. 
6. The lymphatic and blood vessels regenerate and the dermis is healed by tissue 
repaIr. Wound contraction occurs as a normal process of wound closure resulting in 
minimum scar. During granulation tissue formation migrating fibroblasts differentiate 
into myofibroblasts. These myofibroblasts are responsible for force generation and 
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produce tissue contraction. The scar diminishes in size with the return of normal tissue 
function. 
7. Between day 4 and 10 the wound cavity has become covered with new 
epidermis and the granulation tissue is replaced by a new dermis. In the later stages, 
remodelling leads the orientation of the dermal collagenous bundles to the original lines 
of stress. The epidermis ultimately develops a normal profile and the dermis' 
vasculature is also restored to normal contractility. Scar formation occurs when there 
has been significant damage to the dermis. See Figure 1.7 for an illustration of skin 
wound healing at a glace. 
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Figure 1.7. Skin wound healing at a glance. (1) Immediately serotonin, histamine and 
prostaglandins are released to initiate an inflammatory reaction. (2) Fibrin clotting binds 
the wound edges. Extravasation of leukocytes and plasma from dilated blood vessels. This 
is followed by oedema, redness, warmth and pain. Neutrophils and monocytes are 
attracted to wound site by inflammatory mediators, such as growth factors and peptides 
cleaved from bacterial proteins and the by-products of proteolysis of fibrin and other 
matrix components. Neutrophils are the first type of leukocytes to be attracted into the 
wound. The activity of neutrophils essentially cleanses the wound bed of bacteria and 
cellular debris and are also a source of pro-inflammatory cytokines (e.g. TNF-a, IL-Ia and 
-fJ). The activated macrophages produce a variety of cytokines that regulate tissue repair 
(e.g. platelet-derived growth factor (pDGF) and fibroblasts growth factor (FGF». (3) 
Adjacent healthy tissue supplies blood, fibroblasts and proteins forming the granulation 
tissue. This begins to bridge the wounded area. (4) Epithelial cells at the wound edge 
multiply and migrate toward the wound centre over the new reconstructed dermis and a 
scar tissue is formed. 
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1.8. ANTI-INFLAMMATORIES 
Anti-inflammatories are substances which. have properties to reduce or eliminate 
inflammation and pain as these medications may also contain analgesics. There are two 
forms of anti-inflammatories: the Steroidal Anti-Inflammatory Drugs (SAIDs) and the 
Non-Steroidal Anti-inflammatory Drugs (NSAIDs). Both anti-inflammatory drugs act 
against inflammation, however their mechanisms of action and effects are different. 
The Steroidal Anti-inflammatory Drugs are specifically glucocorticoids, and can 
reduce inflammation by binding to cortisol receptors. These drugs are often referred to 
as corticosteroids. Glucocorticoids influence all types of inflammatory events by 
inducing lipocortin-l synthesis, which then binds to cell membranes preventing 
phospholipase A2 from coming into contact with its substrate arachidonic acid. This 
leads to diminished eicosanoid production. Therefore, the two main products in 
inflammation (prostaglandins and leukotrienes) are inhibited and therefore 
cyclooxygenase expression (both COX-I and COX-2) is also suppressed. Lipocortins 
escaping into the extracellular space bind to leukocyte membrane receptors and inhibit 
various inflammatory events such as epithelial adhesion, emigration chemotaxis and 
phagocytosis, including the inhibition of the release of various inflammatory mediators 
like lysosomal enzymes, cytokines and chemokines from neutrophils, macrophages and 
mastocytes. Hence, anti-inflammatory steroids suppress all elements of the immune 
response. 
NSAIDs include among others, aspirin and ibuprofen. Aspirin or acetylsalicylic 
acid (acetosal) is a drug in the family of salicylates, often used as an analgesic, 
antipyretic and anti-inflammatory. It is also recognised for its anticoagulant effects and 
has been used in long-term low doses to prevent heart- attack and stroke (Miner and 
Hofthines, 2007). 
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Once NSAIDs inhibit cyclooxygenase, prostaglandin production is limited and 
biosynthesis of COX-l and COX-2 is reduced. COX-l is constitutively produced at 
basal levels in most tissues and plays a central role in platelet aggregation and gastric 
cytoprotection. COX-2 is expressed constitutively in the human kidney and brain and its 
expression is induced in many tissues during inflammation, wound healing and 
neoplasia (Thun et ai., 2002; de Souza Pereira, 2009). 
Ibuprofen is a NSAID widely known under various trademarks including Act-3, 
Advil, Brufen, Motrin, Nuprin and Nurofen. It is used for relief of symptoms of arthritis, 
primary dysmenorrhoea, fever, and as an analgesic, especially where there is an 
inflammatory component. Its mechanism of action is also through inhibition of COX-I 
and COX-2 expression, inhibiting prostaglandin synthesis. Its analgesic, antipyretic and 
anti-inflammatory activities are achieved principally through COX-2 inhibition whereas 
COX-I inhibition is responsible for its acting in platelet anti-aggregation and inducing 
gastro-intestinal mucosa ulcers (Andersohn et al., 2006; Layton et al., 2008). 
The first generation of NSAIDs such as aspirin, can cause life-threatening 
stomach ulcers. More selective NSAIDs for example COX-2 inhibitors, which are 
designed to avoid side effects such as stomach ulcers, have unfortunately been 
associated with an elevated risk of AMI (Acute Myocardial Infarction) (Andersohn et 
al., 2006; Brophy et at., 2007; Greenberg et ai., 2009). However, there is also evidence 
to suggest that a regular intake of NSAIDs that non-selectively block COX-2 protects 
against the development of many types of cancer (Thun et al., 2002; Greenhough et ai., 
2009). 
In order to discuss melanoma and the skin's essential defence mechanisms it is 
important to discuss inflammation and its role in cancer. 
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1.9. JNFLAMMA TION AND CANCER 
The inflammation-cancer connection IS especially intriguing as in some 
circumstances the immune system, which sustains inflammation, should inhibit tumour 
development. However, many studies (Balkwill and Mantovani, 2001; COllssens and 
Werb, 2002; Balkwill, 2004; Balkwill et al., 2005; Kulbe et al., 2004; Marx, 2004; 
Karin, 2005; Mantovani, 2005; Rollins, 2006, Hussain and Harris, 2007; Wang and Du 
Bois, 2008; Porta et al., 2009) have shown that inflammation can also playa key role in 
exacerbating cancer development. 
While many researchers have paid attention to observing the role of various 
genetic mutations in cell DNA in promoting abnormal cell growth that may lead to 
malignant cell clones, recently research workers are exploring the concept that both 
mutation and inflammation are major processes that if unchecked and untreated may 
lead to potentially malignant tumours with a poor prognosis. 
Melanoma may be caused (among others) by excess of UV radiation exposure 
which suppresses the immune response in skin and it is believed that it might also be 
caused in part by uncontrolled inflammation of the skin. There is increasing evidence 
that strongly supports the link between inflammation, infection, and many types of 
cancer. Chronic inflammation has been associated with cancer of the lung, colon, 
pancreatic and bladder tumours (Shacter and Weitzman, 2002) whereas infections such 
as hepatitis Band C are associated with an increased risk for primary liver cancer (Perz 
et al., 2006). Also, chronic infection with the ulcer---causing microorganism Helicobater 
pylori is the world's leading cause of stomach cancer (Ernst and Gold, 2000). 
Hence, some types of cancer arise from tissues that have been irritated, infected, 
inflamed and wounded. During inflammation, cancer cells can produce chemokines to 
attract nutrients and other support structures to facilitate their survival. Some of these 
chemokines recruit neutrophils to a tumour. These in tum may facilitate cancer cells 
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travelling through blood vessels. It is therefore believed that cancer cells may take 
advantage of the expression of the adhesion molecules that help neutrophils to adhere to 
the blood vessel walls during extravasation and also use the same transport system from 
the vessels to the tissue. Infiltration of cancer cells may also occur during wound 
healing. Normal skin cells such as fibroblasts produce tissue remodelling substances 
and, neutrophils, macrophages, monocytes and lymphocytes produce growth factors 
which stimulate blood vessel growth. This allows normal tissue development that can 
also be utilized by tumour cells facilitating their survival and proliferation, promoting 
tumour development. 
The metastatic sequence involves the detachment of cells within a pnmary 
tumour, local migration and invasion through the local tissue, intravasation and transit 
in the blood and lymphatic vessels, extravasation from vessels, formation of small sites 
of metastasis, local migration, attachment and eventually proliferation (Chambers et al., 
2002). 
It is believed that in human tissues an inflammation-induced protein called NF-
kB (Nuclear Transcription Factor-kappaB) may playa key role in cancer development 
(Barnes et al., 1997). It is an intermediary in promoting cellular changes leading to the 
uncontrolled growth of cancer cells and also, to later changes that help metastatic cells 
escape from the original tumour and spread to new sites in the body. Also, NF-kB 
activity leads to inhibition of the programmed cell death (apoptosis) that can eliminate 
defective cells, thus contributing both to cancer development and resistance to drug and 
radiation therapies (Bradley, 2008). 
1.10. Anti-inflammatories and Cancer 
A review study has indicated that NSAIDs particularly the highly selective COX 
inhibitors, show promise as anticancer drugs (Harris et aI., 2005; Kast, 2007). Chronic 
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intake of NSAIDs may reduce carcinogenesis by inhibiting production of prostaglandins. 
cytokines, and angiogenic factors. NSAIDs may act by reducing the production of 
selected inflammatory factors. 
Another review study showed a significant decline in cancer risk with increasing 
intake of NSAIDs (primarily aspirin and ibuprofen) for at least four major types of 
cancer: breast, prostate, colon and lung (Harris et at., 2007). Preclinical investigations 
provide consistent evidence that both selective and non-selective NSAIDs effectively 
inhibit chemically-induced carcinogenesis of epithelial tumours (Harris et at., 2005). 
A third component that has been recognised as a NSAID is capsaicin (Dasgupta 
et al., 1998; Patel et at., 2002a; Patel et al., 2002b). Capsaicin (or 8-methyl N-vanillyl 
6-nonamide), is a chemical component mostly found in chilli peppers and is recognised 
for its ability to produce the burning hot sensation of chilli-laced spicy foods. Capsaicin 
has been part of the human diet and used as a medication for htmdreds of years. An old 
popular belief stated that high and continuous intake of capsaicin has a prejudicial effect 
in the stomach. In addition to this, a report states that dietary capsaicin is a suspected 
carcinogen (Verschoyle et at., 2007). However a review study revealed that capsaicin is 
not the cause of ulcer formation as it does not stimulate, but actually inhibits acid 
secretion. In fact it stimulates alkali, mucus secretions and gastric mucosal blood flow 
which all help in the prevention and healing of ulcers (Satyanarayana, 2006). 
Initial reports of using capsaicin as an anti-inflammatory/anti-cancer medication 
came from Dasgupta et al. (1998) as a treatment for human bladder cancer. In their 
study, 20 patients had repeated instillations of intravesical capsaicin (1-2 mmolll). 
Cystoscopy and bladder biopsies were performed before and after capsaicin for 
surveillance. No further pre-malignant or malignant changes were found in the biopsies 
of the patients who had repeated capsaicin instillations for up to 5 years. However, as 
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the morphological effects of chemical carcinogens may not be apparent for 10 years, it 
was suggested that further surveillance was necessary and is being continued. 
Morn.~ et al. (1996) reported that NADH (nicotinamide adenine dinucleotide) 
oxidase activity was inhibited preferentially in the A375 melanoma cells but not in the 
primary melanocytes by capsaicin. These authors suggested that this inhibition of cell 
surface NADH oxidase activity may be correlated to the inhibition of growth and 
capsaicin-induced apoptosis. 
MornS et al. (1997) reported that capsaicin-inhibited NADH oxidase activity was 
found in sera over a broad spectrum of cancer patients including patients with solid 
cancers (e.g. breast, prostate, lung, ovarium), leukemias and lymphomas. 
Brar et at. (2001) reported that catalase, N-acetylcysteine, ebselen, dicumarol 
and capsaicin also inhibited growth of melanoma and other malignant cell lines. These 
results raise the possibility that ROS (Reactive Oxygen Species) produced 
endogenously by mechanisms involving the NAD(P)H:quinone oxidoreductase (NQO) 
can constitutively activate NF-kappaB in an autocrine way. Hence suggestions may 
come up for new antioxidant strategies for interruption of oxidant signalling of 
melanoma cell growth. See Figure 1.8 for further explanation about TNF-a induced 
ROS activation. 
Patel et at. (2002a) reported that down regulation of constitutive and induced 
NF-kB activation leads to inhibition of IL-8 expression in malignant melanoma cells. In 
the same year, Patel et al. (2002b) suggested. that inhibition of NF-kB activation 
impedes cellular growth and proliferative signals in human melanoma cells. Further 
results from these authors were that the NF -kB activation may trigger stress-signalling 
pathways causing enhanced HIF-a (Hypoxia Inducible Factor-alpha) expression and it's 
binding to HRE (Hypoxia Response Element). Hence this leads to an enhanced VEGF 
(Vascular Endothelial Cell Growth) production by the remaining melanoma cells. 
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Figure 1.8. Inflammation at the molecular level: TNF -a induced ROS and NF-kB 
activation. (1) TNF -a entrance to the cell and inducing of ROS; (2) Increase of ROS in 
mitochondria; (3) Translocation of nuclear transcription factor NK-kB from cytoplasm to 
nucleus, activation of p65 gene. TNF -a protein synthesis and migration to cell periphery; 
(4) Extrusion of TNF-a receptors on cell surface, induces its own production by cell 
activation in an autocrine and paracrine fashion. This leads to enhanced ICAM-l and 
integrin expression. As a result, increased cell surface adhesion and infiltration of cells is 
facilitated. 
A China-Japan research group (Gong et al., 2005) studied the mechanisms of 
capsaicin-induced apoptosis of human melanoma A375-S2 cells in a time- and dose-
dependent manner. They found that capsaicin induces A375-S2 cell apoptosis and that 
down-regulation of ICAD (Inhibitor of Caspase Activated DNases) contributes to this 
process. 
Mori et al. (1996) reported that capsalcm inhibited NF-kB activation by 
preventing its nuclear migration. They suggested that given the clinical tolerability of 
capsaicin a clinical trial of this agent seems appropriate in selected individuals with 
prostate cancer. 
Capsaicin combined with genistein demonstrated to have an anti-inflammatory 
and anticarcinogenic properties (Hwang et ai., 2009), to act as non-steroidal anti-
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inflammatory drug (M6zsik et aI., 2009) and to inhibit platelet aggregation and 
thromboxane biosynthesis (Raghavendra and Naidu, 2009). 
As capsaicin is considered a natu~al dietary anti-inflammatory and 
chemopreventive agent, its effects on cancer prevention and treatment seems to be a 
promising area for people at risk and, for those needing treatment, and deserves further 
study. 
1.11. APOPTOSIS 
In this study, after observing the effects of NSAIDs on melanoma cell migration 
and viability, the effects of NSAIDs on melanoma cell viability was further investigated 
using apoptosis assays. 
Apoptosis means "programmed cell death". It is an essential process that allows 
embryonic development (e.g. finger separation during foetal development) and 
physiological maintenance in multicellular organisms. Apoptosis enables the body to 
regulate homeostasis by eliminating dysfunctional and unwanted cells thus avoiding 
diseases or infection. Apoptosis can be induced by the tumour suppressor protein p53 
which is a major senescence and cell death inducing transcription factor (Moll et al., 
2005; Speidel, 2009). p53 has also an additional extra cellular effect on cell-cycle 
arresting (Galluzi et al., 2008). 
Apoptosis differs from necrOSIS. Apoptosis affects individual cells within a 
multicellular tissue or organ which are phagocyted by macrophages and other 
phagocyte-like cells. It is stimulated by physiological inductions, such as lack or excess 
of signals (e.g. lack of growth factors or excess of ultraviolet light), and very 
importantly, it does not trigger an inflammatory response. Morphological changes in 
apoptotic cells are recognised by cell shrinkage and eventual whole cell fragmentation 
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without the release of cellular contents into the tissue vicinity. On the other hand, 
necrosis is caused by chemical and physical agents such as toxins, lack of oxygen, 
radiation and trauma. Morphological changes in necrotic cells are swelling and the 
appearance of holes in the plasma membrane. Once homeostasis is lost, plasma 
membrane and intracellular contents are released into the surrounding 
microenvironment. Necrosis affects partial or regional tissue or cell groups in which 
phagocytosis of macrophages occurs and an unavoidable inflammatory response takes 
place. Inflammation and necrosis may tum into an expanded process affecting the 
surrounding tissue area and resulting in a poor prognosis if not treated. 
Basically, apoptosis involves activation of many cellular agents that lead to 
morphological and biochemical changes in the cell. The entire apoptosis process is not 
understood yet. Apoptosis is induced by stimulation of cell membrane surface receptors 
and/or activation of the mitochondrial apoptotic pathway, leading to changes in the 
cytoplasm and nuclear changes and ultimately, whole cell fragmentation. 
1. t 1. t. Apoptosis pathways - The participation of the caspases cascade. 
Apoptosis initiates as the signal molecules (ligands) released by other cells bind 
to specific transmembrane receptors. The accumulation of these receptors on the cell 
membrane recruits proteins in the cell cytoplasm which then activate the caspase 
cascade. Caspases are cysteine-dependent, aspartate-specific proteases, existing in the 
cell cytoplasm in an inactivated form of pro-caspases. Once caspases are activated the 
process reaches an irreversible apoptotic pathway. 
The first mammalian or human caspase (caspasc-l or ICE - Inlerleukin 
Converting Enzyme) was identified as an important regulator of the inflammatory 
process (Yu and Finlay, 2008). Caspases can be divided into two different groups: the 
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initiator caspases, including caspase-2, -8, -9 and -10 and, the effector caspases which 
include caspase-3, -6, and -7 (Riedl and Shi, 2004). 
Mediation of apoptosis can be divided into two pathways: (I) by stimulation of 
transmembrane receptors or via receptor-mediated or extrinsic pathways (such as Fas 
receptors by Fas ligand or TNF-a mediated) in the plasma membrane (Csipo et al., 
1998). The cell receptor-mediated pathway activates the initiator caspase-8; and, (2) by 
the release of mitochondrial factors or, via a mitochondrial or intrinsic pathway which 
occurs in the cell mitochondria (Riedl and Shi, 2004). 
The apoptosis mitochondrial pathway is associated with the pro-apoptotic Bcl-2 
family of proteins and this stimulates the release of cytochrome c and other proteins 
which activates the initiator caspase-9. The initiator caspase-9, cytochrome c and ATP 
(Adenosine Triphosphate) collaborate to form apoptosome, which in tum activates the 
effector caspase-3 and, cell degradation and DNA fragmentation begins. Cell fragments 
are engulfed by macrophages and a neat and organised clean up occurs within the 
surrounding tissue. 
It is worth noting that the intrinsic and extrinsic pathways are activated through 
the caspase-8-mediated cleavage of BID, a BH3-only member of the Bcl-2 family of 
proteins, which eventually activate caspase-3 and initiates the release of mitochondrial 
proteins. This ends up in cell degradation and fragmentation, making this system very 
efficient. 
In the cell cytoplasm, the outer mem~rane of the mitochondria becomes 
permeable and proteins such as cytochrome c, Smac/DIABLO (second mitochondria-
derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI), 
and Apoptosis-inducing Factor (AIF), located in the intermembrane space are released 
into the cytoplasm (Riedl and Shi, 2004). The release of cytochrome c is followed by 
the loss of the mitochondrial transmembrane potential which results in the release of 
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Ca2+ and the disruption of electron transport. The mitochondrial outer membrane 
permeabilization is regulated by proteins, specially the Bcl-2 family members of 
proteins Bax and Bak. It is believed that the so-called pro-apoptotic members of Bcl-2 
proteins Bax and Bak support mitochondrial oute~ membrane permeabilization resulting 
in the activation of caspase 9, marking the end of this phase. 
Alterations in the cell nucleus occur as DNA is cleaved into large fragments. 
This is followed by further cleavage into small nucleosomal units. The DNA 
fragmentation is a response of caspase-activated DNase (CAD). Normally in the cell, 
CAD is kept inactivate by a complex of inhibitor of CAD (lCAD). If an apoptotic signal 
is received, such as from caspase-3, ICAD is cleaved and CAD is released to fragment 
DNA. 
1.12. APOPTOSIS AND CANCER 
The study of apoptosis has gained much attention in health management as 
apoptosis has been shown to be closely related to several diseases such as autoimmune 
diseases, AIDS and cancer (Fischer and Schulze-Osthoff, 2008). In cancer, the build up 
of mutations within cells means that these cells lose their ability to follow normal 
apoptotic pathways and hence transform into immortal cells. 
Alterations in the mitochondrial pathway are often a common cause in the first 
steps to cancer development. This is because mitochondrial stress is easily caused by 
DNA damage and heat shock. Mutation of the p53 protein is a common cause of tumour 
genesis as it regulates DNA repair, senescence and cell life-cycle (Guida et at., 2008). 
In a recent study (Freedberg et al., 2008) identification ofp14ARF as the 9p21 gene was 
the most commonly inactivated in melanoma than p 16. The role of p 16 inactivation in 
melanoma is well known whereas p53 mutation IS well established in the development 
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of many types of cancer (Rodolto et aI., 2005). However the contribution of p53 m 
melanoma development needs to be elucidated. 
Apoptosis is regulated by the Bel-2 family of proteins, which modulate outer 
mitochondrial membrane permeability. This family of proteins is categorised as anti-
apoptotic members (such as Bel-2, Bel-xL and, Mel-I) as well as pro-apoptotic 
members, which consist of multi domain proteins (such as Bax, Bak, Bid, Bim, and Bik) 
(Tsujimoto, 2003). 
As a prototypic member of this family, Bel-2 can contribute to neoplastic cell 
expansion by preventing normal cell turnover caused by physiological cell death 
mechanisms. High levels of Bel-2 gene expression are found in a wide variety of human 
cancers (Reed, 1999). In addition, Bel-2 is implicated in chemoresistance as over-
expression of Bcl-2 can inhibit the killing effect of many current anticancer drugs by 
blocking the apoptotic pathway (Bettaieb et aI., 2003; Fernandez-Luna, 2008; Marzo 
and Naval, 2008). 
Therefore, the inhibition of over-expressed Bel-2 protein in tumour cells could 
be used as a strategy for either restoring the normal apoptotic process or making tumour 
cells more susceptible for conventional chemotherapy. 
It has been demonstrated that HA 14-1 (2-Amino-6-bromo-a-cyano-3-
(ethoxycarbonyl)-4H-l-benzopyran-4-acetic acid ethyl ester) can bind to Bel-2 protein 
and induce apoptosis of tumour cells (Wang et ai., 2000). Thus this supports a role for 
Bcl-2 over-expression being linked to tumour development, inhibition of apoptosis and, 
being associated with chemotherapy resistance. 
It has also been suggested by some authors that HA 14-1 may represent a 
promising candidate for treatment of drug resistant cancer either as a mono therapy on in 
combination with current cancer therapies (Tian et aI., 2007). 
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In summary all of this research suggests that regulation of apoptosis may be a 
central part in tumour development. 
1.13. BACKGROUND OF THIS WORK 
The current research is based on a growing literature associating inflammation 
'-
with cancer progression and in the case of melanoma, the phenomenon of "local 
recurrence" . 
With respect to inflammation and melanoma, recent studies from the MacNeil 
group have shown that TNF -alpha increases melanoma cell invasion and migration in 
vitro (Katerinaki et aI., 2003) and that anti-inflammatory agents such as a-MSH (alpha-
Melanocyte Stimulating Hormone) can reduce melanoma cell invasion and protect cells 
against proinflammatory cytokine attack in cells with the wild-type receptor (HBL) 
(Eves et aI., 2003). Interestingly, a-MSH has been shown to act as a "protector" of 
melanoma cells from pro inflammatory cytokine action, but also to have anti-invasive 
abilities which are consistent with a-MSH working in an anti-inflammatory capacity 
(Zhu et aI., 2002). 
Another study (Canton et aI., 2003), reported that TNF-a significantly increased 
the invasiveness of uveal melanoma cell lines in the aqueous humor, while a-MSH 
reduced the invasion of cells through human fibronectin by 45-50% and also protected 
uveal melanoma cells from the pro-invasive actions of TNF-a. These data are consistent 
with the hypothesis that inflammation is playing a major role in affecting the metastatic 
ability of uveal melanomas. 
Recent results from this group have shown that sodium salicylate can effectively 
inhibit TNF-alpha-induced uprcgulation of NF-kappaB and ICAM-I expression during 
in vitro migration and invasion of human melanoma cells. This indicates that non-
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steroidal anti-inflammatory drugs may be a useful therapeutic approach to oppose 
inflammation-induced melanoma invasion and metastasis (Katerinaki et af., 2006). 
With respect to local recurrence of melanoma this is a phenomenon in which 
melanoma cells invade an inflamed wound created after surgical excision of a primary 
melanoma. 
There are many interactions that may influence cancer cell progression within 
their environment and influence their survival and metastases. Therefore, to be able to 
study melanoma cell migration through a structure that resembles as much as possible 
an in vivo physiological microenvironment, a 3-D model of reconstructed human skin 
was used. 
This model was also wounded and inflammation induced to represent some of 
the conditions which occurs following melanoma excision. In this model, normal skin 
cells are added to de-epidennised dermis (skin without the original epidermal layer), 
which retains a residual BM. Melanoma cell lines can then bc added into the 
reconstructed human skin and melanoma cell migration and invasion occurs during the 
incubation period. The disadvantages of this methodology are the difficulty of tracking 
cell movements with time requiring the sacrifice of many samples of the reconstructed 
human skin for histology. 
Tissue engineered skin was discovered by the classic experiments of Rheinwald 
and Green in 1977 (Rheinwald and Green, 1977; Price et af., 2008). Reconstructed 
human skin as a 3-D model was established by Chakrabarty et al. (1999). This study 
demonstrated a successful method for sterilization of human dennis, achieving an 
acellular dermis and retention of collagen IV, allowing clinical usc as dermal 
replacement material and also for production of dermal-epidermal composites in ill \'itro 
studies. A further study showed that the reconstructed skin model could be used to 
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investigate interactions between melanoma cell lines and normal fibroblasts and 
keratinocytes, as well as the components of the basement membrane (Eves et aI., 2000). 
TNF-a is a primary mediator of the inflammatory response and has been 
ascribed a wide range of biologic activities. TNF-a regulates gene expression in 
epidermal keratinocytes and acts as a key component in organizing a response to skin 
injury. Hence it is involved in regulating a wide scope of biological processes ranging 
from immune responses to cell migration, epidermal differentiation and tissue repair 
(Banno et aI., 2004; Artuc et aI., 2006). 
Experimental studies are consistent in terms of the tumour promoter effect of 
TNF- a (Pikarsky et aI., 2004). Some workers have demonstrated that TNF-a is a 
cytokine that has been associated with tumour progression (Szlosarek et aI., 2006). 
Others have suggested further exploration of TNF blockade as an adjunct to cancer 
therapies (Monk et al., 2006). 
1.13.1. Aims and Objectives 
The aim of this work was to investigate the role of inflammation in melanoma 
invasion using a 3D model of tissue engineered skin and to study the role of NSAIDs in 
these models. The justification for this work is based on the serious nature of melanoma 
as a cancer which is particularly difficult to treat with a low survival rate upon late 
diagnosis. There are many studies re-enforcing the relationship between inflammation 
and cancer. 
Our hypothesis is that NSAIDs may be an important approach to blocking or 
reducing the negative effects of inflammation on melanoma cell migration, invasion and 
survival. 
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The Specific objectives were: 
1. To study the effects of inflammation on melanoma cell migration. This was 
achieved using a two-dimensional (scratch wound) model using three different 
melanoma cell lines. The effects of NSAIDs (ibuprofen released from a hydrogel and 
capsaicin) were studied on melanoma cell migration, opposing to the pro-inflammatory 
cytokine TNF -u. 
2. To develop a 3D model of a fibrin clot to observe melanoma cell invasion. 
3. To investigate melanoma cell invasion and the effects of NSAIDs in a 3D 
model of reconstructed human skin. 
4. To develop and establish a skin wound model using a tissue engineered 
hUlnan skin model in which to study the effects of wounding and inflammation on 
melanoma invasion. 
5. To examine the effect ofTNF-u on melanoma cell NF-kB transcription factor 
activation. 
6. To investigate the effect of two combined drugs (one NSAID, capsaicin and, a 
pro-apoptotic agent, HA 14-1) on melanoma cell survival by assessing cell viability, and 
cell apoptosis assessed using Annexin V and DNA damage assays. 
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CHAPTER 2 
MATERIALS AND METHODS 
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2.1. MATERIALS 
Cell culture media, antibiotics and additives were purchased from Gibco BRL 
(Life Technologies, Paisley, UK) and Sigma Aldrich Ltd (Poole, UK). Foetal calf serum 
(FCS) was purchased from GlobePharrn Limited (Esher, UK); newborn calf serum 
(NBCS) was obtained from Sigma-Aldrich Ltd (Poole, UK); trypsinlethylenediamine-
tetraacetic acid (EDT A) and phosphate-buffered saline (PBS) tablets were purchased 
from Oxoid Ltd (Basingstoke, UK). MTT [3-( 4,5-dimethylthiazol-2-yl)-
2,5diphenyltetrazoliUlTI bromide] for viability test; TNF-a, (Tumour Necrosis Factor-
alpha), Sodium Ibuprofen (NaIbu) and Capsaidn as NSAID were purchased from 
Sigma Aldrich Ltd (Poole, UK). Pluronic F-127 polymer was also purchased from 
Sigma Aldrich Ltd (Poole, UK). Fibrinogen and thrombin (from bovine plasma) were 
purchased from Sigma-Aldrich Ltd. For protein assay, BCAT\1 Protein Assay Reagent A 
and BCA™ Protein Assay Reagent B were purchased from Pierce US. HA14-1 was 
purchased from TocrisTM. Twelve well culture plates were purchased from Costar 
Corning Incorporated; and inserts (ThinCert), pore diameter 8.0 11m, were purchased 
from Greiner Bio-One, UK. Six and twenty-four culture well plates were purchased 
from Costar Coming Incorporated. 
For NF-kB activation in melanoma cells by immunolabelling for the intracellular 
position of the p65 gene, the following materials were used: TNF -a was purchased from 
Sigma Aldrich™; 10% (w/v) paraformaldehyde purchased from BDH/Merck, Poole, 
Dorset, UK in phosphate-buffered saline (PBS); unreacted binding sites were blocked 
with 50/0 (w/v) dried milk powder (in PBS). Primary anti-NF-kB/p65 (C-20) goat 
polyclonal IgG antibody sc-l09 was purchased from Santa Cruz Biotechnology, 
California, and secondary biotinylated anti-goat IgG antibody BA-5000 from Vector 
Laboratories Inc., California. Fluorescein streptavidin SA-500 1 was purchased from 
Vector and DAPI (4' ,6-diamino-2phenylindole) from Sigma-Aldrichn1 . 
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For DNA Damage Assay (fluorescent), the kit containing reagents were 
purchased from Active Motif Europe, Belgium. 
For cell viability and apoptosis assay a Guava Nexin ™ Kit was purchased from 
Guava Technologies Inc. USA. Camptothecin was purchased from Sigma Aldrich TM. 
Anticollagen IV antibody, rabbit-derived S-100 antibody: mouse-derived 
HMB45 antibody; and, mouse anti-cytokeratin AEIAE3 antibody were purchased from 
Dako (Carpintera, CA, U.S.A.). All other chemicals were of analytical grade. 
2.2. CULTURE OF MELANOMA CELLS 
2.2.1. Culture of C8161 melanoma cells 
The human C8161 melanoma line was established from an abdominal wall 
metastasis from a menopausal woman with recurrent melanoma (kindly donated by 
Professor F. Meyskens, University of California, Irvine, USA, via Professor M. 
Edwards University of Glasgow, UK). Cells were cultured in Eagle's modified essential 
medium (EMEM) containing 4.5 giL glucose, supplemented with 10% (v/v) FCS, 2mM 
L-Glutamine, 100 units/ml penicillin, and 100/-lg/ml streptomycin sulphate, 1.2 mg/ml 
amphotericin B, 1.5% (v/v) (of 100x stock solution) vitamin concentrate, 1 mM sodium 
pyruvate, 1 %} (v/v) non essential amino acids (NEA) and 0.187% (w/v) sodium 
hydrogen carbonate (Sigma-Aldrich, Poole, UK). Cells were incubated at 37°C in a 
humidified 5% carbon dioxide/95% air environment under standard conditions. Cells 
were passaged when 80-90% confluent using 0.02% (w/v) EDT A for five to ten 
minutes, and pelleted at 300g for experiments and for expanding the cell stock. Cells 
were used between passages 10 - 60 for experimentation. 
2.2.2. Culture of A375SM melanoma cells 
The melanoma cell line A375-SM was a generous gift from Professor IJ Fidler 
(USA) via Professor MJ Humphries (University of Manchester, UK). The A375 
melanoma cell line was established in culture from a lymph node metastasis. These cells 
are heterogeneous in nature and a highly metastatic variant (A375-SM) was established 
in culture from lung metastases produced by parental A375 cells growing 
subcutaneously in nude mice (Kozlowski et aI., 1984). C8161 and A375SM melanoma 
cells were cultured in Eagle's modified essential medium (EMEM) containing 4.5 giL 
glucose, supplemented with 10% FCS, 2mM L-Glutamine, 100 unitslml penicillin, and 
100J-lg/ml streptomycin sulphate, 1.2 mglml amphotericin B, 1.5% (of 100x stock 
solution) vitamin concentrate, 1mM sodium pyruvate, 1 % non-essential amino acids 
(NEA) and 0.187% sodium hydrogen carbonate, all purchased from Sigma-Aldrich Ltd 
(Poole, UK). Cells were incubated at 37°C in a humidified 5% carbon dioxide/95% air 
environment under standard conditions. Cells were passaged when 80-90% confluent 
using 0.02% (w/v) EDT A for five to ten minutes, and pelleted at 300g for experiments 
and expanding stock. Cells were used between passages 30-60 for experimentation. 
When C8161 and A375SM melanoma cells were passaged prior to being added to the 
wells they were resuspended in EMEM. 
2.2.3. Culture of HBL Melanoma Cells 
The human cutaneous melanoma cell line HBL was originally established and 
described by Professor Ghanem Ghanem (Laboratory of Oncology and Experimental 
Surgery, Free University of Brussels, Belgium) from a lymph node metastasis of a 
nodular melanoma (Ghanem et aI., 1988). Cells were cultured in Ham's FlO medium 
(Gibco: Paisley, Scotland) containing 1 giL glucose, supplemented with 5% (v/v) fetal 
calf serum (FCS). 5% (v/v) newborn calf serum (NBCS; Advanced Protein Products, 
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UK). 2mM L-Glutamine, 100 units/ml penicillin. 100/1g/ml Streptomycin, 250/1g/ml 
amphotericin. Cells were cultured in T75 vented flasks at 37°C in a humidified 
atmosphere of 5% CO2/95°/0 air. Cells were passaged when 80-90% confluent using 
0.02% (w/v) EDT A for five to ten minutes, and pelleted at 300g for experiments and 
expanding stock. Cells were used between passages 17 and 50. 
2.3. PREPARATION OF SOLUTIONS 
2.3.1. TNF-u Solution Preparation 
TNF-a solution was prepared from a 10/11 stock containing 10.000 U/ml. TNF-a 
was dissolved in media to make concentrations as desired. 
2.3.2. Pluronic Hydrogel Characteristics 
Pluronic F -127 is a triblock copolymer consisting of polyethylene glycol (PEG) 
and polypropylene glycol (PPG) arranged as [PEG]n-[PPG]m-[PEG]n where nand m 
are the number of monomer units in the PEG and PPG blocks, respectively. Pluronic 
solutions undergo a reversible transition on warming from a liquid solution to a clear, 
transparent, soft gel on heating. This transition is reversible. Gel temperature decreases 
with increasing polymer content, and, for a 30% Pluronic gel, this occurs around 13°C. 
Below the transition temperature the gel reverts to a liquid which can be readily 
pipetted. 
2.3.3. Ibuprofen Sodium Salt (NaIbu) Hydrogel Preparation 
Nalbu (in powder) was weighed and dissolved in sterile PBS to give a desired 
concentration, then passed through a 0.20 /1111 pore filter (non-pyrogenic sterile - R). 
Hydrogels were prepared using 30% (wi\') Pluronic F-127 polymer dissolyed in PBS. 
56 
Dissolution of the polymer was achieved by holding for approximately one week at 
approximately 5°C. On subsequent warming to room temperature, the liquid sol 
transformed to a soft gel. The gel was sterilised in an autoclave. The hydrogel was then 
cooled down to -20o e which enabled the incorporation of NaIbu solutions at a ratio of 
870/0 volume hydrogel to 13% volume Nalbu to achieve final concentrations of 33x 1 0-6, 
66xl0-6, 99xl0-6, 131 xl0-6 M Nalbu hydrogel (which correspond to Nalbu 
concentrations of 0.05%, 0.10%, 0.15% and 0.20%). 13% volume of PBS only added to 
the hydrogel gave a concentration of 0% at unloaded gel. 
2.3.4. Release of Ibuprofen Sodium Salt from F127 Hydrogel 
The release profile of the drug from the gel loaded with 131 x 1 0-6M ibuprofen 
sodium salt was obtained by assessing the amount of drug released from gels held in 
PET cell co-culture baskets with porous PET membranes in 12 well plates. 300/l1 
aliquots of gel cooled below the gel point were pipetted into the baskets. The baskets 
were suspended in 12 well plates in an incubator at 37°e, at which temperature gelation 
occurred. Iml of distilled water was placed in each well on the outside of the basket. At 
times of 2 4 6 8 and 24 hours baskets were removed. Three wells were used for each , , , , 
time point. The content of sodium ibuprofen which had been released from the gel into 
the distilled water was then determined from the characteristic ibuprofen UV 
absorbance at 264nm using a UV spectrometer. 
2.3.5. Capsaicin (8-Methyl-N-vanillyl-trans-6-nonenamide) Solution Preparation 
Capsaicin is an active ingredient in chilli peppers and it gives a pungent flavour 
to food. Capsaicin is used medically to deal with pain (Tesfaye, 2009). A stock solution 
of capsaicin (in powder) 0.328 M was made by dissolving 50 mg in 0.5 ml of ethanol. 
57 
Different concentrations of capsaicin were obtained by adding the stock solution into 
cell culture medium to give the desired concentrations in IlM. 
2.3.6. HA14-1 (2-Amino-6-bromo-a-cyano-3-( ethoxycarbonyl)-4H-l-benzopyran-4-
acetic acid ethyl ester) solution preparation 
HA 14-1 is a small molecular compound which interacts with Bcl-2 protein and 
inhibits the anti-apoptotic effect of Bc1-2. A stock solution of HA14-1 (in powder) 
0.024436 M was made by dissolving 10 mg in 1 ml of ethanol. Different concentrations 
of HA 14-1 were obtained by adding the stock solution into cell culture medium to give 
the desired concentrations in IlM. 
2.4. ASSAYS 
2.4.1. Migration Assay 
Prior to seeding cells, the underside of the tissue culture wells (12 well plates) 
were marked with 3 horizontal lines with an indelible pen to provide reference points 
for relocating scratches post wounding. Cells were then plated in 12-well culture plates 
in supplemented EMEM + 10% FCS at a density of 1 x I 05 cells I ml per well and were 
incubated for 3 days under standard culture conditions. On the third day, a "scratch 
wound" for migration assay (Cha et al., 1996) was made in each well using a plastic 
pipette tip, traversing the three horizontal lines. This created a cell free zone in each 
well. Scratches greater than 700llm or less than 300llm were omitted from the 
experiment at time point O. For studies looking at drug effects on TNF-a stimulated 
migration, TNF -u was added on the second day, for a 24 hour period. 
The culture medium was then removed and replaced with an equal volume of 
fresh medium. For experiments using Nalbu Hydrogels, inserts (ThinCerts ™ Greiner 
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Bio One) containing 300111 Nalbu hydrogels were added to each well and submerged 
within the same medium that covered the melanoma cells to allow diffusion of drug 
from the hydrogels. For experiments using capsaicin, 1 ml of media was added to each 
well at the desired capsaicin concentration. Photographs were taken at predetermined 
intervals of 0, 4, 8 and 24 hours after the scratch was made on the cell monolayer, using 
an Apple MacIntosh video microscope (Open Lab 3.0.4 software). Measurements of the 
distance between the two edges of the scratch were recorded for each different time 
point. The reduction of distance between the scratch edges at different time points 
represented the migration (in 11m) of melanoma cells. Triplicate measurements were 
obtained from each experiment guided by the three horizontal lines. The 12 well-culture 
plates with cells and inserts were incubated at 37 °e, 5% CO2 during experiments. 
2.4.2. Cell Viability Assay 
At the end of migration and other viability assays, the same plates containing 
melanoma cells, fibroblasts, melanocytes and keratinocytes were used for an MTT 
assay. This was carried out to assess the toxicity of sodium ibuprofen, capsaicin or 
HA 14-1 on melanoma and skin cells. MTT acts as an artificial hydrogen acceptor 
substrate which forms a coloured formazan product, which is then eluted from the cells 
using acidified isopropanol. This cyto-biochemical assay provides a direct indication of 
the viability of cells and can be used to provide an indirect reflection of cell ntl~ber. 
The inserts and media were removed and cells were washed in PBS. MTT 
solution (0.5mg/ml PBS/well) was added to each well and incubated at 37°e for 40 
minutes. Following removal of MTT 300 ~l acidified isopropanol was added to elute 
the stain. The result was read on a multi-well scanning spectrophotometer MRX -11 
Microplate Reader - Dynex Technologies using Revelation software set at a wavelength 
of 540 nm with a reference wavelength of 630 nm. 
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2.4.3. Melanoma Cell Degradative Capability in Fibrin Clot Scaffolds Assay 
This method was used in order to evaluate the protein quantity from fibrin clots 
left in the wells by melanoma cells after a period of 24 hour incubation. Initially, a 
fibrin clot scaffold was added to the well and cells were added and incubated for a 
period of 24 hours. It was observed that after this incubation period, cells totally or 
partially degraded the fibrin clot, making it impossible to study the cell invasion. 
However, the degradative capacity of the melanoma cells could be measured using a 
simple protein assay in which the amount of fibrin clot protein could be stained and 
analyzed in a plate reader. 
2.4.3.1. Fibrin Clot Scaffold Preparation 
42 mg of plasminogen-free bovine fibrinogen was dissolved in 24 ml of sterile 
PBS, giving a 57% fibrinogen solution. After mixing thoroughly with bovine thrombin 
(10 Vlml), the fibrinogen solution was quickly transfelTed into a 24 well-culture plate at 
a volume of 0.5 mllwell. This was incubated overnight to in order allow thrombin to 
convert fibrinogen to fibrin which polymerizes forming an insoluble clot. 
2.4.3.2. Seeding Melanoma Cells on a Fibrin Clot Scaffold 
C8161 and A375SM melanoma cells were seeded at a density of 5xl04 cells/ml 
per well and HBL cells were seeded at a density of 4xl 04 cells/ml per well. The cells 
were then incubated for 24 hours. The protein assay was then performed as described 
below (2.5.4). 
2.4.3.3. Melanoma Cell Visualization on Fibrin Clot scaffold 
Cell culture wells could provide melanoma cell visualization within the gel 
using light and immunofluorescence microscopy without sectioning the fibrin scaffold. 
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300 nM DAPI was used to stain all cell nuclei. After 24 hours, the wells were gently 
washed three times with PBS, fixed in 4% (w/v) paraformaldehyde for 30 minutes and 
pemleabilised with 0.20/0 (w/v) Triton X-I 00 in PBS for 5 minutes. After 3 final washes 
with PBS, epifluorescent images were taken using an Apple MacIntosh video 
microscope (OpenLab™ 3.0.4 software) for DAPIInuclei visualization. 
2.4.3.4. Fibrin Clot Protein Assay 
After the incubation period, the volume (ml) of medium left was measured in 
each well using a lml plastic pipette. A protein assay was performed to measure the 
amount of the fibrin protein not degraded by melanoma cells. 
After removing the media, the wells were washed twice with PBS. 500111 of 
Digestion Buffer (0.04% SDS (sodium dodecyl sulphate) diluted in PBS plus 8M or 2 
M urea solution) was added and incubated for 30 minutes. Using the Protein Assay Kit, 
a mixture of 200 III of reagent Band 10 ml of reagent A was made. After the incubation 
period, 10 III of degraded fibrin clot protein was transferred into a 96 well plate. 200 III 
of the reagent mixture was added to each well and incubated for 30 minutes. The result 
was read on a multi-well scanning spectrophotometer MRX -II Microplate Reader -
Dynex Technologies using Revelation software set at a wavelength of 540 nm with a 
reference wavelength of 630 nm. 
2.4.4. DNA Damage Assay - Apoptosis Investigation 
Double stranded DNA breaks were measured as a marker of apoptosis using a 
fluorescent DNA Damage Assay (Active Motif, Carlsbad, CA). Cells were seeded at a 
density of lxlO-" cell/2501l1 per well in a 96 well plate and were cultured in the presence 
of various concentrations of capsaicin for 24 hours. Control cell were incubated with 
medium alone (negative control) or 20 IlM camptothecin (as positive control). 
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Camptothecin is originated from a deciduous tree found in southern China and was used 
as cancer treatment (Cao et al., 2009). It is known to be a cell proliferation inhibitor and 
apoptotic agent (Ding et ai., 2009) which blocks the enzyme topoisomerase-I and stops 
DNA replication within the cell (Punchihewa et al., 2009). Cell were fixed with ice-cold 
methanol for 10 minutes, washed, incubated with 5% BSA in PBS for 1 hour at RT and 
washed again. Cells were incubated at 4°C overnight with an anti-DNA break antibody 
(Anti-phospho-H2AX (ser 139)), washed and incubated with a fluorescently labelled 
secondary antibody (Chromeo™ 488 Goat anti-Rabbit IgG) for 1 hour at RT. Washed 
cells were incubated with propidium iodine (PI) for 30 minutes to stain all fixed cells. 
The plate was then scanned using a fluorescent plate reader and the ratio of DNA-
damaged cells to total cells was calculated. A ratio of PI and Chromeo 488 was 
calculated and converted to percentage of viable cells. 
2.4.5. Immunofluorescent Labelling of NF -kB/p65 in Melanoma Cells 
An immunofluorescent labelling assay was used to assess the NF-kB activation 
for the intracellular position of the p65 transcriptionally active subunit in cultured 
melanoma cells. Melanoma cells were cultured until 60% confluence and stimulated 
with TNF-a (U/ml) for 1-2 hours. Experiments were stopped by addition of 10% 
(wt/vol) paraformaldehyde in PBS. Cells were washed three times in PBS between 
treatments. Unreacted binding sites were blocked with 5% (w/v) BSA (Bovine Serum 
Albimin) or milk powder in PBS for 30 minutes. Cells were then incubated with the 
primary anti-NF-kB/p65 (C-20) goat polyclonal IgG antibody for 1 hour at room 
temperature (1: 100 (v/v) in PBS). Cells were washed with PBS (x3) then incubated with 
biotinylated anti-goat IgG antibody (1: 1000 vol/vol in PBS) for 1 hour at room 
temperature, washed with PBS (x 3), followed by incubation with fluorescein 
streptavidin (1: 100 v/v in PBS) and 300 nM DAPI for 30 minutes. 
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NF -kB/p65 images were captured usmg Fluorescein isothiocyanate (FITC) 
fluorescence for NF-kB cellular position and DAPI for nucleus localisation (See Table 
2.1). The boundary between the cell nucleus and cytoplasm was circumscribed by 
ImageXpress analysis software (ImageXpress Console 1.0) 
Fluorescence micrographs of immunolabelled samples were taken by 
illumination at Aex = 495nm, Aem = 515nm (for fluorescein isothiocyanate (FITC)/NF-
kB visualisation) and Aex = 358nm, Aem = 461nm (for DAPIInuclei visualisation). 
Cell nuclei were first located using DAPI (blue colour) signal alone giving the 
total · number of cells in a focused area. NF -kB/p65 images were captured using 
Fluorescein isothiocyanate (FITC, green colour) for NF-kB cellular position in the cell 
nucleus. Therefore NF-kB activation was assessed by counting the total number of cells 
(100 to 200 cells located by DAPI, in a focused area at 20x magnification) and the 
number of cells showing NF-kB/p65 activation in the cell nucleus, giving a percentage 
of activated cells. 
Table 2.1. TNF -a stimulated melanoma cells. 
Modified from Moustafa et aZ.(2002) and Grubb(2007). 
DAPI labelling FITC 
for celVnucleus Immunolabelling 
location ofNF-kB for 
location of p65 
@ (QJ 
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2.4.6. Flow Cytometric Investigation of Apoptosis by Looking at Loss of 
Membrane Integrity and Annexin-V Binding 
Cells were plated at a density of 5xl04 cells/ml per well in 24 well plates 
(Costar) in their respective culture media and incubated for 72 hours. After this 
incubation period cell media was removed and 1 ml of treatment solution (e.g. TNF-a, 
Nalbu, Capsaicin or HA14-1) at desired concentrations was added to the cells and 
incubated for 24 hours. Control samples were incubated with media only. Camptothecin 
(20/-lM) was used as a positive control. 
Cells were prepared for flow cytometry by removing culture media, washing 
with PBS (x2) and detached using 0.02% (w/v) EDT A. Aspirated culhlfc medium and 
PBS washes (potentially containing late apoptotic and dead cells) were combined 
together with detached cells and centrifuged at 300 g for 5 minutes. Cell pellets were 
resuspended in 150 III cold PBS buffer and divided into three parallel samples. Samples 
were then used to measure cellular viability or investigate phosphatidylserine (PS) 
externalisation. 
2.4.6.1. Determination of Externalised Phosphatidylserine by Annexin-V-PE 
B' d' G N' ™ 10 109: uava exlO 
The Guava Nexin™ assay exploits the use of Annexin V which has a strong 
affinity and specificity in the presence of calcium for phosphatidylserine (PS). The 
externalisation of PS to the cell surface is one of the early apoptotic events. The kit 
includes Annexin V conjugated phycoerythrin (PE: Acx = 480nm; Acm = 578nm) and 7-
aminoactinomycin D (7-AAD: Acx = 555nm: Acm = 655nm). a viability stain. 7-AAD is 
excluded from live cells and binds to GC rich regions of DNA within the cell allowing 
identification and distinguishing between apoptotic cells (Annexin V positive) in early 
(7-AAD negative) and late (7-AAD positive) stages. Annexin V is able to access 
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internal PS as a result of increased permeability so simultaneous staining with 7 -AAD is 
essential. The use of the Nexin® kit to quantify external PS has recently been described 
(Moustafa et al., 2002). Briefly, cells (~ lxl05) suspended in 100111 cold PBS buffer 
were washed once with 1 ml ice cold 1 x Nexin~ buffer (Guava Technologies) and 
centrifuged at 300 g for 5 minutes. Cells were resuspended in 40111 ice cold 1 x Nexin® 
buffer and incubated on ice in the dark with 5111 Annexin-V-PE and 5111 7-AAD for 20 
minutes. 450111 1 x Nexin~' buffer was added to each tube, gently agitated and 
measurement of 1000 single cell PE versus 7-AAD fluorescence events were made via 
flow cytometry (Guava PCA). Acquired data was analysed using Cytosoft (v 2.0) 
software, with differences in apoptosis detennined by relative PE versus 7-AAD 
fluorescence. 
2.5. SKIN COMPOSITES 
2.5.1. History 
Engineered human skin in vitro has been developed in the Kroto Laboratory 
with the objective of treating patients with bums, who need extensive full thickness skin 
replacement. Previously, a sterilization technique was developed for de-epidermised 
dermis (DED) using glycerol and ethylene oxide (EO). This was based on previous 
studies by Chakrabarty et al. (1999), comparing glycerol and EO treatment for dermis in 
l'itro and in vivo in nude mice. However, in this work, samples of non-sterile DED were 
used for research as there was no requirement of this skin to be destroyed or utilized for 
clinical purpose. 
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2.5.2. Harvesting Split-Thickness Skin Grafts (STSGs) 
DED was produced from STSGs obtained from routine plastic surgery of breast 
reduction and abdominoplasties. The STSGs were harvested and placed in sterile saline 
and stored at 4 °C until processing (within 24 hours). 
2.5.3. De-Epidermisation of Split-Thickness Skin Grafts 
STSGs were stored in PBS for a minimum of 48 hours and then immersed in 
sterile 1 mollL sodium chloride for 18 hours, resulting in an acellular DED. The 
epidermis was separated from the underlying dermis using forceps and the remaining 
DED samples were washed several times in PBS (See Figure 3.1). The DED samples 
were stored in DMEM (Dulbecco's minimum essential medium) supplemented with 5% 
FCS, 2 x 10-3 mollL glutamine, 100 IV/mL penicillin, 100 J.lg/mL streptomycin and 
0.625 )lg/mL amphotericin B. This medium is referred as to fibroblast culture medium 
(FCM). 
As it was of interest to keep the basement membrane (BM) to observe the ability 
of melanoma and/or other human skin cells to migrate into the dennis, no attempt was 
made to remove the BM antigens. 
2.5.4. Isolation and Culturing Human Skin Cells 
2.5.4.1. Keratinocyte Culture 
STSGs were obtained as previously described. Samples of this skin were cut into 
0.5 cm~ pieces using a scalpel blade (No.22) and were incubated overnight (12-24 
hours) at 4°C in 0.1 % w/ ..... trypsin. FCS was added to neutralize the trypsin and the 
epidermal and dermal layers were carefully separated using a pair of forceps with fine 
points. A scalpel blade was used for gently scraping basal keratinocytes from the 
undersurface of the epidermis and the papillary surface of the dermis (See Figure 2.1). 
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The cells were collected into a mixture of FCS and PBS in sterile 25 ml 
universal containers. The cell suspension was then centrifuged at 300g for 5 minutes 
and the cells were resuspended in a known volume of keratinocyte culture medium 
(KCM). This medium consists of DMEM and Ham's F12 medium in a 3:1 ratio 
supplemented with 10% FCS, 10 ng/mL EGF; 0.4 Ilg/mL hydrocortisone; 1.8 x 10-4 
mol/L adenine; 5 Ilg/mL insulin; 5 Ilg/mL transferrin; 2 x 10-3 mol/L glutamine; 2 x 10-7 
mol/L tri-iodo thyronine; 0.625 Ilg/mL amphotericin B; 100 IU/mL penicillin and 100 
/lg/mL streptomycin. 
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For De-e idermised Dermis 
l 
Split Thickness Skin Grafts from 
Theatre 
o 0 0 000 
For Isolating Cells 
Keratinocytes and Fibroblasts 
~ 
Incubate for 18 hours in 1 M N aCI Incubate Skin (STSGs) for 18 hours at 4
0 C in 0.1 % 
Trypsin 
o 0 0 0 0 0 
l 
Gently Remove Epidermis 
Retain Native BM 
Ready for making composites 
o 0 0 0 0 0 
Peel off Epidermis from Dermis 
Scrape underside of epidermis and papillary surface of 
dermis to isolate Keratinocytes 
Dermis is minced and added 
to Collagenase A and 
incubated for Fibroblasts 
isolation 
Keratinocytes are 
collected in a solution 
of FCS and PBS 
Figure 2.1. Step-by-step procedure for isolating skin cells and production of DED. 
(Modified from Eves, 2001). 
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For keratinocytes expanded in culture, freshly isolated keratinocytes in KCM 
suspension were seeded on to a pre-coated feeder layer of lethally irradiated 3T3 
fibroblasts (i3T3) in KCM. Cell cultures were re-fed every 3 days until approximately 
800/0 confluent, usually by 5 to 7 days. Residual i3T3 cells were removed with 2 ml 
0.020/0 EDT A before keratinocytes were detached using 2 ml trypsin and used 
experimentally. Keratinocytes were not used above passage 3. 
2.5.4.2. Fibroblast Culture 
STSGs were trypsinized as described previously for the isolation of 
keratinocytes. The epidermal and dermal layers were separated and the dermal parts of 
the specimens were collected. These dennal samples were washed several times in 
sterile PBS and then finely minced with a scalpel blade. The dennal mince was 
incubated at 37°C overnight in 10 ml of a 0.5% collagenase A solution (See Figure 3.1). 
The following day, the collagenase digest was spun down in a centrifuge at 300g for 10 
minutes, the supernatant was discarded and the pellet of cells was resuspended in FCM. 
Cells were passaged when fibroblasts reached 80-90% confluence using 2 ml of a 1: 1 
mixture of 0.1 % w/v trypsin and 0.02 5 w/v EDT A per T25 flask. Fibroblasts were used 
between passages 4 and 9. 
2.5.4.3. Melanocyte Culture 
Melanocytes were isolated In exactly the same manner as for human 
keratinocytes (as described in 2.8.3. Isolation and Culturing Human Skin Cells; and 
2.8.3.1. Keratinocyte Culture), using 0.1 % trypsin. Once isolated, cell suspensions were 
seeded at 4 x 106 cells/T25 flask in a low calcium MCDB 153 basal media 
supplemcnted with 2 % chelatcd FCS, 25 /lg/ml bovine pituitary extract (BPE), 0.6 
no-/ml basic fibroblasts growth factor (bFGF), 10/lg/ml insulin, 10/lg/ml transferrin, 2.8 
o 
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Jlg/ml hydrocortisone, 2 mM/1 L-glutamine, 100 IU/ml; 100 Jlg/ml 
penicillin/streptomycin, 10 U/ml nystatin, 1 Jlg/ml a-tocopherol, 100 ng/ml cholera 
toxin and 10nM/1 phorbol 12-myristate 13-acetate (PMA). Geneticin (100 Jlg/ml) was 
added to the media over the first few days to prevent fibroblast contamination. 
Melanocyte cultures were fed twice weekly with this Melanocyte Growth Medium. For 
co-culture, melanocytes were trypsinised using 2 ml of a 1: 1 mixture of 0.1 % w/v 
trypsin and 0.02% w/v EDTA. Once detached 1:2 trypsin inhibitor (TI) was used to 
block the effects of trypsin and melanocyte growth medium was added to the cells prior 
centrifuging. Cells were resuspended in this medium and seeded at the desired density. 
Melanocytes were not used for experiments after passage -t. 
2.5.5. Engineered Human Skin Model 
De-cellularised human skin was obtained as previously detailed which resulted in a 
DEO, with retained basement membrane. The dermal pieces were then cut into 
approximately 2x2. cm pieces to fit into a six-well tissue culture plate. The OED was 
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placed in each well with the reticular surface uppermost. Sterile 0.8cm- stainless steel 
rings were placed in the middle of each piece of dennis and a seal was obtained between 
steel ring and dennis by application of gentle pressure. FCM was added to the inside of 
each ring to check for any leakage. The surrounding dermis was then flooded with 
FCM. Once satisfied that a sufficient seal had been obtained, FCM from inside each 
ring was removed and fibroblasts at density of Ixl05 cells per composite were added to 
each ring in a volume of 500 JlI of FCM. After 24 hours incubation the medium within 
each ring was carefully removed and replaced with fresh FCM. Following a further 
overnight incubation at 37°C, to allow migration of fibroblast into the dermis reaching 
down the papillary layer, all the medium was carefully removed. Each ring was 
70 
removed and the pIeces of DED were inverted so that the papillary surface was 
uppermost. Steel rings were then applied to the dennal surface as before and a check for 
leakage was again made using KCM. Once a tight seal had been demonstrated, 250 III 
of melanoma cells at density of 5x I 04 cells per composite ring were seeded. After a 
period of one to two hours, 250111 keratinocytes were seeded into each ring at density of 
lxl06 cells. The following day, the medium in 'each ring was carefully removed and 
replaced with fresh KCM. After 24 hours of incubation the rings were removed and the 
composites were raised onto stainless steel grids in new six-well culture plates. Fresh 
KCM was added to the level of the base of the composite so that the KCM lapped over 
the edges of the composites (but not the seeded area) fonning an air-liquid interface 
(ALI). Culture medium was changed every 2-3 days. When pharmacological agents 
(e.g. Nalbu, TNF-a) or fibrin clots were being used in composites experiments, KCM 
containing these freshly prepared agents was added and composites were then kept at 
37°C. Following an examination of their morphology composites were ended after 10-
19 days culture at an ALI. See Figure 2.3. 
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o 0 0 0 0 0 
Media 
Place dermis in well with the 
reticular surface uppermost. 
Place stainless steel ring on 
dermis. 
Add fibroblasts into ring at 1x105 
cells/ring (volume = 500JlI). 
Culture in DMEM for 2 days. 
Turn dermis with the 
papillary layer upper most 
Place ring and add melanoma cells at 
5x104 cells/ring and/or keratinocytes at 
1x106 cells/ring. Total volume = 500 JlI 
Skin 
Composite 
Lift the Skin Composite 
into an Air-Liquid Interface 
and culture for 15-19 days 
Stainless steel grid 
Figure 2.2. Making an Engineered Human Skin Model. (Modified from Eves, 2001). 
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2.5.6. Wounding Skin Composites 
After a period of 10 days at an Air Liquid Interface (ALI), the skin composites 
were ready for wounding. The wounds were made frrstly using a needle (19G 2" 
1.1xSOmm, BD Microlance Drogheda, Ireland). As these initial wounds could not be 
detected by subsequent histology of skin composites, larger full thickness wounds were 
then made using a scalpel blade, making a cross wound in the region where the cells 
were seeded. Once the wound was made, a fibrin clot solution with and without TNF-(1 
(300 U/ml) was added on the composites. To the skin composites without fibrin clot, 2.S 
to 3 ml of media with TNF-(1 at a concentration of300 U/ml was added to each well. 
Wound+Fibrin clot+ TNF-a o 
Epidermis 
-~ .. o o o o o o 
Dermis 
Figure 2.3. Diagram of a wounded skin composite and the addition of fibrin clot plus TNF-
o. 
Initial skin wounds were made in the shape of a cross but it proved difficult to 
keep the wound edges together. As these proved difficult to heal, wounds were then 
made with a single cut in to the seeded area. Skin composites were initially wounded 
after a period of 10 days at an ALL However, this was later modified and wounds were 
made on the 3rd day after being lifted in ALL 
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2.5.7. Assessment of Tissue Engineered Human Skin 
ALI exposure was initially kept for 10-19 days. As this was considered a long 
time for incubation (increasing the risks for infection) this time was then reduced to 7 to 
10 days. After an ALl period, tissue engineered human skin was processed for 
histological analysis. Samples were fixed in 10% phosphate buffered formaldehyde for 
at least 24 hours before routine histological procedure. All samples were assessed for 
overall morphology, the presence of BM, keratinocytes differentiation in the epidermis, 
fibroblast penetration into the dermis, melanoma invasion into the dermis and wound 
healing. 
2.5.7.1. Histological Investigation 
Formaldehyde-fixed specimens were processed into paraffin wax usmg an 
Automatic Tissue Processor (Leica TP 1 020 - Leica Microsystems), which over a period 
of 17 hours impregnates the tissue with paraplast (plasticized paraffin wax). The tissues 
were then embedded in the same paraffin wax, in tissue cassettes using an Automatic 
Tissue Processor (Leica EG 1160 - Leica Microsystems ). 4 /-lm sections were cut from 
each tissue block on a rotary microtome (Leica RM2145 - Leica Microsystems) and the 
sections were stained manually with Carazzi's Haematoxylin and Eosin (H&E). 
Sections were mounted using a glass cover slip. 
2.5.7.2. Histological Imm unostaining 
Antibody staining for melanoma cells, keratinocytes and BM localization was 
done in the Department of Histopathology at the Northern General Hospital (Sheffield, 
UK). As the cells were invading into the dermis, an antibody staining technique was 
performed to be able to distinguish between the cell types in the skin composites and to 
detect the basement membrane. Standard H&E staining were done for overall contrast. 
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2.5.7.3. Preparation of Paraffin Wax Sections for Immunohistochemistry 
Paraffin wax sections were cut, transferred to Poly-L-Lysine coated slides and 
then kept at 60°C overnight. These slides were d"ewaxed in xylene, rehydrated through 
descending grades of alcohol and washed in running tap water for at least 10 minutes. 
Any masking of antigenic sites by the processing procedure was reversed by the use of 
an antigen retrieval method - either enzyme digestion or ultra-heat treatment. The type 
of antigen retrieval method used was specific to the antibody used. 
2.5.7.4. Enzyme Digestion 
Sections were placed in distilled water at 37°C to equilibrate. To a water bath 
containing 500ml of distilled water at 37°C, 10 ml of 5% calcium chloride and 0.25g of 
trypsin were added. The trypsin solution was adjusted to pH 7.8 by the addition of 
sodium hydroxide. The slides were incubated in t~is solution for 14 minutes at 37°C and 
thcn transferred to running water for at least 10 minutes to prevent further enzymic 
digestion. 
2.5.7.5. Ultra Heat Treatment 
Sections were placed in a pressure cooker containing enough boiling citrate 
buffer (pH 6) to cover the tissue sections and then taken up to approximately 120°C for 
2 minutes. The pressure was carefully released and the lid removed from the pressure 
cooker. The slides remained in the hot buffer solution for 20 minutes and were then 
transferred to a glass trough of running tap water. 
2.5.7.6. Immunohistochemical Methodology 
After antigen retrieval, all sections were placed in Tris-Buffered Saline (TBS) 
pH 7.8 with 5 Jll of 0.10;() Tween for 10 minutes. Sections were then incubated for 10 
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minutes in blocking serum (I :25 horse serum in TBS/Tween for monoclonal antibodies 
and 1 :25 swine serum in TBS/Tween for polyclonal antibodies) to decrease background 
staining. The blocking serum was tipped off the slides and the primary antibody applied 
for an incubation time of 60 minutes. After this primary antibody incubation, the slides 
were washed in TBS/Tween for 10 minutes. The sections were then incubated with the 
secondary antibody (biotinylated anti-mouse secondary antibodies for monoclonals and 
biotinylated anti-rabbit secondary antibodies for 'polyclonals) for 30 minutes, followed 
by a 10 minute wash in TB S/Tween. 
The alkaline phosphatase Avidin Biotin Complex kit was prepared as per 
instructions and the slides incubated with the complex for 30 minutes. The slides were 
again washed in TBS/Tween for 10 minutes. The alkaline phosphatase substrate kit was 
prepared and applied to the slides for 10 minutes (checked microscopically) followed by 
a final wash in TBS/Tween. The sections were washed in running water, stained in 
Haematoxylin (20 seconds), differentiated in acid/alcohol (1 second), "blued" 10 
running tap water, dehydrated, cleared and mounted for microscopic examination. 
2.5.7.7. Antibodies Used 
Anti-collagen IV antibody was used at a dilution of 1:40 to stain for the presence 
of the BM. Rabbit derived S I 00 antibody was used at a dilution of 1 :2500 to stain for 
melanocytes and mouse derived HMB45 antibody (HMB45 recognizes premelanosomal 
vesicle in premature developing melanocytes and melanoma cells (Schaumburg-Lever 
et a I., 1991) and as such has been found to be very useful for distinguishing between 
melanocytes and melanoma cells (Gown et al., 1986) was used at a dilution of 1:40 to 
stain for melanoma cells. A dilution of 1 :50 of mouse anti-cytokeratin AE I AE3 
antibody was used to stain keratinocytes. 
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2.5.8. Cell Invasion Assay 
In order to quantify cell invasion into the composites, an invasion score was 
used as previously established by Eves et al. (2000) and Eves (2001). The score was 
based on the number of cells invaded into the dermis counted in each skin composite 
slide. A score above 1.5 was considered as evidence of clear invasion of cells. 
Table 2.2. Cell invasion score. 
Score Number of cells 
0 No cells present in the dennis 
0.5 1-5 cells in the dermis 
1.0 6-15 cells in the dermis 
1.5 16-20 cells in the dennis 
2.0 21-30 cells in the dennis 
2.5 31-40 cells in the dennis 
3.0 +50 cells in the dermis (florid invasion) 
2.6. STATISTICS 
For melanoma cell migration assay the statistical analysis compared control 
versus treated cells using a Multiple Comparison test and Bonferoni correction, 
presuming equivalent variances. 
Melanoma cell viability and compansons between invasion scores were 
analysed by comparing control versus treated cells using a repeated Student t-test for 2 
samples presuming equivalent variances. 
All statistical tests were considered as non-parametric. Differences between 
means were taken as significant at the p<O.05 (significant); p<O.O 1 (very significant); 
p<O.OO 1 (extremely significant) level. 
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2.7. RESEARCH ETHICS APPROVAL 
The Kroto Research Laboratory holds a Research Tissue Bank License (Human 
Tissue Authority (HT A) License Number 12179). All tissue cultures for this work came 
from patients who signed a Research Consent Form for tissue to be used for research 
purposes. See details in Appendix 1. 
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CHAPTER 3 
EFFECTS OF TNF-a, IBUPROFEN AND CAPSAICIN ON 
MELANOMA CELL MIGRATION AND VIABILITY 
79 
3.1. RELEASE OF IBUPROFEN FROM F127 PLURONICS HYDROGEL 
Initially, NaIbu was incorporated into a hydrogel as described in section 2.3.3 in 
Methods (Chapter 2). The Pluronic hydrogel used (F127) was not cytotoxic to cells as 
will be shown later in this chapter. Figure 3.1 illustrates the release of Nalbu from a 
30% F127 Pluronics hydrogel over a period of 24 hours. This was assessed by the 
content ofNalbu which had been released from the hydrogel into the distilled water and 
then determined from the characteristic ibuprofen UV absorbance at 264nm using a UV 
spectrometer. 
In vitro suitable controlled drug delivery system based on Pluronic hydrogel has 
been previously demonstrated by Gong et al. (2009). The standard curve (see Figure 
3.1) shows the expected release of ibuprofen from the hydrogel in cell culture medium 
as it was kept at the same Pluronic Fl27 concentration (30%) and incubated at the same 
temperature of 37°C. 
The release of Nalbu was rapid from 2 to 8 hours (from OA to 1.48 11M 
approximately). After this period NaIbu released from the hydrogel was steady up to 24 
hours (from 1A8 to 1.8I1M). 
80 
2.0E-06 
1.8E-06 
1.6E-06 
~ 
c:: 
Q) 1.4E-06 
-0 ... 
Q. 
~ 
::9 1.2E-06 
E 
.= 
"0 1.0E-06 
0 
en 
-
0 8.0E-O? c:: 
0 
~ 
III 
... 6.0E-0? 
-c:: Q) 
u 
c:: 4.0E-0? 0 (.J 
2.0E-0? 
O.OE+OO 
0 2 4 6 8 10 12 14 16 18 20 22 24 26 
Time (h) 
Figure 3.1. Release profile of NaIbu from 30% F-127 Pluronics hydrogel over 24 hours (h). 
The initial concentration of NaIbu in the hydrogel was 131xlO-6 M and the test 
temperature was 37°C (Data obtained from Dr. Alan Waddon). 
3.2. PATTERN OF MELANOMA CELL MIGRATION OVER TIME 
Initially, the melanoma migration pattern was studied using three mean control 
values (treated with media only) obtained from three different experiments. These 
experiments were: 1) Effects ofNalbu hydrogel on melanoma cell migration; 2) Effects 
of Nalbu (in media) on melanoma cell migration; and 3) Effects of Capsaicin on 
melanoma cell migration. Figure 3.2 shows the pattern of migration of three different 
melanoma cell lines at different time points (2, 4, 8 and 24 hours). 
A non-parametric Spearmans' Correlation test was used to examine how linear 
the rate of melanoma cell migration was over time. Overall the rate of migration was 
linear for all these cell lines at 24 hours with high correlation values (76% to 92%) as 
shown Figure 3.2. HBL cell migration showed an evident linear pattern over a period of 
24 hours (correlation test resulted in r=0.972, p<O.OOI). Migration of A375SM was 
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slow until 4 hours however, overall over 24 hours migration was nearly linear 
(correlation test resulted in r=0.756, p<0.05). C8161 cell migration was faster at 8 hours 
and migration was linear over 24 hours (correlation test resulted in r=0.972, p<O.OOI). 
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Figure 3.2. Pattern of melanoma cell migration over 24 hours (h). = HBL cells, = 
A375SM cells, . = C8161 cells. Values are expressed as Mean+SEM. The dotted line shows 
a linear plot between 0 hour and 24 hours for the distance migrated by C8161 cells. 
3.3. 2D MODEL FOR MELANOMA CELL MIGRATION 
Melanoma migration was investigated using a 2D model in which a monolayer 
of cells was formed after seeding the cells in a 12 well plate. After 72 hours of 
incubation, a scratch wound was made using a sterile plastic Gilson's pipette tip. This 
created a zone free of cells. The media was removed and 1 mVwell of new fresh media 
was added to the wells. 
Scratch photographs were taken from each well for later measurement of 
migration at time zero. This was made by measuring the distance between the two edges 
in micrometres (/lm). The cells were then incubated until the next migration 
measurement time points of 2, 4, 8 and 24 hours. Migration was later calculated by 
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subtracting the distance between the edges at each time point from the initial scratch 
distance at zero time. 
Figure 3.3 illustrates a scratch wound model in which C8161 cells were stained 
with DAPI at 24 hours (end of migration experiment). Cells were treated with unloaded 
hydrogel and the different concentrations of NaIbu hydrogel. C8161 cell migration was 
reduced with the increasing NaIbu hydrogel concentrations. 
Figure 3.3. Scratch wound model. Migration of C8161 cells at (A) Unloade~ hydrogel and 
(B) 33ILM , (C) 66ILM , (D) 99ILM and (E) 131ILM Nalbu hydrogel concentrations. Scale bar 
= 50ILm. 
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3.4. EFFECTS OF TNF-u, IBUPROFEN AND CAPSAICIN ON MELA:\OlVIA 
CELL MIGRATION 
In these experiments, the effects of the NSAIDs Ibuprofen and Capsaicin were 
investigated on three melanoma cell lines. The pro-inflammatory cytokine TNF -(1 was 
used to pre-stimulate melanoma cell migration and the addition of Ibuprofen or 
Capsaicin in reducing melanoma cell migration was investigated. In some experiments 
NaIbu was also incorporated into a Pluronics hydrogel for further investigation of the 
effects of NaIbu hydrogel on melanoma cell migration. 
3.4.1. Effects of Nalbu (in media) on lVIelanoma Cell Migration 
In these experiments the effects ofNaIbu (in media) on melanoma cell migration 
was investigated. Nalbu (powder) was dissolved in media to give 2 different 
concentrations of 661lM and 1311lM. 1 ml/well of Nalbu (in media) or media only were 
added to the cells. Melanoma cells treated with media only were considered as controls. 
HBL cell migration was significantly reduced at 661lM Nalbu (p<O.OO 1). 
However, at 1311lM Nalbu concentration, HBL cells were detaching from the wells at 
24 hours of incubation making migration measurements not possible. Sc~ Figure 3.4 A. 
For A375SM cells a significant reduction occurred at a higher concentration of 
131llM (p<O.Ol) ofNaibu at 24 hours. See Figure 3..+ B. 
For C8l61 cells, a significant reduction in migration was observed at 1311lM 
NaIbu (p<O.Ol) at 24 hours. See Figure 3.4 C. 
Although these are measures of melanoma cell migration only, it should be 
considered a combination of melanoma cell migration and cell proliferation, particularly 
for C8161 cells as they proliferate more rapidly than the other two melanoma cell lines 
(HBL and A375SM cells). Figure 3.5 illustrates the effects of Nalbu in media on the 
three melanoma cell lines over 24 hours. Table 3.1 shows a statistical summary of these 
results. 
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Figure 3.4. Effects of Nalbu in media on melanoma cell migration over 24 hours (b). (A) 
HBL cells, (B) A375SM cells, and (C) C8161 cells . • = Media, = 66,...M, • = 131,...M. 
Values are expressed as Mean+SD. N=4. ** = p<O.Ol; *** = p<O.OOl, relative to control 
media. 
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Figure 3.5. Effects of N albu in media on melanoma cell migration at 24 hours. 0 = HBL 
cells, 0 = A375SM cells, I = C8161 cells. Values are expressed as Mean+SD. N=4. ** = 
p<O.OI; *** = p<O.OOI, relative to control media. 
Table 3.1. Statistical Summary for comparison between treatments - Effects of Nalbu (in 
media) on Melanoma Cell Migration (p values). 
Time Points (hours) 
2 4 8 24 
HBl Cells 
Media vs 66lJM ns ns ns 0.0001 
Media vs 131lJM ns ns ns Cell detachment 
A375SM Cells 
Media vs 66lJM ns ns ns ns 
Media vs 131lJM ns ns ns 0.0050 
C8161 Cells 
Media vs 66lJM ns ns ns ns 
Media vs 131pM ns ns ns 0.0010 
3.4.2. Effects of Nalbu Hydrogel on Melanoma Cell Migration 
The effect of N aIbu hydrogel on melanoma migration was investigated using a 
2D model as previously described. Cells were seeded in a 12 well plate. After 72 hours 
of incubation time a scratch wound was made and the media was removed and 1mlJwell 
of fresh media was added to the wells. 
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Scratch photographs were taken from each well at time zero to measure cell 
migration. In these experiments 300111 of increasing NaIbu hydrogel concentrations 
were added to 12 well tissue culture inserts (ThinCert™). Cells were also treated with 
unloaded hydrogel. The inserts were then placed in each well containing a monolayer of 
cells in media. The cells were then incubated until the next scratch photographs for later 
migration measurement at the time points of 2, 4, 8 and 24 hours. 
Melanoma cell migration decreased with increasing concentrations of NaIbu 
loaded on a hydrogel in a dose-dependant manner in the three melanoma cell lines used. 
Statistical comparisons considered the unloaded hydrogel treated cells as control. Figure 
3.6 illustrates the effects of NaIbu hydrogel on migration of three melanoma cell lines. 
HBL cell migration was unchanged at different concentrations of NaIbu 
hydrogel at 2 hours (p>0.05) relative to the unloaded hydrogel. Migration was 
significantly reduced at 331lM and 1311lM Nalbu hydrogel (p<0.05 and p<O.O 1 
respectively) relative to the unloaded hydrogel, at 4 hours. HBL cell migration was also 
reduced at NaIbu hydrogel at 661lM and 131llM (p<0.05 respectively) relative to the 
unloaded hydrogel, at 8 hours. At 24 hours, HBL cell migration was markedly reduced 
with the increasing NaIbu hydrogel concentrations with a significant reduced migration 
at 131llM (p<0.05) compared to the unloaded hydrogel. See Figure 3.7 A for an 
illustration of these results. 
For A375SM cells, migration was significantly reduced with the unloaded 
hydrogel (p<0.05) and to each NaIbu hydrogel concentration (p<0.05) relative to the 
cell treated with media only. A375SM cell migration at increasing NaIbu hydrogel 
concentration was not significantly reduced comparing compared to the unloaded 
hydrogel (p>O.05), at 24 hours. See Figure 3.6 B. 
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For C8161 cells, at 4 and 8 hours, migration was reduced at the unloaded 
hydrogel and at increasing Nalbu hydrogel concentrations compared to the cell treated 
with media only. C8161 cell migration was reduced by the increasing concentrations of 
Nalbu hydrogel, however this was not significant (p>O.05) relative to the unloaded 
hydrogel. 
Overall, Nalbu hydrogel reduced migration of the three melanoma cell lines. 
This was more effective on HBL cells followed by A375SM and C8161 cells. 
Reduced melanoma cell migration with increasing concentrations of N albu 
hydrogel at 24 hours is illustrated in Figure 3.7. A statistical summary of these results is 
in Table 3.2. 
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Figure 3.6. Effects of Nalbu hydrogel on melanoma cell migration over 24 hours (h). (A) 
HBL cells, (B) A37SSM cells, and (C) C8161 cells . • = Media, = Unloaded hydrogel, = 
33J1M, • = 66J1M, • = 99J1M, • = 131J1M. Values are expressed as Mean +SD. N=S. * = 
p<O.OS, relative to the unloaded hydrogel. 
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Figure 3.7. Effects of Nalbu hydrogel on melanoma cell migration at 24 hours. (A) HBL 
cells, (B) A375SM cells and (C) C8161 cells. Values are expressed as Mean+SD. * = p<O.05, 
relative to the unloaded hydrogel. 
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Table 3.2. Statistical summary for comparison between treatments - Effects of Nalbu 
Hydrogel on melanoma cell migration (p values). 
HBL Cells 
Time Points {hours} 
2 4 8 24 
Unloaded h~drogel vs Media ns ns ns ns 
Unloaded h~drogel vs 33 ~M ns 0.0102 ns ns 
Unloaded h~drogel vs 66 ~M ns ns 0.0207 ns 
Unloaded h~drogel vs 99 ~M ns ns ns ns 
Unloaded hydrogel vs 131 IJM ns 0.0026 0.0107 0.0491 
A375SM Cells 2 4 8 24 
Unloaded h~drogel vs Media ns ns ns 0.0348 
Unloaded h~drogel vs 33 ~M ns ns ns ns 
Unloaded h~drogel vs 66 ~M ns ns ns ns 
Unloaded h~drogel vs 99 ~M ns ns ns ns 
Unloaded hydrogel vs 131 IJM ns ns ns ns 
C8161 Cells 2 4 8 24 
Unloaded h~drogel vs Media ns 0.0231 0.0003 ns 
Unloaded h~drogel vs 33 ~M ns ns ns ns 
Unloaded h~drogel vs 66 ~M ns ns ns ns 
Unloaded h~drogel vs 99 IJM ns ns ns ns 
Unloaded h~dro~el vs 131 ~M ns ns ns ns 
3.4.3. Effect of Nalbu Hydrogel on TNF-(l Pre-Stimulated Melanoma Cell 
Migration 
In these experiments melanoma cells were pre-stimulated for 24 hours with 
lmllwell of 300U/ml TNF-a. After making a scratch wound, media was changed to 1 
ml/well fresh new media and then inserts containing 300)11 of different concentrations 
ofNalbu hydrogels were added to the cells. 
Figure 3.8 illustrates the effects of NaIbu hydrogel on TNF-a pre-stimulated 
melanoma cell migration. There were cells treated with media only and these were not 
TNF-a pre-stimulated. There were also TNF-a only (in media) treated cells. Unloaded 
and NaIbu loaded hydrogel treated cells were therefore also pre-stimulated with TNF-a. 
The unloaded hydrogel treated cells were considered as control for comparisons. 
HBL cell migration was not significantly reduced by NaIbu hydrogel in TNF-a 
stimulated cells at 2, 4 and 8 hours. Increasing Nalbu hydrogel reduced HBL cell 
migration in TNF -a stimulated cells at 24 hours, however this was not significant 
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(p>0.05) relative to the unloaded hydroge1. Only 99~M NaIbu hydrogel significantly 
reduced HBL cell migration in TNF-a stimulated cells (p<0.05) relative to the unloaded 
hydrogel. 
For A375SM cells~ migration was significantly reduced with the unloaded 
hydrogel at 2~ 4 and 8 hours compared to media (not stimulated with TNF-a) and TNF-a 
only (see Table 3.3 for statistical details). However, at 24 hours, increasing 
concentration of Nalbu hydrogel of 66~M, 99~M and 131~M significantly reduced 
A375SM cell migration in TNF-a stimulated cells compared to the unloaded hydrogel 
(p<O. 05, p<O. Oland p<O. 001 , respectively). 
For C8161 cells, migration was significantly increased by 300U/ml TNF-a 
compared to the unloaded hydrogel (p<0.05), at 2 hours. At 8 hours, migration was 
significantly increased by 300U/ml TNF-a and the unloaded hydrogel treated cells 
(p<O.O L respectively) relative to media treated cells. Also, higher Nalbu hydrogel 
concentrations of 99~M and 131 ~M reduced migration (p<0.05, respectively) compared 
to the unloaded hydrogel, in TNF -a stimulated cells. At 24 hours, C8161 cell migration 
was significantly reduced by 300U/ml TNF-a compared to the unloaded hydrogel 
(p<O.OO 1). Either TNF-a treated cells and unloaded hydrogel significantly increased 
C8151 migration compared to media treated cells (p<O.OO 1, respectively). Increasing 
Nalbu hydrogel concentrations reduced C8161 cell migrations at 33~M and 66~M 
(p<O.Ol for both concentrations) and at 99 ~M and 131 ~M (p<O. 001 for both 
concentrations) in TNF-a stimulated cells. The maximum Nalbu hydrogel concentration 
of 131 ~M reduced cell migration to a similar level of migration of cells treated with 
media only which demonstrated the stimulatory effect of TNF-a on melanoma cell 
migration and the suppressive effect of NaIbu hydrogel on melanoma cell migration. 
See Figures 3.8 C and 3.9 C and Table 3.3 for a summary of these results. 
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Figure 3.8. Effects of Nalbu hydrogel on TNF-a pre-stimulated melanoma cell migration 
over 24 hours (h). (A) HBL cells, N=6. (B) A375SM cells, N=6. (C) C8161 cells, N=5 . • = 
Media, • = TNF-a, = Unloaded hydrogel, = 33f.1M, = 66f.1M, • = 99f.1M, • = 131f.1M. 
Values are expressed as Mean+SD. * = p<O.05; ** = p<O.Ol; *** = p<O.OOl, relative to the 
unloaded gel. 
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Figure 3.9. Effects of Nalbu hydrogel on TNF-a pre-stimulated melanoma cell migration 
at 24 hours. (A) HBL cells, (B) A375SM cells, and (C) C8161 cells. Values are expressed as 
Mean+SD. * = p<O.05; ** = p<O.Ol; *** = p<O.OOl, relative to the unloaded gel. 
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Table 3.3. Statistical Summary for comparison between treatments - Effects of Nalbu 
hydrogel on TNF-u Pre-stimulated Melanoma Cell Migration (p values). 
HBL Cells Time Points (hours} 
2 4 8 24 
Media vs TNF-a ns ns ns ns 
Unloaded h~drogel vs Media ns ns ns ns 
Unloaded h~drogel vs TNF-a ns ns ns ns 
Unloaded h~drogel vs 33 ~M ns ns ns ns 
Unloaded h~drogel vs 66 ~M ns ns ns ns 
Unloaded h~drogel vs 99 ~M ns ns ns 0.0178 
Unloaded hydrogel vs 131 ~M ns ns ns ns 
A375SM Cells 2 4 8 24 
Media vs TNF-a ns ns 0.002 ns 
Unloaded h~drogel vs Media 0.0217 ns ns ns 
Unloaded h~drogel vs TNF-a ns 0.0359 0.0052 ns 
Unloaded h~drogel vs 33 ~M ns ns ns ns 
Unloaded h~drogel vs 66 ~M ns ns ns 0.0184 
Unloaded h~drogel vs 99 ~M ns ns ns 0.007 
Unloaded h~drogel vs 131 ~M ns ns ns 0.0007 
C8161 Cells 2 4 8 24 
Media vs TNF-a ns ns 0.002 0.0001 
Unloaded h~drogel vs Media 0.0436 ns 0.004 0.0001 
Unloaded hydrogel vs TNF-a ns ns ns 0.0004 
Unloaded h~drogel vs 33 ~M ns ns ns 0.0029 
Unloaded h~drogel vs 66 ~M ns ns ns 0.0018 
Unloaded h~drogel vs 99 ~M ns ns 0.0292 0.0002 
Unloaded hydrogel vs 131 f-lM ns ns 0.0141 0.0001 
3.4.4. Effects of Capsaicin on Melanoma Cell Migration 
In these experiments the effects of capsaicin on melanoma cell migration was 
investigated. See Figure 3.10. Melanoma cell were seeded at a density of 1xl0
5 
cells / 
ml per well and incubated for 3 days in media. After this incubation period, a scratch-
wound was made and photographed for migration measurement as previously described. 
Media was removed and 1 ml of fresh media per well (as control) or different capsaicin 
concentrations were added to the cells. 
For HBL cells, overall, increasing capsalcm concentrations reduced cell 
migration compared to control (media). At 8 hours, 500~M capsaicin detached the cells 
from the wells. At 24 hours 500~M capsaicin also detached HBL cells from the wells 
95 
indicating toxic effect of capsaicin on HBL cells. At 8 hours, HBL cell migration was 
significantly reduced at a capsaicin concentration of 300~\1 and 400~M (p<0.05 
respectively), compared to media. At 24 hours migration was further reduced at 
capsaicin concentration of 300~M (p<0.05). See Figures 3.10 A and 3.11 A for an 
illustration of these results and Table 3.4 for statistical summary of results. 
Overall, at 8 hours, A375SM cell migration was reduced by the increasing 
capsaicin concentrations. A375SM cell migration was significantly reduced at 400~M 
and 500~M capsaicin (p<0.05 respectively) relative to media. At 24 hours A375SM cell 
migration was significantly reduced at capsaicin concentrations of 300~M and 400~M 
(p<O.O 1 and p<O.OO 1 respectively) relative to media. At capsaicin concentration of 
500~M however the cells detached from the wells indicating that this concentration was 
toxic to the cells. See Figures 3.10 Band 3.11 B for an illustration of these results and 
Table 3.4 for statistical summary of results. 
Overall, up to 8 hours, C8161 cell migration was slightly increased at a 
capsaicin concentration of 400~M compared to media. At 24 hours, C8161 cell 
migration was slightly increased at capsaicin concentrations of 1 OO~M and 200~M 
respectively. Migration was then reduced at capsaicin concentrations of 300~M, 400~M 
and 500~M which reduced C8161 cell migration below the media value. However. none 
of these were statistically significant (p>0.05). See Figures 3.10 C and 3.11 C for an 
illustration of these results and, Table 3.-+ for statistical summary of results. 
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Figure 3.10. Effects of Capsaicin on melanoma cell migration over 24 hours (h). (A) HBL 
cells, N=6. (B) A37SSM cells, N=S. (C) C8161 cells, N=6 . • = Media, = SO,...M, = 
100,...M, . = 200,...M, . = 300,...M, . = 400,...M, =SOO,...M. Values expressed as Mean+SD. * 
= p<O.OS; ** = P <0.01; *** = p<0.001, relative to media. 
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Figure 3.11. Effects of Capsaicin on melanoma cell migration at 24 hours. (A) HBL cells, 
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Table 3.4. Statistical Summary for comparison between treatments - Effects of Capsaicin 
on Melanoma Cell Migration (p values). 
HBL Cells 
Time Points {hours} 
2 4 8 24 
Media vs 50 ~M ns ns ns ns 
Media vs 100 IJM ns ns ns ns 
Media vs 200 ~M ns ns ns ns 
Media vs 300 ~M ns ns 0.0150 0.0150 
Media vs 400 IJM ns ns 0.0130 Cell detachment 
Media vs 500 IJM ns ns Cell detachment Cell detachment 
A375SM Cells 
Media vs 50 ~M ns ns ns ns 
Media vs 1 00 ~M ns ns ns ns 
Media vs 200 ~M ns ns ns ns 
Media vs 300 ~M ns ns ns 0.0040 
Media vs 400 ~M ns ns 0.020 0.0001 
Media vs 500 ~M ns ns 0.010 Cell detachment 
C8161 Cells 
Media vs 50 ~M ns ns ns ns 
Media vs 1 00 ~M ns as ns ns 
Media vs 200 ~M ns ns ns ns 
Media vs 300 ~M ns ns ns ns 
Media vs 400 IJM ns ns ns ns 
Media vs 500 I:!M ns ns ns ns 
3.4.5. Effects of Capsaicin on TNF -0 Pre-stimulated Melanoma Cell Migration 
In these experiments the effects of capsaicin on TNF-a pre-stimulated melanoma 
cell migration was investigated. Cells treated with 300 U/ml TNF-a only were 
considered as controls. Overall, TNF-a increased melanoma cell migration over 24 
hours whilst the increasing capsaicin concentrations reduced melanoma cell migration 
in TNF-a stimulated cells (see Figures 3.12 and 3,13). 
For HBL cells, increasing capsaicin concentrations reduced migration in TNF-a 
pre-stimulated cells, however this was not significant (p>0.05). However, at 8 hours 
capsacin concentrations of 400llM and 500llM detached the cells in TNF-a pre-
stimulated cells, meaning that these were toxic to the cells. At 24 hours, HBL cell 
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migration was slightly reduced at 300~M capSaICIn In TNF-a pre-stimulated cells 
(p>O.05) relative to TNF-a treated cells. 
At 2, 4 , 8 and 24 hours, A375SM cell migration was significantly increased by 
300U/ml TNF-a compared to media treated cells (p<0.05, p<O.Ol, p<O.OOl and p<O.OOl 
respectively). At 2 hours, A375SM cell migration was reduced at 200~M, 300~M and 
500~M capsaicin in TNF-a pre-stimulated cells (p<0.05 in all cases) compared to TNF-
a treated cells. At 4 hours, 300~M and 500~M capsaicin concentrations reduced cell 
migration in TNF-a pre-stimulated cells (p<0.05 and p<O.OL respectively) relative to 
TNF-a treated cell. At 8 hours, A375SM cell migration was significantly reduced at 100 
and 200 capsaicin in TNF-a pre-stimulated cells (p<0.05 for both cases) and, at 400~M 
and 500~M (p<0.05 and p<O.Ol, respectively) rclative to TNF-a treated cells. At 24 
hours 100~M, 200~M and 300~M capsaicin significantly reduced A375SM cell 
migration in TNF-a pre-stimulated cells (p<0.05, p<O.Ol and p<0.05, respectively) 
relative to TNF-a treated cells. However 400~M and 500~M capsaicin detached 
A375SM cells from the wells and these concentrations were toxic to cells. Figures 3.12 
B and Figure 3.13 B illustrate these results. 
Overall, 300U/ml TNF-a slightly increased C8l61 cell migration compared to 
media treated cells and different capsaicin concentrations in TNF -a stimulated cells. 
This was significant at 2 and 4 hours, comparing TNF -a treated cells and media treated 
cells (p<O.Ol and p<0.05, respectively). At 8 and 24 hours, C8161 cell migration was 
significantly reduced at capsaicin concentration of 500~M in TNF-a stimulated cells 
(p<O.OS) compared to TNF-a treated cells. Figures 3.12 C and Figure 3.13 C illustrate 
these results and Table 3.S for a statistical summary of these results. 
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Figure 3.12. Effects of Capsaicin on TNF -a pre-stimulated melanoma cell migration over 
24 hours (h). (A) HBL cells, N=6. (B) A37SSM cells, N=S. (C) C8161 cells, N=6 . • = Media, 
• = TNF-a, = SO,.M, • = 100,.M, = 200,.M, • = 300,.M, • = 400,.M, =SOO,.M. 
Values are expressed as Mean+SD. * = p<O.OS; ** = p<O.OI, relative to TNF -a treated 
cells. 
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Figure 3.13. Effects of Capsaicin on TNF-a pre-stimulated melanoma cell migration at 24 
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Table 3.5. Statistical Summary for comparison between treatments - Effects of Capsaicin 
on TNF-a Pre-stimulated Melanoma Cell Migration (p values). 
HBl Cells 2 
Time Points {hours} 
4 8 24 
TNF-a vs Media ns ns ns ns 
TNF-a vs 50~M ns ns ns ns 
TNF-a vs 100IJM ns ns ns ns 
TNF-a vs 200~M ns ns ns ns 
TNF-a vs 300~M ns ns ns ns 
TNF-a vs 400IJM ns ns Cell detachment Cell detachment 
TNF-a vs 500IJM ns ns Cell detachment Cell detachment 
A375SM Cells 
TNF-a vs Media 0.0316 0.0030 0.0004 0.0001 
TNF-a vs 50IJM ns ns ns ns 
TNF-a vs 100IJM ns ns 0.0243 0.0168 
TNF-a vs 200~M 0.0159 ns ns 0.0032 
TNF-a vs 300IJM 0.0331 0.0493 ns 0.0274 
TNF-a vs 400~M 0.0521 ns 0.0234 Cell detachment 
TNF-a vs 500IJM 0.0105 0.0014 0.0051 Cell detachment 
C8161 Cells 
TNF-a vs Media 0.0023 0.0211 ns ns 
TNF-a vs 50t!M ns ns ns ns 
TNF-a vs 1 OO~M ns ns ns ns 
TNF-a vs 200IJM ns ns ns ns 
TNF-a vs 300~M ns ns ns ns 
TNF-a vs 400~M ns ns ns ns 
TNF-a vs 500IJM ns ns 0.0293 0.0186 
3.5. EFFECTS OF TNF-a, IBUPROFEN AND CAPSAICIN ON MELANOMA 
CELL VIABILITY 
In prevIous experiments the effects of TNF-a, Nalbu and capSalCll1 on 
melanoma cell migration were investigated. Melanoma cell migration was affected by 
these agents. In order to investigate whether migration was affected by the toxic effects 
of these agents a viability test (MTT assay) was used. These experiments used the same 
cells cultured in 12 well plates after finishing with the migration experiments (24 
hours). The MTT assay provided a reading for cell viability which was converted to a 
percentage of viable cells. 
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3.5.1. Effects of Nalbu (in media) on Melanoma Cell Viability 
In these experiments, melanoma cells were treated with NaIbu in media and 
melanoma cell viability was investigated (See Figure 3.14). Increasing concentrations of 
NaIbu in media reduced viability in three melanoma cell lines at two NaIbu 
concentrations used (66J..lM and 131J..lM) compared to control media. 
HBL control cell viability was normalised to 100%. HBL cell viability was 
significantly reduced to 14.3% and to 2.7% at NaIbu concentrations of 66J..lM and 
131J..lM (p<0.05 andp<O.OI), respectively. 
A375SM control cell viability was normalised to 100%. A375SM cell viability 
was significantly reduced to 25.6% and 2.5% at NaIbu concentrations of 66J..lM and 
131J..lM (p<0.01), respectively. 
C8161 control cell viability was normalised to 100%. C8161 cell viability was 
reduced to 61.4% at NaIbu concentration of 66J..lM. This was not significant (p>0.05). 
Viability was significantly reduced to 33% at 131J..lM NaIbu (p<0.01). Figure 3.14 and 
Table 3.6 illustrate a summary of these results. 
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Figure 3.14. Effects of Nalbu in media on melanoma cell viability. D = HBL cells, N=4. D = 
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Table 3.6. Statistical Summary for comparison between treatments - Effects of Nalbu in 
media on melanoma cell viability (p values) 
HBl Cells 
Media vs 66 ~M 
Media vs 131 ~M 
A375SM Cells 
Media vs 66 ~M 
Media vs 131 ~M 
C8161 Cells 
Media vs 66 ~M 
Media vs 131 pM 
p Value 
0.0125 
0.0021 
0.0045 
0.0007 
ns 
0.0074 
3.5.2. Effects of Nalbu hydrogel on Melanoma Cell Viability 
In these experiments, melanoma cells were treated with different concentrations 
of NaIbu hydrogel and cell viability was investigated (See Figure 3.1S). 
Viability of HBL cell treated with media only was normalised to 100%. HBL 
cell viability was unchanged by the unloaded hydrogel (98.2% viable cells) compared to 
media treated cells. HBL cell viability increased to 118% at 33 JlM Nalbu hydrogel 
concentration and was reduced to 87% and 60% at NaIbu hydrogel concentrations of 
66JlM and 99JlM, respectively. However, these were not significant (p<O.OS) relative to 
the unloaded hydrogel. A significant reduction in HBL cell viability to 26% occurred at 
NaIbu concentration of 131 JlM (p<O.O 1) relative to the unloaded hydrogel. 
Viability of A37SSM cell treated with media only was normalised to 100%. 
Overall, A37SSM melanoma cell viability was reduced with increasing concentrations 
of NaIbu hydrogel. A37SSM cell viability was slightly reduced to 78%, 62% and S7% 
at NaIbu hydrogel concentrations of 66JlM, 99JlM and 131 JlM respectively. Although 
99JlM and 131 JlM Nalbu hydrogel reduced A375SM cell viability compared to the 
unloaded hydrogel, these effects were not significant (p>O.OS). 
lOS 
Viability of C8161 cells treated with media only was normalised to 100%. 
C8161 cell viability was unchanged by the unloaded hydrogel (97.6% of viable cells) 
compared to media treated cells. Overall, C8161 melanoma cell viability was slightly 
reduced with increasing concentrations of N albu hydrogel compared to the unloaded 
hydrogel (p>0.05). 
These results suggest that Nalbu hydrogel had no toxic effect on A375SM and 
C8161 cells. See Figure 3.15 for an illustration of these results. 
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3.5.3. Effects of Nalbu hydrogel on TNF-a Pre-stimulated Melanoma Cell Viability 
In these experiments melanoma cells were pre-stimulated for 24 hours with 
300U/ml of TNF-u. After this incubation period, media was removed and fresh media 
was added to the cells. Inserts containing 300~1 of increasing Nalbu hydrogel 
concentrations were added to the wells. The cells exposed to unloaded hydrogels were 
also TNF-u pre-stimulated and were considered as controls. See Figure 3.16. 
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For the three melanoma cell lines, viability was unchanged at the unloaded 
hydrogel in TNF-a pre-stimulated cells compared to the cells treated with media or 
TNF-a only (p>0.05 respectively). 
Viability of HBL cells treated with media only was normalised to 100%. HBL 
cell viability was significantly reduced to 62%-, 21 % and 4% at 66~M, 99~M and 
131 ~M Nalbu hydrogel in TNF-a pre-stimulated cells (p<0.05, p<O.OOl and p<O.OOI 
respectively) relative to the unloaded hydrogel. 
Viability of A375SM cells treated with media only was normalised to 100%. 
A375SM cell viability was significantly reduced to 79.6%, 73%,65% and 48% at 33 
~M, 66~M, 99~M and 131 ~M Nalbu in TNF-a pre-stimulated cells (p<0.05, p<O.OI, 
p<O.OO 1 and p<O.OO 1 respectively) relative to the unloaded hydrogel. 
Viability of C8161 cells treated with media only was normalised to 100%. 
C8161 melanoma cell viability was reduced with the increasing concentrations ofNalbu 
hydrogel in TNF -a pre-stimulated cells relative to the unloaded hydrogel. C8161 cell 
viability was significantly reduced to 56% at 1311lM Nalbu hydrogel in TNF-a pre-
stimulated cells (p<0.05) relative to the unloaded hydroge1. See Figure 3.16 for an 
illustration of these results and Table 3.7 for a statistical summary. 
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Table 3.7. Statistical Summary for comparison between treatments - Effects of Nalbu 
hydrogel on TNF -a pre-stimulated melanoma cell viability (p values) 
HBL Cells p values 
Media vs TNF-a ns 
Unloaded hydrogel vs Media ns 
Unloaded hydrogel vs TNF ns 
Unloaded hydrogel vs 33 !-1M ns 
Unloaded hydrogel vs 66 !-1M 0.0226 
Unloaded hydrogel vs 99 !-1M 0.0001 
Unloaded hydrogel vs 131 !-1M 0.0001 
A375SM Cells 
Media vs TNF-a ns 
Unloaded hydrogel vs Media ns 
Unloaded hydrogel vs TNF-a ns 
Unloaded hydrogel vs 33 !-1M 0.0204 
Unloaded hydrogel vs 66 HM 0.0014 
Unloaded hydrogel vs 99 HM 0.0001 
Unloaded hydrogel vs 131 !-1M 0.0001 
C8161 Cells p Value 
Control vs TNF-a ns 
Unloaded hydrogel vs Media ns 
Unloaded hydrogel vs TNF-a ns 
Unloaded hydrogel vs 33 HM ns 
Unloaded hydrogel vs 66 HM ns 
Unloaded hydrogel vs 99 HM ns 
Unloaded hydrogel vs 131 !-1M 0.0455 
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3.5.4. Effect of Capsaicin on ~Ielanoma Cell Viability 
Capsaicin (in powder) was dissolved in O.S ml ethanol to give a stock solution 
for further dilutions in media. An initial experiment was done in triplicate to investigate 
the effects of ethanol on melanoma cells. A volume of pure ethanol was added to the 
media. This volume was equivalent to the volume used from the capsaicin stock 
solution to make a 600~M capsaicin concentration (18.24 ~l of ethanol in 10 ml media), 
resulting in media 0.18% ethanol. 
Increased capsaicin concentrations reduced viability of melanoma cells 
comparing cells treated with media only or media containing ethanol over 24 hours. As 
there was a single experiment of media containing ethanol, two controls were used for 
comparisons - media only or media containing ethanol compared to the increasing 
capsaicin concentrations. These results are included in Figure 3.17. 
Viability of HBL cells treated with media only was normalised to 100%. HBL 
cell viability was reduced to 61 % with media containing ethanol, compared to cells 
treated with media only. This was not significant (p>O.OS). Capsaicin concentrations 
significantly reduced HBL cell viability to 16.8%, 2.4% and 2.S% at capsaicin 
concentrations of 300~M, 400~M and SOO~M respectively (p<O.OO 1, p<O.O 1, p<O.OS 
respectively) relative to media containing ethanol. HBL cell viability was significantly 
reduced to 600/0, So%, 16.8%, 2.4% and 2.S% at capsaicin concentrations of I OO~M, 
200~M, 300~M, 400~M and SOO~M respectively (p<O.OS, p<O.OS, p<O.OOl. p<O.OOI 
and p<O.OO 1 respectively), compared to media only. 
Viability of A37SSM cells treated with media only was normalised to 100%. 
A37SSM cell viability was reduced to 66% with media containing ethanoL compared to 
cells treated with media only. Capsaicin reduced A37SSM cell viability to 51.So/0. 
16.1 % and I.S6% at concentrations of 300~M, 400~M and SOO~M (p<O.Ol. p<0.05. 
and p< 0.01, respectively) compared to media containing ethanol. A37SSM cell 
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viability was significantly reduced at capsalcm concentrations of 100JlM, 200JlM, 
300JlM, 400JlM and 500JlM (p<0.01 , p<O.Ol, p<O.OO l, p<O.OO l and p<O.OO l 
respectively), compared to media treated cells. 
Viability of C8161 cells treated with media only was normalised to 100%. 
C816l cell viability was reduced to 65% at media containing ethanol compared to cells 
treated with media only, however this was not significant (p<0.05). Capsaicin at 500JlM 
reduced C8l61 cell viability to 9.3% (p<0.01) relative to media containing ethanol. 
C816l cell viability was significantly reduced to 71.6%, 47.6%, 74.5%, 40.6% and 
9.3% at capsaicin concentrations of 100JlM, 200JlM, 300JlM, 400JlM and 500JlM 
respectively (p<0.05, p<O.Ol, p<0.05, p<O.Ol and p<0.05 respectively), compared to 
media treated cells. See Figure 3.17 for a summary of these results and Table 3.8 for a 
statistical summary of results. 
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Table 3.8. Statistical Summary for comparison between treatments - Effect of capsaicin on 
melanoma cell viability (p values) 
HBL Cells p Value HBL Cells p Value 
Media vs Media+ethanol ns Media vs Media+ethanol ns 
Media+ethanol vs 50 IJM ns Media vs 50 IJM ns 
Media+ethanol vs 100 IJM ns Media vs 100 IJM 0.0478 
Media+ethanol vs 200 IJM ns Media vs 200 IJM 0.0255 
Media+ethanol vs 300 IJM ns Media vs 300 IJM 0.0001 
Media+ethanol vs 400 IJM ns Media vs 400 IJM 0.0001 
Media+ethanol vs 500 IJM 0.0111 Media vs 500 IJM 0.0005 
A375SM Cells A375SM Cells 
Media vs Media+ethanol ns Media vs Media+ethanol ns 
Media+ethanol vs 50 IJM ns Media vs 50 IJM ns 
Media+ethanol vs 100 IJM ns Media vs 100 IJM ns 
Media+ethanol vs 200 IJM ns Media vs 200 IJM 0.0018 
Media+ethanol vs 300 IJM 0.0021 Media vs 300 IJM 0.0001 
Media+ethanol vs 400 IJM 0.0402 Media vs 400 IJM 0.0001 
Media+ethanol vs 500 IJM 0.0060 Media vs 500 IJM 0.0001 
C8161 C8161 
Media vs Media+ethanol ns Media vs Media+ethanol ns 
Media+ethanol vs 50 IJM ns Media vs 50 IJM ns 
Media+ethanol vs 100 IJM ns Media vs 100 IJM 0.0413 
Media+ethanol vs 200 IJM ns Meuia vs 200 IJM 0.0011 
Media+ethanol vs 300 IJM 0.0003 Media vs 300 IJM 0.0156 
Media+ethanol vs 400 IJM 0.0015 Media vs 400 IJM 0.0018 
Media+ethanol vs 500 IJM 0.0285 Media vs 500 IJM 0.0358 
3.5.5. Effect of Capsaicin on TNF -(1 Pre-stimulated Melanoma Cell Viability 
Increasing concentrations of capsaicin in TNF -a pre-stimulated melanoma cells 
reduced viability in the three melanoma cell lines (see Figure 3.18). 
HBL media treated cell viability was normalised to 100%. HBL cell viability 
was unchanged by TNF-a only treated cells (p>0.05) relative to media. However 
increasing capsaicin concentrations significantly reduced HBL cell viability to 50%, 
53% and below at concentrations of 50IlM, 1001lM, 200llM and 300llM (p<O.OO 1 in all 
cases) in TNF-a pre-stimulated cells, relative to TNF-a treated cells. No viable cells 
were found at capsaicin concentrations of 400llM and 500llM showing a very toxic 
effects on these cells. 
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A375SM media treated cell viability was normalised 100%. An almost 
significant reduction to 80% in A375SM cell viability occurred with TNF-a treatment 
(p=0.0559). A375SM cell viability was then reduced to 57%, 4%, 10%, 3%, 24%, and 
to 1.3% at capsaicin concentrations of 50~M (p<0.05), 100~M (p<0.001), 200~M, 
300~M, 400~M and 500~M (p<0.001) in TNF-a pre-stimulated cells relative to TNF-a 
treated cells. 
C8161 media treated cell viability was normalised to 100%. A significant 
reduction to 68% in C8161 melanoma cell viability occurred in TNF-a only treated cells 
(p<0.05). This was not expected as C8161 are quite resistant cells. C8161 cell viability 
was then reduced to 49%,34%,36%, and to 10% at capsaicin concentrations of200~M, 
300~M, 400~M and 500~M (p<0.01, p<O.OOl, p<O.OOl and p<O.OOl respectively) in 
TNF-a pre-stimulated cells, compared to TNF-a treated cells. See Figure 3.18 for an 
illustration of these results and Table 3.9 for a statistical summary. 
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Figure 3.18. Effect of capsaicin on TNF-a stimulated melanoma cell viability. 0 = HBL 
cells, N=6. 0 = A375SM cells, N=5. I = C8161 cells, N=6. Values are expressed as 
Mean+SD. * = p<0.05; ** = P <0.01; *** = P < 0.001, relative to TNF-a treated cells. 
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Table 3.9. Statistical Summary for comparison between treatments - Effect of capsaicin on 
TNF-a pre-stimulated melanoma ceU viability (p values) 
HBL Cells p Value 
TNF-a vs Media 0.0001 
TNF-a vs 50 lJM 0.0001 
TNF-a vs v 100 lJM 0.0001 
TNF-a vs 200 lJM 0.0001 
TNF-a vs 300 lJM 0.0001 
TNF-a vs 400 lJM 
TNF-a vs 500 lJM 
A375SM Cells 
TNF-a vs Media 0.0559 
TNF-a vs 50 lJM 0.0108 
TNF-a vs 100 lJM 0.0002 
TNF-a vs 200 lJM 0.0001 
TNF-a vs 300 lJM 0.0001 
TNF-a vs 400 lJM 0.0001 
TNF-a vs 500 !-1M 0.0001 
C8161 Cells 
TNF-a vs Media 0.0113 
TNF-a vs 50 !-1M ns 
TNF-a vs 100 lJM ns 
TNF-a vs 200 lJM 0.0097 
TNF-a vs 300 !-1M 0.0002 
TNF-a vs 400 lJM 0.0004 
TNF-a vs 500 !-1M 0.0001 
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3.6. DISCUSSIO~ 
Part of the justification behind this study is the phenomenon of local recurrence 
of malignant melanoma following surgical excision. Cancer cells that leave the primary 
tumour can seed metastases in distant organs. However, circulating tumour cells (CTCs) 
can also colonize their tumours of origin, a process known as "tumour self-seeding" of 
many types of cancer, such as breast, colon and melanoma tumours. Tumour self-
seeding explains this common phenomenon of local recurrence seeded by disseminated 
cells following complete excision (Kim et al., 2009). Surgical excision creates an 
inflammatory wound bed which may be favourable to melanoma cell invasion and 
metastasis. 
The link between inflammation and cancer development is getting stronger and 
the use ofNSAIDs as therapy to reduce or block cancer development is being explored. 
In this chapter the role of the NSAID ibuprofen and of capsaicin in opposing the 
migratory effect of the pro-inflammatory cytokine TNF-a on HBL, A375SM and C8161 
human melanoma cell lines was investigated. Melanoma cell migration (in a 2D model) 
and cell survival were investigated after cells were exposed for 24 hours to TNF-a, 
ibuprofen or capsaicin. 
Three types of melanoma cells used were of different levels of invasiveness and 
origin. HBL cells were obtained from a lymph node metastasis of a malignant 
melanoma, meaning that these cells may have originated from a previous stat i of1(1ry site 
of a cutaneous primary melanoma tumour. Culturing HBL cells demonstrated their 
lower proliferation rate compared to the other two melanoma cell lines used. 
A375SM cells were obtained from an established A375 melanoma cell line from 
a lymph node metastasis. These cells then became highly metastatic as a A375-SM 
subline once established in culture from lung metastasis by parental A375 cells growing 
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subcutaneously in mice. Culturing A375SM demonstrated an intermediate proliferation 
rate compared to HBL cells and the highly proliferative C8161 cells. 
C8161 cells were obtained from a metastatic tumour of the abdominal wall and 
this indicates a very aggressive (invasive and proliferative) melanoma, capable of 
further metastatic cascade and tumour formation. 
Melanoma cells migrated at a linear rate over 24 hours. However this linearity 
changed by the effects of ibuprofen or capsaicin, both reducing melanoma cell 
migration. 
In the first experiments it was investigated the effect of ibuprofen on melanoma 
cell migration. Ibuprofen [(±)-(R, S)-2-4( 4-isobutylphenyl)-propionic acid] is known as 
a NSAID, used to relieve pain and inflammation (Davies, 1998). It works by inhibiting 
non-selectively cyc100xygenase COX-l and COX-2 forms, with analgesic and anti-
inflammatory effects. 
Previous studies have looked at non-steroidal anti-inflammatory agents with and 
without COX-inhibition properties; a-MSH, indomethacin and aspirin respectively, as 
many investigators (Benamouzig et at., 2005; Borthwick et aI., 2006) have suggested 
that anti-cancer properties of NSAID and selective COX-2 inhibitors may be 
independent of their COX-inhibition properties. COX-2 blockade is effective for both 
cancer prevention and therapy (Harris, 2007). 
Initially, Ibuprofen dissolved in media significantly reduced migration III 
melanoma cells. However, it was also toxic to HBL and A375SM cells at the lower 
concentrations of 66/-lM Ibuprofen. This could be attenuated by incorporating ibuprofen 
in a hydrogel resulting in a slow release of ibuprofen. 
Ibuprofen incorporated into a Pluronic F -127 hydrogel demonstrated a slow 
release in distilled water. The hydrogel may had the same pattern of ibuprofen delivery 
in cell culture media, as it was observed a progressive reduction of cell migration 
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associated with low cytotoxicity. Although the release of ibuprofen from the hydrogel 
was measured only in distilled water, the same conditions were kept during the 
melanoma migration experiments for a slow released of ibuprofen from the hydrogel in 
media i.e., the same polymer concentration of 30% and temperature of 37°C during 
incubation. Pluronic F -127 hydrogel has been clinically used. It is a copolymer which 
forms thermo-sensitive hydrogels and may by advantageous as an injectable therapeutic 
formulation for an anti-cancer treatment (Hsu et al., 2003) and, as a carrier for other 
routes of administration such as oral, nasal, topical and ocular (Escobar-Chavez et al., 
2006). 
Ibuprofen hydrogel (Nalbu hydrogel) reduced migration of the three melanoma 
cell lines without inducing toxicity to the cells. As expected, migration of HBL cells 
was reduced more than that of A375SM and C8161 cells. The hydrogel itself had some 
slightly inhibitory effect on cell migration but this was not significant. This may have 
demonstrated that a slower release of Ibuprofen from a hydrogel was more effective in 
reducing melanoma cell migration and yet not toxic to the cells. The only significant 
toxic effect of Nalbu hydrogel was observed on HBL cells at a maximum Nalbu 
concentration of 131 ~M. 
In this study an in vitro inflammatory-like environment was created to study an 
association between inflammation and cancer. Therefore, the first steps in this 
investigation were to find the optimal concentration of TNF-a for melanoma cell 
migration and the concentration at which sodium Ibuprofen becomes toxic. Previous 
work in the Kroto Institute (Redpath et al., 2009) established that a concentration of 
around 300-400 U/ml and exposure for 24 hours produced maximal effects on cell 
migration and, this is consistent with previous studies on HBL melanoma (Katerinaki et 
aI., 2006). Therefore in this Shldy 300U/ml TNf-a was used to stimulate an 
inflammatory condition to melanoma cells in culture. 
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Melanoma cells were 24 hours pre-stimulated with 300U/ml TNF-a and 
Ibuprofen was added to the cells. Accordingly, TNF-a (on its own) increased melanoma 
cell migration for the three melanoma cell lines. Addition of Ibuprofen incorporated into 
the hydrogel reduced migration in melanoma cells below the control level of migration 
for HBL and A375SM cells and, just above control migration level for C8161 cells. For 
hydrogels loaded with 99/lM and 131/lM of ibuprofen this effect was significantly 
greater than the effect of the gel on its own. HBL and A375SM melanoma cell survival 
was significantly reduced by 40% at 66/lM and above concentrations of NaIbu 
hydrogel. A higher concentration of 131/lM NaIbu hydrogel was necessary to 
significantly reduce C8161 cell survival. This is in fair agreement with another study by 
Janssen et al. (2008) who demonstrated that both induction of a cell cycle block and 
apoptosis after S- and R-ibuprofen treatment was in part dependent on p53 in human 
colon cancer cells. 
NSAIDs have been used as an anti-cancer therapy, however, the mechanism of 
these COX inhibitors remain unclear. Melanoma progression is often associated with 
supra-normal levels of IL-I and IL-6. During inflammation, TNF-a is a potent inducer 
of IL-6 gene transcription factor and synthesis. IL-6 is therefore thought to be another 
primary growth factor driving the progression of human melanoma. The likely 
mechanism of COX inhibition leading to IL-6 lowering is due to the tendency for IL-6 
levels to be controlled by intracellular cyclic adenosine monophosphate (cAMP). COX 
inhibitors lower prostaglandin E levels. This lowers intracellular cAMP levels. Lower 
cAMP results in lower IL-6 synthesis (van Kemper et ai., 2006), and therefore reduces 
inflammation. 
TNF-a has been described as a pro-inflammatory cytokine which promotes 
melanoma cell migration, invasion and survival and to upregulate ICAM- L integrin and 
NF-KB expression, with increased melanoma cell migration and invasion (Zhu et aI., 
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2002). All of these effects can be inhibited by a-MSH (Canton et aI., 2003) and sodium 
salicylate (Katerinaki et at., 2006). 
Melanoma cell migration was also investigated under the effects of another 
NSAID, capsaicin. Capsaicin is an extract from the red chilli peppers and it is used 
topically to relieve pain such as in peripheral neuropathy (Tesfaye, 2009). There are 
many suggestions that capsaicin utilizes a vanilloid receptor-l (VR1) which functions as 
a calcium-permeable non-specific cation channel and it is utilized in painful thermal 
stimuli in vivo (Caterina et aI., 1997). Capsaicin has an immunological and neurological 
response against established tumours (Beltran et aI., 2007). It has also been recognised 
as an anti-inflammatory agent (Southall et al., 2003; Zegarska et aI., 2006) and as a pro-
apoptotic agent (Kim et at., 2004). 
Capsaicin significantly reduced HBL and A375SM cell migration at a higher 
concentration of 300J.lM but had no effect on C8161 cell migration. However, 100J.lM 
capsaicin significantly reduced melanoma cell viability by 30-40%. This suggests that 
the suppressive effect of capsaicin on melanoma cell migration may be due to the anti-
inflammatory and pro-apoptotic effects of capsaicin. This is in accordance with another 
study (Patel et aI., 2002a) which demonstrated that capsaicin inhibited cellular 
proliferation and NF-kB transcription factor activity over 96 hours on A375P cells, 
reducing cell viability 50% at 100J.lM capsaicin. 
Capsaicin concentration above 300J.lM significantly reduced migration in the 
three melanoma cell lines. This reduction in migration is associated with the cytotoxic 
effect of capsaicin as comparisons between media containing ethanol reduced cell 
viability at the same capsaicin concentration (300IlM). Considering media only as 
controL capsaicin was toxic at a lower concentrati,on of 1001lM. 
There was one viability experiment in which ethanol in media was used as 
control for comparisons. In this, melanoma cell viability was largely reduced, but not 
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statistically significant. In addition to this, ethanol concentration in media to be used as 
control was higher than the maximum ethanol concentration in media to make up the 
maximum capsaicin concentration of 500/lM used in the experiments. For this reason, 
for the remaining experiments the investigation of the effects of capsaicin on melanoma 
cells and fibroblasts viability, it was decided to use media treated cells as control. 
The effect of capsaicin on TNF-a stimulated melanoma cell migration was also 
investigated. When melanoma migration was pre-stimulated with 300U/ml TNF-a 
migration was increased in three melanoma cell lines however, increasing capsaicin 
concentration suppressed melanoma cell migration. HBL cell migration was stopped 
above 300/lM capsaicin. At 400/lM capsaicin, migration carried on with just a few 
A375SM cells (data now shown). This capsaicin concentration was toxic for most cells 
however, some resistant and residual cells within the cell culture continued migrating. 
This may represent what occurs in vivo, where a few melanoma cells escape from 
chemotherapy or radiotherapy and continue to migrate and invade. TNF -a stimulated 
C8I61 cell migration however, only 500/lM capsaicin significantly reduced migration 
of theses cells. This capsaicin concentration started to be toxic to these cells, showed by 
significant reduction in C8161 cell viability. 
In terms of cell viability TNF-a pre-stimulation and further treatment with 
capsaicin showed toxic effect on three melanoma cell lines at 50/lM. This is in fair 
agreement with Shin et al. (2008) who reported a suppressive effect of capsaicin on 
B 16-F 1 0 melanoma cell migration, targeting P I3-KJ Akt/Rac I-mediated cellular events. 
The anti-inflammatory and anti-migratory effect of capsaicin on melanoma cells 
can also be confirmed by Philip and Kundu (2003) who used curcumin, a known anti-
inflammatory agent which inhibited osteopontin-induccd NF-kB transcriptional activity 
and MMP-2 activation, reducing murine (B 16-F 1 0) melanoma cell migration and 
tumour growth in nude mice. 
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Similar to the proposed mechanisms of ibuprofen, capsaicin is reported to 
modulate the expression of inflammatory iNOS (inducible Nitric Oxide synthase) and 
COX-2 (cyclooxygenase-2) genes in macrophages and may proyide new insights into 
the potential benefits of capsaicin in inflammatory conditions (Chen et al.. 2003). 
Reports on the effects of capSaICIn as an apoptosis inducer are not yet 
completely understood, however capSaICIn may involve plasma membrane or 
mitochondrial targets. It has been therefore suggested that this vanilloid agent may be 
useful for preventing or treating skin cancers or other hyperproliferative skin disorders 
(Hail and Lotan, 2002). 
The fact that TNF-a on its own significantly reduced A375SM and C8161 cell 
viability was unexpected as TNF-a is known 'to promote melanoma cell survival. 
Overall. the accelerated migration in melanoma cells induced by TNF -a was attenuated 
by capsaicin. without the latter being very toxic to these cells. These findings are similar 
to those of other authors (Shin et aI., 2008). 
The stimulatory effect of TNF -a on melanoma cell migration and invasion has 
been previously reported by Katerinaki et ai. (2003). However, the inhibitory effect of 
NSAIDs on melanoma cell migration pre-stimulated with TNF-a has also been 
demonstrated with the utilization of alpha melanocyte stimulating hormone (Zhu et aI., 
2002) and with sodium salicylate (Katerinaki et ai., 2006). 
In conclusion. this data on three very different melanoma cell lines confirmed 
that capsaicin and a hydrogel releasing ibuprofen sodium salt were capable of inhibiting 
human melanoma cell migration. This adds more evidence to previous data on 
inflammation and melanoma migration in demonstrating an anti-migration effect of 
Ibuprofen and Capsaicin on TNF-a stimulated cells. 
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CHAPTER 4 
EFFECTS OF CAPSAICIN ON MELANOMA CELLS 
DEGRADA TION ABILITY IN FIBRIN SCAFFOLD 
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4.1. MELANOMA CELLS AND FffiRIN SCAFFOLD DEGRADATION 
Initially, the aim of this experiment was to look at melanoma cell invasion in a 
simple fibrin 3D model. This was made by adding fibrin clots to a 24 cell culture well 
plate. The volume of fibrin clot added was O.5ml which made a scaffold 2mm in 
thickness in each well of a 24 culture well plate. The plate contained a mixture of 
fibrinogen plus thrombin and was incubated for a period of 24 hours, to allow the 
fibrinogen and thrombin to clot. After this incubation period, melanoma cells were 
added to the fibrin clot at a concentration of 4x104 cells in 1 ml of media per well and 
were again incubated for 24 hours. See Figure 4.1 for an illustration of this method. 
Figure 4.1. Fibrin degradation after 24 hours incubation with melanoma cells. This was 
followed by a protein assay. 
After this incubation period, it was observed that the fibrin clot was broken into 
pieces by HBL and A375SM cells added to the scaffold. However, fibrin to which 
C8161 cells were added remained intact. 
These results suggest that HBL and A375SM melanoma cells have a degradative 
capability and hence destroy the fibrin scaffold. Micrographs illustrate what have 
happened in Figure 4.2 in which HBL and A375SM cells are attached to broken pieces 
of fibrin (see light and fluorescent mIcroscopy (DAPI) staining for cell nuclei) . 
122 
Surprisingly, C8161 cells did not affect the structure of the fibrin clot scaffold. The 
C8161 cell nuclei were not distinguished by fluorescent staining as these cells seemed 
to be invaded into the scaffold. This was unexpected as C8161 cells are the most 
invasive and aggressive of the 3 cell lines as previously demonstrated. 
2 hours 
Light Microscopy C8161 
C8161 
A375SM 
HBL 
24 hours 
Fluorescent Microscopy 
24 hours 
Light Microscopy 
Figure 4.2. Micrographs of light and fluorescent microscopy at 2 and 24 hours showing 
melanoma cells on fibrin clot scaffold. 20x magnification, scale bar = 50,...m. 
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An attempt was made to observe what happened to the melanoma cells after 6 
hours of incubation. In this experiment, 6 hours after seeding melanoma cells on the 
fibrin clot scaffolds did not show any degradative response. In fact, melanoma cells 
seemed to be forming some clusters or isolated cells not attached to the surface of the 
fibrin clot, as the cells were rounded up and clustered together (see Figure 4.3). 
Although these are not good images for visualisation of what had happened, one can 
observe that at 6 hours of incubation the melanoma cells were still suspended in media 
or trying to attach to the surface of fibrin underneath. 
A 
c 
Figure 4.3. Melanoma cells seeded on a fibrin scaffold. A = C8161, B= A375SM, C = HBL 
cells. Melanoma cells were still not attached to the fibrin clot after 6 hours incubation 
period. Scale bars = 100",m. 
The exact time which melanoma cells start their degradative enzymatic activity 
remains to be clarified. Therefore, the next experiments were still carried out incubating 
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melanoma cells for 24 hours to observe the degradative capability of these melanoma 
cells. 
4.2. ASSESSMENT OF THE ABILITY OF MELANOMA CELLS TO DEGRADE 
THE FmRIN SCAFFOLD 
A protein assay was conducted using different volumes of the fibrinogen and 
thrombin mixture, digesting with the digestion buffer as referred in Materials and 
Methods (section 2.4.3.4). 
Absorbance readings were taken at 540 mm with reference of 630 mm. As it can 
be seen in Figure 4.4 the absorbance reading for the protein assay increased with the 
increased volume of fibrin clot added to the wells. This was then used as an assay for 
estimating the volume of fibrin clot remaining in these experiments. 
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Figure 4.4. Assay of fibrin clot volume following protein digestion. 
In the next experiments melanoma cells were incubated for 24 hours on a fibrin 
clot scaffold. HBL and A375SM melanoma cells (but not C8l61 cells) were shown to 
have the ability to degrade and destroy a fibrin clot scaffold during this incubation 
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period. In order to be able to obtain an accurate measure of the amount of fibrin clot left 
by the melanoma cells a protein assay was then used to quantify the amount of fibrin 
clot remaining. At the end of the 24 hours incubation media was removed (this was the 
same volume for all cell lines - not shown) and the remaining fibrin clot quantified. 
The protein assays demonstrated that the amount of fibrin clot protein left by 
melanoma cells was higher in HBL cells than for C8161 (p=O.0475) and A375SM cells 
(p=O.Ol14) (see Figure 4.5). However, this was not consistent when observing by eye 
the amount of fibrin clot left in the wells, after 24 hours incubation with melanoma 
cells. Looking at the wells it was possible to observe that the amount of fibrin clot left 
by C8161 was higher than the other two types of melanoma cells (A375SM and HBL), 
as is shown in Figure 4.2. 
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Figure 4.5. Assessment of amount of residual fibrin clot after melanoma cell digestion. 
Incubation period = 24 hours. Values are expressed as Mean + lSD. N=3. * indicates 
p<O.05, relative to C8161 cells. 
As this experiment was not consistent in terms of measuring the amount of fibrin 
clot, it was possible that the FCS present was preventing digestion of the fibrin clot by 
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the digestion mixture of SDS and urea, this was then investigated in the following 
experiments. 
4.3. ASSESSMENT OF THE ABILITY OF MELANOMA CELLL TO 
DEGRADE THE FmRIN SCAFFOLD IN THE PRESENCE AND ABSENCE OF 
FCS 
In this experiment a comparison was made between the ability of melanoma 
cells to digest fibrin in a medium with and without FCS. This was made to investigate 
whether FCS was blocking the ability of melanoma cells to digest fibrin clot (see Figure 
4.6). 
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Figure 4.6. Assessment of amount of residual fibrin clot with and without FCS . • = C8161, 
• = A375SM and 0 = HBL melanoma cells. Incubation period = 24 hours. Values 
expressed as Mean +SD from calculations of triplicate wells. N=1. 
The results showed that in the absence of FCS there was less residual content 
from the fibrin left by the three melanoma cells. This time, A375SM cells in FCS-free 
media showed degraded all of the fibrin clot scaffold. 
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In the next experiment, degradation of the fibrin clot in the absence of FCS was 
examined. Figure 4.7 showed that C8161 and HBL cells did not degrade the fibrin clot 
after 24 hours incubation period. On the other hand, A375SM cells destroyed most of 
the fibrin clot (see Table 4.1 for a statistical summary of these results). However, there 
was a considerable variance between the experiments as shown by the high SD values. 
A control value of fibrin without any added melanoma cells was used in these 
experiments as a reference. 
0.10 
0.08 
-e-
0.06 
.2 c (JO 
.: ~ 0.04 
~~ 0.02 II.. ClB 0.00 c c 
- III 
=-e 
nI 0 
-0.02 E 1/1 &!~ 
-0.04 
-0.06 
** 
-0.08 
No cells C8161 A375SM HBL 
Figure 4.7. Assessment of amount of residual fibrin clot without FCS. D = shows the fibrin 
clot without any added cells, I = C8161, • = A375SM and D = HBL melanoma cells. 
Incubation period = 24 hours. Values expresses as mean +SD. Student t-test for 2 samples 
presuming equivalent variances. N=3. ** indicates p<O.OI, relative to fibrin clot. 
Table 4.1. Assessment of residual fibrin clot without FCS. Statistical summary. 
Comparisons p values 
C8161 vs A375SM p=O.OO6 
A375SM vs HBL P=O.072 
C8161 vs HBL P=O.073 
C8161 vs PBS (control) P=O.712 
A375SM vs PBS (control) P=O.OO6 
HBL vs PBS (control) P=O.893 
PBS vs Fibrin Clot P=O.779 
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4.4. EFFECT OF CAPSAICIN ON MELANOMA CELL DEGRADATIVE 
ABILITY 
There are many studies suggesting that capsaicin can be used as a NSAID and 
also as an anti-cancer drug. This experiment examined the effects of capsaicin on the 
ability of melanoma cells to degrade fibrin clot. 
The same procedure was followed in this experiment in which 0.5 ml fibrin clot 
was added to a 24 well plate. C8161 and A375SM melanoma cells were seeded at a 
density of 5xl04 cells/ml per well and, HBL cells were seeded at a density of 4xl04 
cells/ml per well. Capsaicin was added to treated wells at 300 ~M/ml per well. Cells 
were incubated for 24 hours. See Figure 4.8 and Table 4.2 for an illustration of these 
results. 
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Figure 4.8. Effects of capsaicin on melanoma cell fibrin degradation capability. 
Assessment of amount of residual fibrin clot in FCS free media. 0 = no added cells, • = 
C8161, • = A375SM and 0 = HBL melanoma cells. Cap 300 = 300~M Capsaicin. 
Incubation period = 24 hours. Student t-test for 2 samples presuming equivalent 
variances. (N=3). Mean +SD. * = p<0.05; ** = p<O.Ol; *** = p<O.OOl, relative to their 
respective control. 
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Table 4.2. Effects of capsaicin on melanoma cell degradative capability in fibrin clot. 
Statistical summary. 
C8161 p values 
Control vs 300 p=0.2285 
PBS vs Control p=0.0743 
PBS vs 300 p=0.0970 
A375SM 
Control vs 300 p=0.7765 
PBS vs Control p=0.0018 
PBS vs 300 p=0.0003 
HBL 
Control vs 300 . p=0.0219 
PBS vs Control p=0.0383 
PBS vs 300 p=0.0018 
For C8161 cells (Figure 4.8) the amount of fibrin clot remammg was not 
significantly reduced by the addition of these cells with or without capsaicin (p>0.05). 
A375SM and HBL cells however significantly reduced the amount of fibrin 
remaining in the well. See Table 4.2 for significant values. 
In contrast, capsaicin significantly reduced the degradative capability of both 
A375SM cells and HBL cells when compared to control wells. 
In conclusion, these results demonstrate the degradative ability of the HBL and 
A375SM cells and that capsaicin reduced this degradative ability. C8161 cells showed 
no degradative enzymatic activity and capsaicin did not influence this. 
4.5. DISCUSSION 
Initially the aim of this study was to investigate melanoma cell invasion in a 3D 
fibrin clot scaffold as a model scaffold which occurs naturally in wound healing. 
However, 24 hours after seeding the melanoma cells, the fibrin clot scaffold was 
destroyed by two of the three melanoma cell lines. 
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The differing degradative ability of the melanoma cell lines was interesting and 
was investigated further. HBL and A375SM cells were very capable of degrading the 
fibrin clot scaffold whilst C8l6l cells did not. 
A recent review indicates that inflammatory leukocytes contribute to cancer 
development either via the release of vesicle-stored growth and survival factors and 
diverse proteolytic enzymes which result in altered pericellular matrix remodelling 
activity (Felding-Habermann et al., 1992). 
To remove a primary melanoma there will always be a wound followed by the 
healing process. Melanoma cells may remain either in the blood/lymphatic circulation 
or melanoma cells may still be present within the wound site. As part of the wound 
healing process inflammation will take place together with the production of 
inflammatory cytokines and chemokines. This is followed by removal of cell debris and 
chemotaxis of new and inflammatory cells, together with the production of fibrin clots 
for tissue regeneration. If melanoma cells are still present in a wound healing site, they 
may contribute to the reoccurrence of melanoma. Invasion may be facilitated by the 
pressure of the fibrin clot which occurs early in wound healing. In recent years this 
hypothesis of inflammation contributing to melanoma invasion have been investigated 
in the Kroto Institute laboratory (Eves et aI., 2003)~ Canton et aI., 2003~ Katerinaki et 
at., 2006). 
It is believed that melanoma cell invasion and migration involves the activation 
of proteolytic enzymes. However, Katerinaki et al. (2003) demonstrated that the pro-
inflammatory cytokine TNF -u increased melanoma migration at 24 hours and invasion 
through fibronectin, but did not upregulate/activate the expression of latent MMP-2 and 
MMP-9 (Metalloproteinases 2 and 9). This study suggested that migratory and invasive 
characteristics of melanoma cells may be helped by other skin cells' enzyme activity (as 
MMP-2 and MMP-9 were found to be elevated in the skin cells of the tissue engineered 
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skin) which is capable of degrading the components of extracellular matrix. Some 
authors (Goldbrunner et aI., 1996) have examined integrin signalling and integrin-
GTPase interplay in the context of cancer cell growth and behaviour. A study by 
Felding-Habermann et al. (1992) suggested that the expression of a single integrin avp3 
is correlated with the most malignant phenotype of human melanoma in situ which can 
interact with fibrinogen and its natural breakdown products suggesting a significant cell 
adhesion mechanism that may contribute toward the metastatic phenotype of human 
melanoma cells. 
Some studies support the theory of down-regulation of integrin expression as a 
potential suppressor of invasion by melanoma cells (Zhu et aI., 2002; Balzac et al., 
1994; Henriet et aI., 2000; Iida et al., 2004). 
The idea of using a fibrin clot scaffold was to be able to observe melanoma cells 
invasion in a simple 3-D model. However, after 6 hours of seeding time, cells had not 
attached to the fibrin clot and, after a 24 hours incubation period unfortunately, the 
fibrin clot scaffold was destroyed by some cells. ,The exact time over which melanoma 
cells start their degradative enzymatic activity remains to be clarified. They may start 
their enzymatic activity after 6 hours of incubation or perhaps develop a sudden activity 
after 20 hours of incubation which may be linked to the increased number of cells in the 
culture. However, this does not seem likely as HBL cells were the melanoma cell line 
which most degraded the fibrin scaffold yet have lowest proliferation compared to the 
other two melanoma cell lines. 
It was much easier to see melanoma cell digestion of the fibrin clots in the 
absence of FCS as the presence of FCS seemed to block the ability of the digestion 
buffer to breakdown the fibrin clot. In the presence of FCS the results obtained did not 
result in what one saw by eye. In the absence of FCS the results did reflect the extent of 
visible breakdown of the fibrin clots. 
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Capsaicin reduced the degradative capability of HBL and A375SM melanoma 
cells but had no effect on C8161 cells. This may help in the prevention of invasion of 
these cells and metastasis formation. 
Interestingly the degradative capability was reduced by capsaicin, as shown for 
A375SM and HBL cells. Surprisingly C8161 cells were not affected by capsaicin. These 
cells seemed to invade through the fibrin scaffold without showing any evident 
degradative capability. This may be explained by the low concentration of capsaicin 
used (300 /lM) on C8161 cells. 
The effects of capsaicin III reducing the degradative ability of 2 out of 3 
melanoma cells could be attributed to the suppressive effect of capsaicin on the 
enzymatic activity of the melanoma cells or, on the integrin binding to fibrin or, a 
combination of these two effects. 
In conclusion, this simple model of just melanoma cells and a fibrin clot shows 
how different the degradative ability of melanoma cells was in vitro. HBL and A375SM 
cells were capable of degrading the fibrin scaffold whilst C8161 cells were not. These 
experiments also demonstrated the effects of capsaicin in reducing the degradative 
capability of HBL and A375SM cells. In reality, in vivo melanoma cells need to invade 
through a more complex skin environment which contains skin cells which will 
themselves remodel the extracellular matrix following wounding and inflammation. 
Accordingly melanoma cell invasion may be influenced by adjacent skin cells and 
wounding. 
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CHAPTERS 
INVESTIGATION OF THE IMPACT OF WOUNDING AND 
INFLAMMATION ON MELANOMA INVASION IN 3D TISSUE 
ENGINEERED SKIN 
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5.1. COMPARISON BETWEEN SKIN COMPOSITES MADE OF STERILISED 
AND NON-STERILISED DED 
In this study, tissue engineered human skin was used to investigate the impact of 
wounding and inflammation on melanoma invasion. The use of acellular dennis was 
previously reported by Chakrabarty et al. (1999) as a dermal scaffold for skin 
composites. Previous skin composites were produced using sterilised human dermis 
using the glycerol/ethylene oxide method described in Eves et al. (2000). This use of a 
sterilisation protocol was primarily because of developing this as tissue engineered skin 
to take to the clinic. 
Firstly in this study the question of whether the model could be used with non-
sterilised DED was investigated. Figure 5.1 comprises composites produced using 
sterilised (A, C and E) and non-sterilised (B, D and F) DED. As can be seen from this 
figure, the standard skin composites (A and B) had a layer of epidennis and, as expected 
a normal dermis. Skin composites produced using DED to which skin cells and C8161 
melanoma cells were added are shown in Figur~ 5.1 (C and D). Figure 5.1 E and F) 
show C8161 cells on DED and there was an evident invasion into the dermis. 
Figure 5.1 shows that there was no difference in morphology between the pairs 
of sterilised and non-sterilised skin composites. Therefore, future studies were carried 
out using non-sterilised (or fresh) DED for the production of human skin composites. 
The advantage of using non-sterilised DED is that the human skin is only treated 
with IMolar NaCI for 18 hours receiving no further treatments. This helps in the 
retention of natural collagen and basement membrane components yet achieves an 
acellular dermis. The disadvantages are the greater risks of infection using this non-
sterilised DED. Table 5.1 and Table 5.2 show a summary of these skin composites 
results. Later in this chapter an analysis of the incidents of infection and integrity of the 
composites on long tenn storage is described in section 5.5.8. 
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Sterilised DED Non-sterilised DED 
A B 
Figure 5.1. Morphological comparison between glycerol/ethylene oxide-sterilised DED 
(left) and non-sterilised DED (right). Standard skin composites to which fibroblasts and 
keratinocytes were added (A and B). Keratinocytes, fibroblasts and C8161 melanoma cells 
were added to DED (C and D); DED to which C8161 melanoma cells were added (E and 
F). 4x magnification. 
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Table 5.1. Sterilised and Non-sterilised Skin composites. 
Number of Experiments Skin Composite 
Sterilised Non-sterilised 
DED+F+K 
DED+F+K +C8161 
DED+C8161 
5.2. STANDARD SKIN COMPOSITES 
2 2 
2 2 
2 2 
More standard skin composites were produced for investigation of cell invasion 
and later comparison to the melanoma skin model. Figure 5.2 shows skin composites 
containing keratinocytes and fibroblasts. In all, twenty-two standard skin composites 
were produced (one lost due to infection) and an invasion score was used to quantify 
invasion of any cells into the dermis (see section 2.5.8 in Chapter 2 - Methods). All of 
these standard skin composites showed an invasion score of 0, meaning that in these 
composites there was no invasion ofkeratinocytes into the dermis (see Table 5.2). 
Epidermis ~ Epidermis 
Dermis 
Dermis 
2500 11m 2500 11m 
Figure 5.2. Standard Skin Composites to which fibroblasts and keratinocytes were added 
to the DED. 4x magnification. 
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5.3. MELANOMA INVASION IN HUMAN SKIN COMPOSITES 
In these composites, melanoma cell invasion in reconstructed human skin was 
studied. Three melanoma cell lines were used which were known to have different 
invasion levels. Figure 5.3 shows examples of the invasion of all three cell types, Figure 
5.6 shows the extent of melanoma cell invasion into the dermis and, Table 5.2 shows the 
invasion score for melanoma cell invasion into the dermis. 
In four composites (four were lost due to infection) to which HBL cells were 
added on their own to the DED, a mean invasion score of 1 was reported (See Table 5.2 
and Figure 5.6). In seven composites (one was lost due to infection) to which HBL cells 
were added with fibroblasts a lower mean invasion score of 0 was observed. In six 
composites to which fibroblasts and keratinocytes were added together with HBL cells, 
four had an invasion score of 0 and, one two had an invasion score of 1 (mean score = 
0.33). Non-parametric Mann-Whitney t-test demonstrated that the invasion score of skin 
composites containing HBL cells, fibroblasts and keratinocytes compared to the 
invasion score of skin composites containing HBL cells and fibroblasts was not 
significant (p>O.05). Skin composites containing HBL cells on their own showed a 
significantly higher invasion score compared to the skin composites containing HBL 
cells, fibroblasts and keratinocytes (p<O.05) and to skin composites containing HBL 
cells and fibroblasts (p<O.O I). Thus this demonstrated that there was clearly more 
invasion of melanoma cells in the presence of fibroblasts and keratinocytes and that the 
presence of fibroblasts only stopped HBL cell invasion in the dermis. 
A375SM melanoma cells when added to the DED on their own were a little less 
invasive when compared to the invasion of HBL cells into the dermis (See Table 5.2 
and Figurc 5.5). In seven composites to which were added only A375SM cells, six had 
an invasion score of 0 and one had a score of 3 (mean score = 0.43). Skin composites 
containing A375SM melanoma cells added with fibroblasts showed no cell invasion. In 
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six composites (one was lost due to damaged DED), all had an invasion score of O. 
A375SM melanoma cells when added together with fibroblasts and keratinocytes, in 
nineteen composites, seven had an invasion score of 0, two scored 0.5, one scored 1, 
two scored 1.5, two scored 2, two scored 2.5 and three scored 3 (mean score = l.21), 
(three composites were lost due to damaged DED). Skin composites containing 
A375SM cells and skin cells had a significantly increased cell invasion score compared 
to skin composites containing A375SM cells and fibroblasts (p<0.05). There was no 
statistical significance between skin composites containing A375SM cells on their own 
compared to skin composites containing A375SM cells and fibroblasts (p>0.05). This 
may be explained by the occurrence of just one out of seven skin composites containing 
A375SM cells on their own with an invasion score of 3 resulting in variability of the 
sample. Cell invasion in skin composites containing A375SM cells, fibroblasts and 
keratinocytes compared to skin composites containing A375SM cells on their own was 
also not significant (p>0.05). 
In order to distinguish between A375SM cells and keratinocyte invasion into the 
dermis, SlOO antibody staining, specific for A375SM melanoma cells was used. The 
A375SM melanoma cells showed little invasion. Surprisingly, A375SM cells when 
added together with normal skin cells "encouraged" keratinocyte invasion into the 
dermis as can be seen in Figure 5.4 A and B. It was possible to observe that some 
groups of cells invaded into the demlis (Figure 5.4 A). The cells invading into the 
dermis were confirmed to be keratinocytes (in purple colour) in the presence of 
A375SM cell (in red colour) (Figure 5.4 B). It appeared that the cells of the epidermal 
layer had entered the dermis, possibly by degradative enzymes facilitating inyasion of 
keratinocytes and melanoma cells. 
C8161 melanoma cells were very invasive when added together with 
keratinocytes and fibroblasts. The results are summarized in Table 5.2 and Figure 5.6. 
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In fifteen of these composites (two were lost due to infection), two had an invasion 
score of 1, one had a score of 2, and twelve had a score of 3 (mean score = 2.67). For 
C8161 cells when added with fibroblasts to the OED, in five composites, two had an 
invasion score of 0.5 and three composites had a score of 3 (mean score = 2). In thirteen 
composites when C8161 cells were added on their own to the OED, one composite had 
an invasion score of 1 and twelve composites had a score of 3 (mean score 2.85). 
Although composites to which were added fibroblasts and C8161 melanoma cells 
resulted in a lower invasion score when compared to the other composites also 
containing C8161 cells, this was not significant (p>0.05). Therefore, C8161 cells 
showed the same level of invasion no matter what other cells were present. In order to 
observe keratinocyte invasion, an antibody staining (AE 1 AE2) for keratinocytes (in 
brown colour) was used. It is worth noting that although C8161 melanoma cells invaded 
the dermis, in these composites, there was also an infiltration of keratinocytes into the 
dennis, as illustrated in Figure 5.4 C and D. 
These results indicate that C8161 melanoma cells are highly invasive, A375SM 
cells have an intermediate level of invasion in th~ presence of skin cells and HBL cells 
had the lowest invasion level in the presence of skin cells when compared to the other 
two melanoma cells. These results confirm those published by Eves et at. (2000). 
It was interesting to note that for two of the weakly invasive melanoma cells 
(A375SM and HBL's) the presence of fibroblasts almost completely stopped cell 
invasion. However A375SM cells in these composites could make some "pocket-like" 
openings in the dermis, demonstrating degraded areas by these melanoma cells. A 
summary of these results can be found in Table 5.2 and Figure 5.5. 
Table 5.2 also lists 11 skin composites experiments that were lost to infection or 
damaged OED. 
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" 
Figure 5.3. Skin composites to which were added melanoma cells. (A) Skin cells 
(fibroblasts and keratinocytes) and HBL melanoma cells in DED (lOx magnification); (B) 
HBL melanoma cells only in DED; (C) Skin cells and A375SM melanoma cells in DED; 
(D) A375SM melanoma cells only in DED; (E) Skin cells and C8l6l melanoma cells in 
DED; (F) C8l6l melanoma cells only in DED (4x magnification). 
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A 
Keratinocytes 
c 
1000 I'm 
Figure 5.4. Antibody staining for melanoma cell invasion visualization. A and B show skin 
composites containing A3758M cells (A) H&E staining, (B) 8100 antibody staining for 
A3758M cells, 4x magnification respectively. (C and D show skin composites containing 
C8l6l cells (C) H&E staining, (D) AE1AE3 antibody staining for keratinocytes only, lOx 
magnification respectively. 
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B Pocket-like structures 
Figure 5.5. Skin composites to which were added fibroblasts and melanoma cells only. (A) 
HBL, (B) A375SM and (C) C8161 cells. lOx magnification and 500/0 zoom on the right 
hand side of each composite. 
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Table 5.2. Invasion Score for melanoma cell invasion into the dermis. 
Skin Composite No. 
Comp 
Sterile F+K 
Sterile C8161 
Sterile F+K+C8161 
F+K 
C8161 
F+C8161 
F+K+C8161 
A375SM 
F+A375SM 
F+K+A375SM 
HBL 
F+HBL 
F+K+HBL 
F+K (22/22 Score 0) 
C8161 (12/13 Score 3) 
F+C8161 (3/5 Score 3) 
F+K+C8161 (12/15 Score 3) 
A375SM (6/7 Score 0) 
F+A375SM (6/6 Score 0) 
F+K+A375SM (3/19 Score 3) 
HBL (4/4 Score 1) 
F+HBL (7/7 Score 0) 
F+K+HBL (2/6 Score 1) 
2 
2 
2 
22 
13 
5 
15 
7 
6 
19 
4 
7 
6 
o 
Lost 
1 
1 
1 
3 
4 
1 
0.5 
Invasion Score 
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1.21 
1 
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Figure 5.6. Differences in the extent of melanoma cell invasion into the dermis. The skin 
composite types are described followed by the number of skin composites in which the 
invasion was scored. The maximum invasion score is indicated in brackets. The 
histograms show the mean + ISEM of all scores. * indicates p<0.05; ** indicates <0.01. 
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5.4. EFFECTS OF NSAIDs ON MELANOMA SKIN COMPOSITES 
In these experiments, two melanoma cell lines (C8161 and A375SM cells) were 
added to the skin composites to investigate the effects of Nalbu hydrogel (containing 
13111M Ibuprofen) on melanoma cell invasion. Control skin composites without NaIbll 
hydrogel produced skin composites composed of an epidermal layer and a normal 
dermis with invaded melanoma cells, as expected. However, the addition of 100111 of 
N albu hydrogel at concentration of 13111M produced skin composites with no cells. 
Figure 5.7 shows examples of melanoma skin composites treated with media only 
(control) and the ones treated with 100111 Nalbu hydrogel. 
Skin composites which were added fibroblasts and melanoma cells also 
produced the same pattern of result. In 13111M Nalbu hydrogel treated composites, no 
cells were present. However controls showed cells attached on composites (see Figure 
5.8). 
The same kind of results was obtained in composites which were added 
melanoma cell only. Figure 5.9 illustrates an example of a composite which was added 
A375SM cells as a control and a composite treated with Nalbu hydrogel. 
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Figure 5.7. Effects of 100p.11 Nalbu hydrogel on skin composites. Skin composite containing 
C8161 cells (A) = control, (B) = 131p.1M Nalbu hydrogel. Skin composite containing 
A375SM cells (C) = control, (D) = 131p.1M Nalbu hydrogel. 4x magnification. 
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Figure 5.8. Effects of 100p.11 Nalbu hydrogel on skin composites. Fibroblasts and C8161 
cells added to DED (A) = control, (B) = 131p.1M Nalbu hydrogel. Fibroblasts and A375SM 
cells added to DED (C) = control, (D) = 131p.1M Nalbu hydrogel. 4x magnification. 
A B 
2500 Jim 2500 Jim 
Figure 5.9. Effects of 100p.11 Nalbu hydrogel on A375SM cells only added to DED. (A) = 
control, (B) = 131p.1m Nalbu hydrogel. 4x magnification. 
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A different but also deleterious effect was observed in C8161 melanoma cells 
skin composites to which were added capsaicin at a concentration of 350JlM. These skin 
composites had a poorly attached epidermis (see Figure 5.10 A+B) and a damaged 
dermis. See Table 5.3 for a summary of these results. 
2500 IUD 2500 I'm 
Figure 5.10. Effects of Capsaicin on C8161 melanoma cell skin composites. (A+B) 350f.1M 
capsaicin (in media). 4x magnification. 
Table 5.3. Effects of Nalbu hydrogel (100f.11 volume) and Capsaicin (in media) on Skin 
Composites. 
Number of 
Skin Composite Results 
Experiments 
F+K+C8161 (Control) Good composites. Invasion score = 3 1 
F+K+C8161+131JiM Nalbu hydrogel No cells 1 
F+K+A375SM (Control) Good composites. Invasion score = 2 1 
F+K+A375SM+131JiM Nalbu hydrogel No cells 1 
F+C8161 (Control) Good composites. Invasion score = 3 1 
F+C8161 + 131 JiM Nalbu hydrogel No cells 1 
F+A375SM (Control) Good composites. Invasion score = 0 1 
F+A375SM+ 131 JiM Nalbu hydrogel No cells 1 
C8161 (Control) Good composites. Invasion score = 3 1 
C8161+131JiM Nalbu hydrogel No cells 1 
A375SM (Control) Good composites. Invasion score = 0 2 
A375SM+NaIbu hydrogel 131JiM No cells 2 
F+K+C8161+ 350JiM Capsaicin Dislodged epidermis and damaged dermis 2 
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In these initial composite experiments 1 OO~1 of hydrogel containing NaIbu was 
used but irrespective of the cell combination used there were no cells detected in these 
composites after 10 days incubation. Also. 350~M capsaicin was demonstrated to 
detach the epidermis from the dermis. The conclusion was that this local concentration 
of NaIbu was toxic to the cells. Accordingly future experiments used only 30~1 of 
hydrogel. (Lower capsaicin concentrations should also be used in future experiments). 
5.5. DEVELOPMENT OF 3D WOUNDED SKIN MODEL 
In this part of the work, wounded tissue engineered human skin was developed 
and melanoma cell invasion was investigated. Fibrin clots and TNF-a were added to 
simulate some of the conditions of the normal inflamed wound bed which would have a 
high concentration of fibrin and TNF-a. 
5.5.1. Skin Composites Wounded with a Syringe Needle 
All of these composites contained normal skin cells and HBL or C8161 
melanoma cells and were then wounded - initially using a syringe needle. Following 
wounding, fibrin clots and TNF-a were added to mimic inflammatory wound healing 
conditions. 
Firstly, normal cells and melanoma cells were added to the DED to make a 
melanoma skin model. These composites were incubated in an Air-Liquid Interface 
(ALI) for 7 days and, after this period a wound using a syringe needle was made. 
After wounding. a plastic ring made of a 'section of a PVC (polyvinyl chloride) 
tube (4mm height x 6mm diameter inside the ring) was placed on the top of the cell 
seeded area of the composite. 300~1 of fibrin clot containing 300U/ml TNF-a was added 
in the ring (See Figure 5.11). These composites were then incubated at an ALI for a 
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further 12 days. The histology results showed no signs of wounds and also, the dermis 
showed no cells, suggesting that these composites were infected (See Figure 5.12 A, B, 
C and D). Table 5.4 shows a summary of 3 such experiments. Clearly wounding with a 
needle alone did not produce any visible wounds after culture for 12 days at an ALI. 
Plastic Ring 
+Fibrin clot 
+TNF 
Stainless 
steel grid 
Skin 
composite 
Figure 5.11. Skin composites at an ALI. A fibrin clot (3001.11) and TNF-a (300U/ml) were 
added into the plastic ring. 
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Figure 5.12. Syringe needle wounded skin composites. (A and B) Skin composite 
containing HBL cells to which were added fibrin clots and TNF -U; 4x magnification. (C 
and D) Skin composites containing C8161 cells to which were added fibrin clots and TNF-
u. No wound was visible and no cells were present; 4x and lOx magnification respectively. 
AU images are from the middle of each composite. 
Table 5.4. Syringe needle wounded skin composites. 
Fibroblasts Melanoma Kerati nocytes TNF-a Visible 
No. Fibrin 
wound 
Experiments Clot 
Yes No 
1 + HBL + + + 1 
2 + C8161 + + + 2 
(+ = present) 
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5.5.2. Skin Composites Wounded with a Scalpel Blade 
As the technique for wounded skin composites using a needle was not successful 
in producing visible wounds, full thickness wounds in a shape of a cross (See Figure 
5.13) were then made using a scalpel blade in the following skin composites. After 
wounding, a plastic ring made from a section of a plastic Pasteur pipette (7mm height x 
12mm diameter) was placed on the top of the cell seeded area of the composite. 300lli 
of a fibrin clot containing 300U/ml TNF-a was added into the ring (See Figure 5.14). 
Wound 
....-,.£---:;f--- Cell seeded area 
Figure 5.13. Diagram of a Skin Composite. Full thickness wounds in a shape of a cross. 
Plastic ring 
+Fibrin clot 
Figure 5.14. Scalpel blade full thickness wounded skin composites in ALI. A fibrin clot 
(300,d) and TNF -a (300U/ml) were added into the plastic ring. 
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In this experiment skin composites containing fibroblasts, keratinocytes and 
C8161 melanoma cells were incubated at an ALI for 10 days then a wound was made 
and composites incubated for a further 7 days. Histology of skin composites revealed a 
full thickness skin wound as shown in Figure 5.15 (A). However no cells were present 
in this composite suggesting an infected composite. In Figure 5.15 B, C and D it is 
possible to observe that more cells were present in the composite, however no wounds 
were visible. This experiment resulted in 2 full thickness wounds of 4 composites 
wounded with a scalpel blade. See Table 5.5 for results. 
A 
Wound 
Figure 5.15. Effects wounding made by a scalpel blade on healing of C8161 cell skin 
composites to which was added 300J11 of a fibrin clot plus 300U/ml TNF -n. (A) Visible 
wound (4x magnification). (B) far left (lOx magnification), (C) middle (lOx magnification) 
and (D) far right pictures of the same composite with no visible wounds (4x 
magnification). F=Fibroblasts; K=keratinocytes; C8161 melanoma cells. 
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Table 5.5. Scalpel blade full thickness wounded skin composites. 
Fibroblasts Melanoma Kerati nocytes TNF-a Visible 
No. Fibrin 
wound 
Experiments Clot 
Yes No 
4 + C8161 + + + 2 2 
(+ = present) 
As in these composites there were not many cells present, in the next 
experiments the amount of fibrin clot was reduced from 300~1 to 30-50~1 to see if this 
improved the composites. Also the fibrin clot was now added in a more localized 
fashion to the wound site rather than using a ring. This was done to increase the skin 
composite surface area not directly in contact with the fibrin clot. In these next 
composites, it is possible to observe then that there were more cells present and closer to 
the wounded site. See Figure 5.16. 
A 
c 
Figure 5.16. Scalpel blade wounded skin composite to which was added skin cells, HBL 
cells, fibrin clots and 300U/ml TNF-a. (A) middle, visible wound, (B) right, (C) left (lOx 
magnification), (D) middle (4x magnification). Wound is indicated by an arrow. 
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In order to examme whether it was the fibrin clot or the TNF -a that was 
reducing the cells in the composites, in the next experiment, TNF-a was added in media 
without any fibrin clot. In 4 experiments treated with TNF -a added in the fibrin clot, 3 
showed visible wounds and only one showed a closed wound. In 2 experiments treated 
with TNF-a in media, 2 of them showed a visible wound (see Figure 5.17). Table 5.6 
shows a summary of these composites produced. Therefore, there was not much 
difference between skin composites with and without a fibrin clot, although one skin 
composite showed a layer of epidermis. 
A 
Epidermis 
Figure 5.17. Scalpel blade wounded skin composites to which were added fibroblasts, 
keratinocytes and HBL cells and, TNF-a in media. (A) visible wound, (B) small wound and 
damaged epidermal layer (lOx magnification). Wound is indicated by an arrow. 
Table 5.6. Effect of fibrin clot on wound healing of skin composites. 
No. Fibroblasts Melanoma Kerati nocytes Fibrin TNF-a Visible 
Experiments Clot wound 
Yes No 
4 + HBl + + + 3 1 
2 + HBl + + 2 0 
in media 
(+ = present) 
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5.5.3. Effect of Fibrin Clot on Wound Healing 
In these early wounded skin composites, there were in retrospect many variables 
included in each experiment, making interpretation difficult. Therefore, simpler skin 
composites were next produced in order to observe the effects of a fibrin clot on wound 
healing. Some skin composites contained no cells, others contained only fibroblasts, 
others contained keratinocytes and fibroblasts. Wounds were made in these composites 
on the 11th day of incubation at ALI and fibrin clots plus TNF-a were added at this time. 
For these fibrin clot studies the volume was kept at 30-50/l1. These were then incubated 
for a further 7 days. Feeding was done every 2 days by removing old media and 
replacing with fresh media and a fresh fibrin clot plus TNF-a solution was made and 
added to the composites. 
Figures 5.18 (A and B) show that there was no morphological difference 
between the cell-free DED and the DED added fibrin clot. However, the wounded DED 
resulted in a wide open wound while a narrow wound was demonstrated when the fibrin 
clot was added to the wounded DED (Figure 5.18 C and D respectively). 
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Figure 5.1S. Addition of wounds and fibrin clot to cell-free DED to which were added 
Fibrin clot and with/without wound. (A) DED; (B) DED+Fibrin; (C) DED+Wound; (D) 
DED+Wound+Fibrin (4x magnification). 
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In the experiments illustrated in Figure 5.19, normal dermis was found (A) when 
fibroblasts only were added to DED. The addition of fibrin clots to DED did not show 
any difference when compared to the added fibroblasts only composites (B). As 
expected in DED containing fibroblasts, the wounded site showed a healed DED with 
very little remaining of the wound (C). However, the presence of the fibrin clot the skin 
composite showed an open wound (D). This may indicate the importance of 
participation of fibroblasts in the wound healing process. Table 5.7 shows a summary of 
these skin composites produced. 
Figure 5.19. Addition of wound and fibrin clots to DED plus fibroblasts. The site of the 
wound is indicated by an arrow. (A) DED+Fibroblasts; (B) DED+Fibroblasts+Fibrin; (C) 
DED+Fibroblasts+Wound; (D) DED+Fibroblasts+Wound+Fibrin. lOx magnification. 
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In the next experiment a wounded standard skin composite was produced to compare 
the wound and healing process with and without the addition of fibrin clots and TNF-a. 
See Figure 5.20. 
A B C 
I I 
2Soo"m 1000 11M 1000 11M 
E 
\ 
1000 "m 
Figure 5.20. Wounded standard skin composites (A, B and C) 4x, lOx and lOx 
magnifications respectively. Standard skin composites with the addition of fibrin clots and 
TNF-a (D and F) lOx magnification. The site of the wound is indicated by an arrow. 
With one exception of an experiment that was lost due to damaged OED, in two 
experiments, in which keratinocytes were added, the epidermis reformed over the still 
openly wounded dermis. Figures 5.20 (A, B and C) show this skin composite. A low 
magnification is used in A (4x) to illustrate the width of the wound at the end of the 10 
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day experiment. Band C are 10 x magnifications to show continuous epidermal, layer 
around the wound edges. 
In another experiment when fibrin clots and TNF -a were added to the 
composites smaller wounds and a closed epidermal layer formed at 10 days as 
illustrated in Figures 5.20 D and E. It was not possible from these 2 experiments to 
interpret the influence of inflammation given by TNF-a so far. A summary of these 
results is shown in Table 5.7. 
Table 5.7. Effect of fibrin clot and normal skin cells on wound healing. 
Fibroblasts Wound Fibrin TNF-a Keratinocytes Result 
- - - - - NormalDED 
- - + - - NormalDED 
- + - - - Open wide wound 
- + + - - Narrowed wound 
+ - - - - Normal Dermis + F 
+ - + - - Normal Dermis + F 
+ + - - - Healed 
+ + + - - Narrowed wound 
+ + - - + Open wide wound 
+ + + + + Small wound 
+ + + + + Epidermis healed, 
narrowed wound 
(+ = present; - = absent) 
5.5.4. Wound Healing in Composites Containing Melanoma Cells 
At this stage only HBL melanoma cells were added together with the normal 
skin cells to the skin composites and the effect of wounding was examined. 
In two experiments produced containing HBL cells, the wounds were open 
however, an epidermal layer formed around the edges of the wound, showing invasion 
of cells in the wound edges site (Figure 5.21 A and B). A summary of this result is in 
Table 5.8. 
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Figure 5.21. Wounded melanoma skin composites without the addition of fibrin clots and 
TNF-a. (A and B) Skin composites containing HBL cells (lOx and 40x magnification 
respectively). The site of the wound is indicated by an arrow. 
Table 5.8. Wounding and healing in melanoma skin composites. 
Number of 
Experiments 
2 
(+ = present) 
Fibroblasts Keratinocytes 
+ + 
HBl 
Cells 
+ 
Results 
Open wide wound 
In the next skin composites, to the DED were added fibroblasts, keratinocytes 
and A375SM melanoma cells, fibrin clots and TNF-u. These composites were incubated 
at an ALI for 10 days then a wound was made and 30-50/ll fibrin clot was added and the 
composite was incubated for a further 7 days. As shown in Figure 5.22 (A), one skin 
composite without TNF-u was healed or demonstrated a very narrow wound. However 
in those composites to which fibrin clots and TNF -u were added a partially healed or 
open wound was demonstrated. These composites also showed cells in the wound (See 
Figure 5.22 B, C, D and E). This can be better seen in Figure 5.22 E, where cells invade 
in a badly made wound. (This particular wound was more clumsily made than others but 
the epidermis was continued to completion to observe what happened). A summary of 
these results is show in Table 5.9. 
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Figure 5.22. Effect of TNF -0 on melanoma cell invasion in wounded skin composite model. 
All figures show composites containing DED+F+K+A375SM that have been wounded and 
a fibrin clot placed in the wound. In addition Figures B, C D and E have also received 
TNF- 0 (300U/ml). The site of the wound is indicated by an arrow. A, Band D, 4x 
magnification. C and E, lOx magnification. 
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Table 5.9. Wounded melanoma skin composites, fibrin clots and TNF-a. 
Number of Fibroblasts Keratinocytes A375SM Fibrin TNF-a Result 
Experiments Cells Clot 
1 + + + Healed 
3 + + + + + Open/partially 
healed 
(+ = present; - = absent) 
Following these results it was decided to simplify the wound by making a single 
scalpel cut rather than a cross with two cuts for future experiments. 
For these next skin composites, fibroblasts, melanoma cells and keratinocytes 
were added to the DED. However, wounds were made on the 3rd day after lifting the 
skin composites into an ALI. A full thickness wound was made by just a single cut 
using a scalpel blade (See Figure 5.23). After wounding, fibrin clots and TNF-u were 
added to the wound site. The skin composites were then incubated for a further period 
of 10 days. 
...-..,t.---/-- Cell seeded area 
Figure 5.23. Diagram of a Skin Composite. Full thickness wound made by a single cut. 
As an example of this method control wounded skin composites (without TNF-
u), are shown in Figure 5.24 (A). This figure shows 3 skin composites to which were 
added fibroblasts, keratinocytes, A375SM and the open wound was made using a single 
cut using a scalpel blade on the 5th day after wounding. To these composites were also 
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added fibrin clots in the wounded area. After 10 days of incubation, the wounds were 
visibly healed. See Figure 5.24 (B). These skin composites were then sacrificed for 
histology (Figure 5.25). 
Figure 5.24. Wounded sldn composites to which were added fibroblasts, keratinocytes, 
A375SM cells and fibrin clots. (A) open wounds 5 days after wounding. (B) Healed wounds 
in skin composites after 10 days incubation into ALI. 
164 
Figure 5.25. Wounded skin composites to which were added fibroblasts, keratinocytes, 
A37SSM cells and fibrin clots. A, C and E show the top of each composite. B, D and F 
show the top-middle with the wound sites indicated by an arrow and a dotted line. Scale 
bars = 100 Ilm. 
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The histological results show that these three skin composites containing A375SM cells 
had achieved good healing and the site of the wounds can be seen as demonstrated in 
Figure 5.25. See Table 5.10 for a summary of these results. 
Melanoma skin composites containing A375SM cells to which were added 
fibrin clots and TNF-a, demonstrated partially healed wounds. Histological observations 
of these wounds in these composites showed they were more evident than the ones 
without TNF -a. This may indicate that TNF -a delayed the wound healing process 
(Figure 5.26 A, B and C). 
Wounded melanoma skin composites containing HBL cells to which were added 
fibrin clots and TNF-a, showed an inconsistent pattern of wound healing. These 
composites showed either a totally open wound in which the epidermal layer formed 
around the open wound edge (Figure 5.26 D) and a wound which had almost completely 
healed as shown in Figure 5.26 (E). A summary of these results are in Table 5.10 
Table 5.10. Effects of fibrin clot and TNF-a in full thickness wounded skin composites 
containing melanoma cells. 
Number of F Melanoma K Fibrin TNF-a Open Partially Extensively 
Experiments Clot wound healed healed 
wound wound 
3 + A375SM + + 0 0 3 
3 + A375SM + + + 0 3 0 
4 + HBL + + + 2 
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Figure 5.26. Wounded skin composites containing DED+F+K+ Melanoma cells to which 
were added fibrin clots and TNF -a. (A, B and C) Skin composites to which were added 
A375SM cells, fibrin clots and TNF-a showing partially healed wounds (lOx, 4x and lOx 
magnification respectively). (D and E) Skin composites to which were added HBL cells, 
fibrin clots and TNF -a showing one open wound (D) and a wound which had almost 
completely healed (E) (4x and lOx magnification respectively). The site of the wound is 
indicated by an arrow. 
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5.5.5. Effect of NSAIDs on Wounded Melanoma Skin Composites 
In these experiments, skin composites were produced by adding normal skin 
cells and C8161 melanoma cells. The wounds were made after 7 days of incubation at 
an ALl. A volume of 30~1 hydrogel releasing ibuprofen sodium salt (Nalbu hydrogel) 
was added on the top of the wound site. Unloaded hydrogels and NaIbu hydrogel at 
concentration of 131 ~M were used. These composites were incubated for a further 
period of 7 days and were fed every 2-3 days with fresh media followed by a fresh 
topical application of NaIbu hydrogel. One skin composite to which was added skin 
cells and C8161 cells without any treatment demonstrated an almost healed wound (this 
served as a control sample). Both unloaded hydrogel and 131 ~M Nalbu hydrogel 
treatments on skin composites also showed healed wounds in these C8161 melanoma 
skin models. Figure 5.27 shows the histology of these skin composites and Table 5.11 
shows a summary of the results for this experiment. 
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A 
Figure 5.27. Effects of Nalbu hydrogel on wound healing of wounded melanoma skin 
composites. DED+F+K+C8l6l (A). DED+F+K+C8l6l+unloaded hydrogel - top (B). 
DED+F+K+C8l6l+unloaded hydrogel- bottom (C). F+K+C8l6l+NaIbu hydrogel13lIJ.M 
(D). lOx magnification. The site of the wound is indicated by an arrow 
169 
In the next experiments HBL melanoma skin composites were treated \vith capsaicin or 
Nalbu sodium salt, both added to media. 
Figure 5.28 shows wounded skin composites to which were added HBL cells 
and different treatments with NSAIDs. Open wide wounds were found in these samples. 
Figure 5.28 (A and B) shown an open wide wound in media treated composites (control 
samples). The 40x magnification micrograph (B) showed some cells invading into the 
wound edges. Open wide wounds also occurred when 100llM capsaicin (in media) was 
added to the wounded composites (C and D), however there may be less cells invading 
into the wound edges. Wounded skin composites treated with 100llM Nalbu in media 
also demonstrated wide open wounds and some infiltrating cells on the wound edge (E 
and F). A summary of these results is shown in Table 5.11. 
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Figure 5.2S. Wounded skin composites. DED+F+K+HBL cells (A and B). DED+F+K+HBL 
cells+ lOOIlM Capsaicin (C and D). F+K+HBL cells+lOOIlM Nalbu in media (E and F). lOx 
and 40x magnifications respectively. The site of the wound is indicated by short arrow. 
Invading cells are indicated by long arrows. 
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Table 5.11. Effects of NSAIDs on wounded skin composites. 
No. of Fibroblasts Melanoma Keratinocytes Treatment Wound 
Composites 
+ C8161 + Control Healed 
2 + C8161 + Unloaded Healed 
hydrogel 
2 + C8161 + Nalbu Healed 
hydrogel 
131IJM 
2 + HBL + Control Open 
2 + HBL + Capsaicin Open 
100IJM 
2 + HBL + Nalbu Open 
100jJM 
(in media) 
In the next set of experiments, skin composites containing A375SM cells were 
wounded on the 3rd day after being lifted to an ALI. These composites were fed with 
fresh media every 2-3 days, however some of these composites also received different 
treatments as follows: 
1. Control- wounded A375SM skin composites treated with media only; 
2. Treatment with fibrin clots plus TNF-a - to these composites, fibrin clots 
plus TNF-a (300U/ml) were added in the wound site at every feeding; 
3. Treatment with fibrin clots plus TNF-a and a further treatment with Nalbu 
hydrogel - these composites were treated as previously described in item 2. 
and also received a further treatment with unloaded hydrogel or 1 OO~M 
Nalbu hydrogel (See Figure 5.29). 
All of these skin composites were ended on the 9th or lOth day after wounding. 
Figure 5.29 (A) shows the A375SM skin composites after 2 days of wounding. It 
shows a full thickness wound made in all skin composites. Figure 5.29 (B) shows each 
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skin composite after treatment with fibrin clot plus TNF-a (300U/ml). The lower line of 
wells containing skin composites were the ones which also were treated with NaIbu 
hydrogel (l OO~M). Figure 5.29 (C) shows the skin composites at the end of the 
experiment (9th day after wounding). One out of the three skin composites which was 
not treated with NaIbu hydrogel showed a visible open wound. However all three skin 
composites which were treated with 100~M NaIbu hydrogel showed apparent healed 
wounds. 
Figure 5.30 shows the histological results of control wounded skin composites 
containing skin cells and A375SM cells. One of these composites had an open 
epidermal layer and cell invasion (See Figure 5.30 A, B and C). Another composite 
showed a disrupted epidermal layer, cell invasion and a small breakage of the lower part 
of the dermis (see Figure 5.30 D, E and F). These composites showed a poor quality 
dermal layer. 
A375SM skin composites to which fibrin clots plus TNF-a were added to the 
wounds are shown in Figure 5.31. The histology results from this experiments 
confirmed one open wound and two healed wound composites which were not treated 
with NaIbu hydrogel. One of these skin composites showed a thicker epidermal layer 
when compared to the other two skin composites. In these three skin composites, the 
dermal layer was very poor quality. 
A375SM skin composites to which were added fibrin clots plus TNF-a and a 
further treatment with the unloaded hydrogel showed healed composites but with 
extensive destruction of the lower part of the delmis. Figure 5.32 shows an example of 
these composites which had a very disrupted dermis and an apparently healed 
epidermis. However, it is worth observing that in this composite, cells invaded into the 
dermis and formed a "rounded mass" of cells at'the bottom of the dermis (See Figure 
5.32 C and D). 
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Figure 5.33 shows A375SM melanoma skin composites to which were added 
fibrin clots plus TNF-a followed by 100JlM Nalbu hydrogel treatment. In these 
composites the wounds were healed and there was a thin but evident epidermal layer 
present. The dermis was also intact and there were no signs of broken regions. A 
summary of these results is shown in Table 5.12. 
c 
Figure 5.29. A375SM Melanoma skin composites to which were added with fibrin clots 
plus TNF-a (300U/ml) and a further treatment with lOOIlM Nalbu hydrogel. (A) Nalbu 
hydrogel treated skin composites after 2 days of wounding. (B) Each skin composite after 
treatment with fibrin clot plus TNF -a (300U/ml). Only the lower line of wells containing 
skin composites were the ones which also were treated with Nalbu hydrogel (lOOp.1M). (C) 
Shows the skin composites at the end of the experiment (9th day after wounding). 
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Figure 5.30. Wounded A375SM skin composites - controls. (A, B and C) = broken 
epidermis with healed dermis and cell invasion. (D and E) = disrupted epidermis with 
invasion of epidermis into the dermis. (F) = broken DED and invasion of cells. Wounds are 
indicated by an arrow. Scale bars = 1001lm. 
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Figure 5.31. Wounded skin composites containing A375SM melanoma cells to which 
were added fibrin clots plus TNF-a (300U/ml). (A) Open wound (lOx magnification), (B 
and C) healed wounds, damaged DED (4x magnification). 
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Figure 5.32. A375SM Melanoma skin composites to which were added with fibrin clots 
plus TNF-a (300U/ml) and a further treatment with unloaded NaIbu hydrogel (30J.11 
volume). (A, top) = disrupted epidermis; (B, half of middle) = healed wound with invasion 
of cells; (C, lower middle) = formation of a mass of invasive cells, indicated by a dotted 
line. (D, bottom) = cell invasion (also indicated by a dotted line) and slight breakage of 
dermis. 5x magnification, scale bars= l00J.1m. 
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Figure 5.33. A375SM Melanoma skin composites to which were added with fibrin clots 
plus TNF-a (300U/ml) and a further treatment with lOOf.1M NaIbu hydrogel (30f.11 
volume). (A and C) 4x magnification; (B and D) lOx magnification. 
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Table 5.12. Effects of Nalbu hydrogel on A375SM cell wounded skin composites. 
Treatment Description 
For A375SM wounded composites 
No treatment 
Fibrin Clot+ TNf-a 
Fibrin Clot+TNF-a 
NaIbu Unloaded Hydrogel Treated 
Fibrin Clot+TNF-a 
lOO!lM NaIbu Hydrogel Treated 
Results 
I partially healed wound and 
1 healed wound but with destruction of 
the lower DED 
I open wound and 
4 healed but with destruction of the 
lower DED in all cases 
2 healed but with some destruction of 
the lower DED in all cases 
5 healed good skin composites 
Good quality OED 
A summary of these skin composites can be seen in Figure 5.34. 
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Total ~o. 
Composites 
2 
5 
5 
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Figure 5.34. Effects of Ibuprofen on wounded melanoma skin composite model. All 
composites contained fibroblasts, keratinocytes and A375SM cells and fibrin clots plus 300 
VIm] TNF-a (as in A and C). To E and G was added unloaded hydrogel. To B, D, F and H 
were added 100",M NaIbu hydrogel. B, C, D, E, G and H = 4x magnification; A and F = 
lOx magnification. 
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5.5.6. Effects of Wounding and of NSAIDs on Melanoma Cell Invasion 
The effects of wounding and of NSAIDs on melanoma cell invasion are 
illustrated in Table 5.13. Melanoma invasion was scored in non-wounded and wounded 
skin composites to which were added Ibuprofen or Capsaicin. 
Firstly, only one wounded standard skin composite was analysed for the 
invasion score of normal skin cells. There was no apparent invasion in a wounded skin 
composite. This invasion score was the same for the twenty-two non-wounded standard 
skin composites (mean invasion score = 0), previously demonstrated in this study. In 
three wounded standard skin composites to which were added fibrin clots and TNF-a 
(300U/ml), two scored 0 and one scored 2.5 (mean invasion score = 0.83). This high 
invasion score in one of these composites may have been due to infiltration of 
keratinocytes induced by TNF -a. 
In six non-wounded skin composites containing HBL cells the mean score was 
0.3 (see Table 5.13). In six wounded skin composites, to which were added skin cells 
and HBL cells, two scored 1.5, one scored 2, one scored 2.5 and two scored 3 (mean 
invasion score = 2.25) which was significantly higher than the non-wounded skin 
composites (p<O.OO 1). This suggests that the wounds may have helped cell invasion into 
these composites. In two wounded skin composites containing HBL cells and TNF-a 
added in the media, one scored 0 and one scored 1 (mean invasion score 0.5). This \vas 
significantly lower compared to wounded HBL c,ell skin composites (p<0.05). The low 
invasion score shown by TNF-a in these composites was unexpected and TNF-a had 
previously been demonstrated to increased melanoma cell migration in the 2D model. A 
similar result was observed in wounded skin composites to which were added skin cells, 
HBL cells. fibrin clots and TNF -a. In six of these composites, three scored 0 and three 
scored 1 (mean invasion score = 0.5). This was also significantly lower compared to 
wounded HBL cell skin composites (p<O.OO I). The low invasion score shown by TNF-a 
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in these composites was unexpected as TNF -a had preyiously been demonstrated to 
increase melanoma cell migration in the 20 model. 
Addition of 100JlM Nalbu (in media)' inhibited HBL cell invasion (mean 
invasion score = 0.75) (p<0.05) and, capsaicin (lOOJlM) slightly (non-significantly) 
reduced cell invasion (mean invasion score = 1.83), relative to wounded HBL skin 
composites. 
In nineteen non-wounded skin composites containing A375SM cells, the mean 
invasion score was 1.21 (see Table 5.13). In two wounded A375SM cells skin 
composites the mean invasion score was 2.5 (one scored 2, one scored 3). This showed 
that the mean invading score doubled in wounded skin composites, however this was 
not significant (p>0.05) relative to wounded A375SM cell skin composites. In three 
wounded skin composites to which were added A375SM cells and fibrin clots the 
invasion score was 0, suggesting that fibrin clots may have contributed to a faster 
healing and therefore the cells were not invading into the dermis (p<O.OO 1) compared to 
wounded A375SM cell skin composites. On the other hand, in seven wounded skin 
composites to which were added skin cells, A375SM, fibrin clots and 300U/ml TNF-a, 
three scored 0, three scored I and one scored 3 (mean invasion score = 0.86). This 
demonstrates that when TNF -a was added to the fibrin clots in these composites, the 
invasion score was slightly increased compared to the ones treated with fibrin clot only. 
Cell invasion was reduced in wounded A375SM skin composites containing fibrin clot 
and TNF-a, however this was not significant (p>0.05) related to wounded A375SM cell 
skin composites. 
In wounded A375SM skin composites to which were added fibrin clots plus 
TNF-a and a further treatment with the unloaded·hydrogel the mean cell invasion score 
was 2.75 (one scored 2.5 and one scored 3). This was a similar len~l of invasion as 
demonstrated in wounded A375SM cell skin composites. 
182 
Interestingly, in wounded A373SM melanoma skin composites to which were 
added fibrin clots, 300U/ml TNF-a and a further treatment with 100flM NaIbu 
hydrogel, melanoma invasion was significantly lower as in five composites four scored 
o and one scored 1 (mean invasion = 0.2), than the control wounded A375SM cell skin 
composites (p<O.OOI) compared to wounded A375SM skin composites. In addition. 
100flM NaIbu hydrogel treatment significantly reduced cell invasion compared to the 
unloaded hydrogel treatment (p<O.OOI). See Table 5.13, Figure 5.35 for a summary of 
these results. 
In 15 non-wounded skin composites containing C8161 cells the invasion score 
was 2.67. A wounded skin composite containing C8l61 cells also had a high invasion 
score of 3. This invasion score of 3 was as expected as invasion in the non-wounded 
skin composites was already so high. In four wounded skin composites to which were 
added skin cells, C8161 cells, fibrin clots and TNF -a (300U/ml) one scored 1, two 
scored 2, and one scored 2.5 (mean invasion score = 1.88) as shown in Figure 5.33 and 
Table 5.13. In wounded skin composites to which were added C8161 cells, 30-50fll 
volume of unloaded hydrogel or 131flM Nalbu hydrogel were added to the wounded 
area. Both treatments had no effect on C816l melanoma cell invasion in four 
composites, as a florid invasion occurred in all caSes. 
An overview of these skin composites invasion score is shown in Table 5.13 and 
Figure 5.35. 
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Table 5.13. Effects of NSAIDs on melanoma invasion in wounded skin composites. 
Invasion Score 
Mean 
Total 
Skin Composite 0 0.5 1 1.5 2 2.5 3 Invasion 
No. 
Score 
F+K 22 22 0 
F+K+W 0 
F+K+W+Fn+TNF-a # 3 2 0.83 
F+K+HBL 6 4 2 0.3 
F+K+HBL+W 6 2 2 2.25 *** 
F+K+HBL+W+TNF-a (in media) 2 0.5 * 
F+K+HBL+W+Fn+TNF-a 6 3 3 0.5 ** 
F+K+HBL+W+ Nalbu 100llM 2 1 0.75 * 
F+K+HBL+W+Capsaicin IOOIlM 3 2 1.83 
F+K+A375SM 19 7 2 '"l 2 2 3 1.21 -
F+K +A375SM+W 2 1 2.5 
F+K+A375SM+W+Fn 3 3 0** 
F+K +A375SM+W+Fn+ TNF-a 7 3 3 0.86 
F+K+A375SM+W+Fn+TNF- 2 1 2.75 
a+Unloaded hydrogel 
F+K+A375SM+W+Fn+TNF-a+Nalbu 5 4 0.2 ** 
IOOIlM hydrogel 
F+K+C8161 15 2 12 2.67 
F+K+C8161+W 3 
F+K +C8161 +W+Fn+ TNF-a 4 2 1.88 
F+K+C8161+W+Unloaded hydrogel 2 2 3 
F+K+C8161+W+Nalbu 131 11M 2 2 3 
hydrogel 
# =Invasion of Keratinocytes; * = p<0.05; ** = p<O.Ol; *** = p<O.OOl. 
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Figure 5.35. Differences in the extent of melanoma cell invasion in wounded skin 
composites and the different treatments used. All composites contained keratinocytes and 
fibroblasts but in addition (A) contained C8161 cells; (B) contained A375SM cells and (C) 
contained HBL cells. To the composites were added W=Wound, Fn=Fibrin clots, 
TNF=300U/ml TNF-a, NaIbu=Ibuprofen hydrogel as indicated. Values (bars) are 
expressed as Mean+SEM of invasion score. * indicates p<O.05; ** indicates p<O.Ol ; *** 
indicates p<O.OOl, relative to wounded skin composites. 
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5.5.7. Effects of Melanoma Cells on Wound Healing and Dermal Quality 
Wounded skin composites were analysed looking at the impact of wounding 
healing and dermal integrity in composites to which were added different melanoma cell 
lines. 
5.5.7.1. Effects of Melanoma Cells on Wound Healing 
F or these~ wounded skin composites were analysed looking at the impact of 
wounding healing in composites to which were added different melanoma cell lines and 
received no treatment. Initially this was observed in standard (control) skin composites. 
In two wounded standard skin composites, one healed and another did not. HBL skin 
composites did not to heal in 4 out of 4 composites while A375SM showed some 
healing characteristics as 2 out of 3 healed and the one C8161 skin composite showed 
good healing. See Table 5.14 for an illustration of these results. 
Clearly however these numbers of composites are too low for real assessment. 
Therefore it was decided to look at the composites which had wounds (irrespective of 
whether they had fibrin, TNF -u or not. 
Table 5.14. Effects of Melanoma Cells on Wound Healing (number of skin composites). 
Skin Composite 
Standard 
HBL Cells 
A375SM Cells 
C8161 Cells 
No Healing 
4 
2 
o 
Intermediate Healing 
o 
o 
o 
o 
Good Healing 
o 
The impact of the melanoma cells on wound healing was then examined 
irrespective of the treatments used. These results are summarised in Table 5.15. 
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HBL skin composites proved to be the most difficult ones to heal as 15 out of 20 
(75%) did not heal. A few of these skin composites (3 out of 20, or 15%) showed some 
intermediate healing and only 2 out of 20 (10%) showed good healing. 
A375SM cells were slightly better at healing as 9 out of 20 (45%) healed, with 
an intermediate healing in 6 out of20 (30%) whilst only 5 out of20 (25%) did not heal. 
For C8161 cells 7 out of7 wounded composites healed completely (100%). 
Table 5.15. Effects of Melanoma Cells on Wound Healing (number of skin composites). 
Skin Composites 
HBL Cells A375SM Cells C8161 Cells 
No Healing 15 5 0 
Intermediate Healing 3 6 0 
Good Healing 2 9 7 
5.5.7.2. Effects of Melanoma Cells on Dermal Quality 
The effects of melanoma cells on dermal quality was analysed by looking at 
damage of the dermis as a result of cell invasion. Table 5.16 illustrates these results. 
Normal skin cells did not significantly affect the quality of the dermis In 
standard (control) skin composites. 
The effects of melanoma cells on dermal integrity varied according to the 
melanoma cell type. In six non-wounded skin composites containing HBL cells, 2 
showed a reduction in the quality of the dermis. Similarly 2 out of 6 composites post 
wounded had a dermal quality that was suboptimal. However, 6 out of 6 HBL skin 
composites to which were added fibrin clots and TNF-a showed a good dermis quality. 
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Wounding and the addition of Ibuprofen resulted'in good dermal integrity in 2 out of 2 
composites, 
In nineteen non-wounded skin composites containing A375SM cells, 15 showed 
good a dermis while 4 had a less good dermis. Wounding was associated with a poor 
dermal integrity in 2 out of 2 composites. Wounding and the addition of fibrin clots plus 
TNF-a significantly reduced dermal quality in 5 out of 7 composites. Two A375SM 
skin composites treated with unloaded gel showed lower quality of dermis. Wounding 
and the addition of fibrin clots plus TNF- a and a further treatment with NaIbu hydrogel 
showed good quality of dermis in 5 out of 5 composites. 
Interestingly, all 22 skin composites containing C8161 cells showed good 
dermal quality irrespective of wounding or TNF-a or Ibuprofen. See Table 5.16 for a 
summary of these results. 
Table 5.16. Effects of Melanoma cells on dermal quality (number of skin composites). 
Control Wounding Wounding Wounding Total ~umber 
+Fibrin+ T~F-a +Ibuprofen Composites 
Standard Skin Good 20 1 2 Not done 26 
Comp Reasonable 2 0 I Not done 
HBL Cells Good 4 4 6 2 20 
Reasonable 2 2 0 0 
A375SM Cells Good 15 0 2 5 33 
Reasonable 4 2 5 0 
C8161 Cells Good 15 1 4 2 22 
Reasonable 0 0 0 0 
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Figure 5.36. (A) Effects of Melanoma Cells on Wound Healing; I = Intermediate or no 
healing, 0 = Good healing. (B) Effects of melanoma cells on dermal quality (B); I = Poor, 
0= Good. 
Figure 5.36 (A) shows that in terms of invasion and healing properties, HBL 
cells were less invasive than the two other melanoma cell types but they delayed wound 
healing in the skin composites. 
A375SM cells showed an intermediate level of invasiveness and wound healing. 
On the other hand, C8161 cells were the most invasive of all three cell lines and 
unexpectedly resulted in good wound healing in all skin composites. 
Figure 5.36 (B) shows that in terms of dermal quality, HBL resulted poor quality 
DED in 20% of HBL cell skin composites and, A375SM cells resulted poor quality 
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DED in 33% of A375SM cell skin composites whilst C8161 cells always demonstrated 
good quality DED. 
5.5.S. Quality of DED used in Skin Composites 
In this study a total of 208 skin composites were made based on DED from 22 
individuals. Of these 192 skin composites were of good quality. 11 were lost due to 
infection and 5 were poor quality due to damage to the dermis. As it was possible that 
some of these poor results might have been due to the length of storage of the DED this 
was examined by plotting the quality of the DED (good, infected or clearly damaged) 
against the length of the time the DED was stored in the fridge (at 4°C) as shown in 
Figure 5.37. There was no clear pattern that would have been consistent with 
deterioration ofDED with time. 
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5.6. DISCUSSION 
In this study, tissue engineered human skin was used to investigate the impact of 
wounding and inflammation on melanoma cell invasion. An initial comparison between 
skin composites made of sterilised and non-sterilised DED confirmed that non-sterilised 
DED produced skin composites identical to the sterilised DED. These were suitable to 
be used for the reconstruction of human skin in this work. 
Tissue engineered human skin resulted in a normal skin structure which has a 
defined epidermal layer securely attached to the underlying dermis with a reasonable 
number of keratinocytes organising an epidermal layer ranging from basal cells with 
large nuclei to flat-shaped keratinocytes lacking nuclei. The dermis contained a 
relatively low density of cells identified as fibroblasts. This reconstructed skin has been 
previously demonstrated by Chakrabarty et al. (1999), Eves et al. (2000), Eves (2001) 
and Lee et al. (2003). However, the addition of melanoma cells resulted in a disrupted 
morphology of these reconstructed human skin. 
The addition of HBL cells had slightly affected the organisation of the epidermal 
layer but there was very little disruption to the dermal layer. The addition of A375SM 
cell shows melanoma cells (identified by antibody staining for S 1 00 cell marker) mainly 
within the epidermal layer which was poorly organised. There were also cell within the 
dermis which were identified as keratinocytes (by antibody staining AE lAE2 cell 
marker) not normally present in the dermis in the absence of melanoma cells. In 
contrast the addition of C8161 cells led to an extensive invasion of these cells into the , 
dermis. Very few of these were identified as keratinocytes by specific staining for these 
cells into the dermis. The residual epidermis was poorly organised. 
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Influence of skin cells on melanoma cell invasion 
Tissue engineered composites were prepared so that they contained melanoma 
cells alone, melanoma cells and fibroblasts or melanoma cells and fibroblasts and 
keratinocytes. The extent of cellular invasion into the dermis was then quantified. In 
standard tissue engineered skin composites there was no evidence of epidermal cell 
invasion into the dermis, as expected. 
The three melanoma cell lines used were previously known to have different 
invasion levels. This is in agreement with previous work by Eves et at. (2000). For HBL 
cells, these were moderately invasive into the dermis on their own but the presence of 
fibroblasts completely blocked their invasion and the presence of keratinocytes and 
fibroblasts slightly reduced their invasion. 
A375SM cells were not very invasive on their own in the dermis and as 
observed with HBL cells, invasion was completely blocked by the addition of 
fibroblasts (unfortunately because of the large variability in the invasion of the cells on 
their own this was not significant). However, these cells were most invasive in the 
presence of keratinocytes and fibroblasts. Comparing the invasion seen in the presence 
of both skin cells to that seen in the presence of fibroblasts alone it is clear that the 
fibroblasts tended to reduce the less invasive cells (HBL and A375SM) invasion 
whereas keratinocytes tended to exacerbate it. 
In contrast, C8161 cells were extremely invasive. The addition of fibroblasts had 
no significant effect on this neither did the addition of fibroblasts and keratinocytes. 
This melanoma cell line remained aggressively invasive in all experiments. 
This model indicates that invasion through dermis is more difficult for certain 
melanoma cell lines in the presence of fibroblasts. Fibroblasts are the cells with the 
major responsibility for tissue repair. Thus fibroblasts repair of the dermis by 
synthesising new collagen or by also down-regulating MMPs (Matrix 
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Metalloproteinases) activation may make this a' more difficult matrix for melanoma 
cells to invade through. 
It is known that normal cells need contact with the ECM (Extra-Cellular Matrix) 
which regulates the cell cycle and mediates cell anchorage. The loss of these 
requirements is a hallmark of malignant cells. This idea is supported by the fact that 
integrin mediated contact between malignant cells and the ECM influences their 
behaviour (Goldbrunner et aI., 1996). For example, human M24met melanoma cells 
remain responsive to growth regulatory signals that result from contact with type I 
collagen and that effect on proliferation depends on the physical structure of the 
collagen. On polymerised fibrillar collagen, M24met cells are growth arrested at the 
G liS checkpoint and maintain high level of p27K1P1 mRNA and protein. In contrast, on 
non-fibrillar (denatured) collagen, the cells enter the cell cycle and p27K1P1 is down 
regulated (Henriet et at., 2000). Also, lida et al. (2004) reported that MT I-MMP 
(Membrane Type 1 Matrix Metalloproteinase) in Bowes melanoma cells promoted 
selective invasion into matrigel but not matrices consisting of type-I collagen. 
Furthermore, MTI-MMP expressing melanoma cells exhibit increased migration in 
response to laminin 1 but not to type-lor type-IV collagen. 
The addition of keratinocytes helped cell invasion into the dermis. One 
hypothesis for this is based on the fact that keratinocytes release soluble factors which 
inhibit fibroblast matrix production (Harrison et al .. 2005) and melanoma cells ruled the 
interaction between normal skin cells. An inflamed environment (with the addition of 
TNF-a) stimulates melanoma cells and keratinocytes to invade the dermis. 
Keratinocytes respond to the pro-inflammatory cytokine TNF-a, expressing integrins 
for cell adhesion and invasion (Franchi et al., 2008). 
Prior work from this group has shown that for some melanoma cells to invade in 
3D reconstructed skin model the presence of fibroblasts and keratinocytes are required 
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(Eves et al., 2000). Almost certainly the wound bed these cells create in modifying the 
dermal matrix with upregulation of matrix metalloproteinases to break down mature 
collagen is conducive to melanoma cell invasion. However it does not follow that the 
melanoma cells themselves upregulate degradative enzyme - another study from this 
group have shown that MMP-2 and MMP-9 are 1!0t upregulated in invading melanoma 
cells but in the surrounding keratinocytes and fibroblasts (Katerinaki et al., 2003). 
Therefore, from these results it is suggested that while fibroblasts synthesized 
components (collagen and matrix) for a stronger dermis, keratinocytes may have 
contributed to melanoma cell invasion. 
Effect of mechanical wounding and addition of fibrin and TNF -(1 on wound 
healing in tissue engineered skin 
This tissue engineered skin study is based on the clinical fact that when 
cutaneous malignant melanoma is excised surgically an inflammatory environment is 
created, as occurs at any injured tissue site. It has been suggested that local melanoma 
recurrence following excision of a primary melanoma may be initiated by the 
inflammatory environment at the excision site - establishing an environment that is 
favourable to neoplasia/metastasis. As discussed in Katerinaki et al. (2003), this has 
been demonstrated in animal models (Bogden et al., 1997; Hofer et al., 1998; Hofer et 
al., 1999), where inflammatory mediators promote the growth, invasion and metastatic 
potential of human melanoma and other malignant tumour xenografts. 
Initial attempts at wounding skin composites were done using a syringe needle. 
However, these composites showed to be impossible to obsen'e signs of the wound sites 
in histology. Also, in many events, there were some infections in the tissue culture 
resulting in poor skin composites. In addition to this, the volume of fibrin clot and 
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hydrogel initially used covered much of the tissue surface area, contributing to 
unsuccessful skin composites. 
However, full thickness wounds made with a single scalpel blade cut were more 
successful resulting in either open wound or less healed wounds, depending on the skin 
composite type and the cells added to it. 
Simple experiments of wounded acellular DED showed that fibrin clots help 
wound healing and DED plus fibroblasts are essential for wound healing. From this it 
appears that a wounded model containing fibroblasts or fibroblasts plus fibrin has a 
good chance of healing. This is explained by the provision of temporary fibrin clot 
scaffold for cell migration and fibroblasts to synthesise new dermal extracellular matrix 
components, as demonstrated by Rizzi et al. (2010). 
Standard skin composites showed an open wound with continuation of the 
epidermis around the wounded edge. Standard skin composites to which were added 
fibrin clots plus TNF -a surprisingly showed largely healed wounds with a continuous 
epidermis or evident dermal wound with continuous epidermal layer. In wounded skin 
composites, fibrin clots plus TNF -u were added in the wounds to imitate an inflamed 
healing process. Surprisingly fibrin clots plus TNF-u did not interfere with wound 
healing. 
The impact of the melanoma cells on wound healing depended on the melanoma 
cell line. HBL cells added to the engineered skin proved to be the most difficult wounds 
to heal. A375SM cells added to engineered skin were slightly better with an 
intelmediate level of healing. Surprisingly. CS 161 cells added to engineered skin 
showed complete normal healing. In terms of invasion and healing properties, HBL 
cells were less invasive than the other melanoma cell lines but they clearly delayed 
wound healing in the skin composites. A375SM cells showed an intermediate level of 
invasiveness and wound healing. On the other hand. C8161 cells were the most invasive 
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of all three cell lines and unexpectedly resulted III good wound healing III all 
composites. 
The slow healing process in wounded composites containing two of the three 
melanoma cells can be related to the unhealed wounds and cancer or to the ulceration 
present at wound sites. This is in fair agreement with a clinical report which showed a 
cutaneous malignant melanoma 4.6mm deep with signs of ulceration (Schottler et al .. 
2009). Also, according to the final version of melanoma staging and classification 
(Balch et at., 2009), it was reported that patients with regional metastasis also had 
ulceration of the primary melanoma. Therefore, melanoma cells may have a role to play 
in deteriorating DED and maintaining a wound that does not heal in vitro, by the 
expression or activation of the MMPs. One possible explanation for C8161 cell invasion 
without influencing wound healing may be related to the expression of CD44 and 
hyaluronan on C8161 cells, as reported by Edward et al. (2005). However, the 
differences in melanoma cell invasion and healing process remains to be clarified. 
Effects of Sodium Ibuprofen on Melanoma Cell Invasion 
Initially experiments using ibuprofen and capsaicin added to non-wounded skin 
composites used high concentrations and therefore no cell attachment to the dermis was 
found. Lower concentrations gave better results on skin composites. 
The interaction between melanoma cells invading into wounded skin composites 
and the impact of adding ibuprofen was complex. HBL cells appeared to be in the 
dermis following wounding however, following the addition of ibuprofen gel there was 
less invasion and growth of cells in an unhealed wound. 
With respect to A375SM cells these were very moderately invasive without 
wounding and more invasive following wounding. The addition of ibuprofen gel in 
wounded A375SM skin composites showed reasonable healing and less invasion. Also 
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very strikingly, although A375SM cells invasion caused damage in the dennis, this was 
very effectively blocked by the addition of ibuprofen. 
With respect to C8161 cells, in non-wounded and wounded engineered skin 
there was still extensive in\'asion despite good wound healing and ibuprofen had no 
input in this. 
Topical treatment with ibuprofen has been successfully developed as a 
therapeutic approach to the reduction of wound pain in patients with chronic, exudating 
leg ulcers (Sibbald et al., 2007; Price et al., 2007). However, there are no reports on the 
effects of ibuprofen as a topical treatment in pre- and post-surgery primary melanoma 
removal. While further studies on the effects of topical ibuprofen still remains to be 
elucidated, there have been some approaches on the use of systemic COX inhibitors in 
clinical trials, such as Pioglitazone and Rofecoxib combined with Trofosfamide in the 
treatment of far-advanced melanoma and soft tissue sarcoma (Reichle et al., 2004) and, 
Treosulfan chemotherapy in combination with Rofecoxib (Spieth et al., 2003). This 
result is in fair accordance with Lejeune et aI, (2006), who demonstrated a case study on 
a patient with a metastatic melanoma of the leg who experienced a complete and 
sustained regression of skin metastases upon continuous single treatment with the 
cyclooxygenase-2 inhibitor rofecoxib. 
Quantitation of the effects of wounding and inflammation on melanoma cell 
invasion in tissue engineered skin 
This analysis is based on a large number of experiments looking at the impact of 
wounding and the pro-inflammatory cytokine TNF-a and ibuprofen on melanoma 
invasion into tissue engineered skin. HBL cells were weakly invasive but much more 
cells are present in the dennis following mechanical wounding. Paradoxically this was 
reduced by the addition of TNF-a or tibrin plus TNF-a but the addition of sodium 
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ibuprofen clearly reduced, by approximately 50%, the extent of invasion seen In 
response to wounding. 
A375SM cells are moderately invasive cells. Invasion was slightly increased 
following wounding but was reduced by the addition of fibrin. Addition of TNF-a 
slightly reduced cell invasion. The addition of a hydrogel carrier did not reduce invasion 
which was very high in these wounded composites but when the hydrogel contained 
sodium ibuprofen this invasion was massively decreased. 
Finally, C8161 cells showed extensive invasion pre-wounding and post 
wounding. This was not changed by the addition of fibrin plus TNF -a or the addition of 
ibuprofen. Essentially these cells remained aggressively invasive under all conditions. 
Effects of melanoma cell on dermal integrity 
The effects of melanoma cells on dermal integrity was analysed by looking at 
damage of the dermis as a result of cell invasion. Normal skin cells did not significantly 
affect the quality of the dermis in tissue engineered skin. The quality of the dermis did 
not seem to be much affected by wounding and the addition of fibrin clots and TNF-a. 
The effects of melanoma cells on dermal integrity were then analysed. All 
experiments were used for this analysis except for those with ibuprofen. The effects of 
melanoma on dermal integrity varied according to the melanoma cell type. HBL cells 
reduced the quality of the dermis in 4 out of 20 skin composites. A375SM cells reduced 
the quality of the dermis in 11 out of 33 skin composites whilst composites containing 
C8161 cells resulted in good dermal quality at all cases. 
Similarly in the presencc of wounding and the addition of fibrin and TNF-a 
HBL cells or A375SM cells reduced the quality of the dermis. 
In all cases the addition of ibuprofen resulted in good quality dermis. 
Surprisingly C8161 cells showed good quality of dermis under all circumstances. 
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Although all the DED samples used in these experiments were not sterilised, 
there was no indication of deterioration of DED with storage over 14 months. This 
excluded the possibility that poor dermal integrity was due to any storage problem with 
the DED. 
These results confirm and extend previous findings from the Kroto Institute. They 
illustrate the complexity of melanoma cell interactions with skin cells and the 
differences in invasion, wound healing and dermal integrity achieved with different 
melanoma cell lines. They provide further evidence for a wound healing environment 
being conducive to melanoma invasion but encouragingly they also provide evidence 
that the local addition of a major anti-inflammatory cytokine such as sodium ibuprofen 
can attenuate this invasion. These are in fair agreement with many other studies 
(Balkwill and Mantovani, 2001; Coussens and Werb, 2002; Thun et al., 2002: Balkwill, 
2004; Harris et al., 2005; Balkwill and Coussens, 2004, Harris, 2007; Hussain and 
Harris, 2007; de Souza Pereira, 2009). 
Conclusions 
These results extend our previous studies and confirm that melanoma cells interact 
with skin cells in the extent to which they invade into the skin but this relationship 
appears to be dictated by the melanoma cells. Although there was some variability in 
the experiments, some melanoma cells become more aggressively invasi\'e in the 
presence of skin cells, for others. the skin cells reduce the invasion of the melanoma 
cells. 
These results also show for the first time' that fibroblasts on their own tend to 
inhibit the invasion of some melanoma cell lines. This was found for the two least 
invasive melanoma cell lines. It is possible that fibroblasts tend to repair any damage to 
the dermis. Mechanical wounding increased invasion of the two least aggressi\'e 
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melanoma cell lines. The addition of TNF-a and fibrin also paradoxically tended to 
reduce the invasion of these melanoma cell lines. Possibly this also tended to reduce 
damage to the denll1s. 
Finally ibuprofen significantly reduced in\'asion of melanoma cells in this 
complex wound model. This was seen for HBL cells where the extent of the invasion 
following wounding was reduced by at least 50% by the addition of 1 OO~M sodium 
ibuprofen. It was also seen for A375SM cells. Invasion of these cells was associated 
with considerable degradation of the underlying dermis. This was very much reduced by 
the usc of a hydrogel releasing ibuprofen with invasion reduced from around 2.75 to 
0.25. Unfortunately ibuprofen was without effect on the invasion of the very aggressive 
C8161 cells in this model. 
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CHAPTER 6 
INFLAMMATORY CYTOKINE TNF-(l ACTIVATION OF THE 
NUCLEAR TRANSCRIPTION FACTOR NF-kB IN MELANOMA 
CELLS 
201 
6.1. EFFECTS OF TNF-a ACTIVATING THE NUCLEAR TRANSCRIPTION 
FACTOR NF-KB IN MELANOMA CELLS 
The next experiments set out to investigate what concentrations of TNF-a lead 
to activation of the pro-inflammatory NF-kB transcription factor in melanoma cells. 
The major pro-inflammatory cytokine TNF-a was used to activate the 
transcription nuclear factor NF-kB. In a 2D model of migration, melanoma cells were 
exposed to 300U/ml TNF-a for 24 hours. The same concentration was used in media 
used in 3D tissue engineered skin for the same purpose. 
Figure 6.1 shows photographs of melanoma cells exposed to the inflammatory 
effects of TNF -a. As it can be observed, melanoma cells were responding to the 
SOOU/ml TNF-a stimulus and activated the nuclear transcriptor factor NF-kB which was 
translocated from the cytosol to the cell nucleus, ,indicated by the green fluorescent dye 
FITC. 
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Resting Cells NF -kB activated Cells 
Figure 6.1. Micrographs of melanoma cells exposed to 500U/mi TNF-a for 1.5 hours and 
the activated nuclear transcription factor NF -kB. HBL cells (A) control, (B) TNF-a 
stimulated; A375SM cells (C) control, (D) TNF-a stimulated; C8161 cell (E) control and 
(F) TNF -a stimulated. Examples of NF -kB (FITC staining) activated cells are indicated by 
a red arrow. 
Figure 6.2 illustrates the effects of TNF-a in stimulating the nuclear 
transcription factor NF-kB in the three melanoma cells lines. 
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Figure 6.2. NF-kB p65 gene stimulated by TNF-a (300 and 500 U/ml) for 1-2 hours in 
melanoma cells. I = C8161, • = A375SM, D = BBL cells. 100 U/ml LPS was used as a 
positive control. Values are expressed as Mean +SEM. N=3. 
In these experiments (Figure 6.2) it was demonstrated that 300U/ml TNF-a 
slightly increased the activation ofNF-kB transcription factor. However, 500U/ml TNF-
a significantly increased NF-kB activation in C8161, A375SM and HBL cells (p<0.05). 
These melanoma cells were exposed to TNF-a for a period of 1-2 hours. Although 
300U/ml TNF-a only slightly increased NF-kB activation, this was probably enough to 
mimic an inflammatory microenvironment either in the 2D melanoma migration and 3D 
tissue engineering skin models used in this study. 
100 U/ml LPS was used as a positive control, and also slightly increased NF-kB 
activation in C8161 and A375SM cells whilst HBL cells were significantly affected 
(p<0.05). 
6.2. DISCUSSION 
In this study, two different TNF-a concentrations (300 and 500U/ml) were 
demonstrated to activate the nuclear transcription factor NF-kB in melanoma cells. 
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Although 300U/ml TNF-a only slightly increased the NF-kB activation, the 
same TNF-a concentration was enough to demonstrate an increase in melanoma cell 
migration and viability in a 2D model of migration and to increase viability in HBL 
cells, the least aggressive melanoma cell line. 
It is known that TNF-a induced activation of NF-kB activity is linked to the 
upregulation of integrins and ICAM-l expression which facilitates melanoma cell 
attachment. invasion (Zhu et al., 2002) and proliferation (Kim et al., 2006). 
Although 300U/ml TNF-a only slightly increased activation of NF-kB, it was 
related to an increase of dennal degradation in melanoma wounded tissue engineered 
skin. The effect of TNF-a in attenuating melanoma cell invasion in wounded tissue 
engineered skin may be due to the simultaneous addition of TNF-a and fibrin clots 
which were demonstrated to help to heal the wounds. However it seems that this low 
TNF-a concentration was associated with some degree of melanoma cell invasion, 
which was attenuated with the administration of ibuprofen in wounded tissue 
engineered skin. Therefore, a slightly inflamed wound bed was created for the 
investigation of melanoma cell invasion which was demonstrated in Chapter 5. 
These results confirm that the pro-inflammatory cytokine TNF -a activated the 
nuclear transcription factor NF-kB in melanoma cells. This created an inflamed 
microenvironment that is known to upregulate integrins expression (Zhu et al., 2002). 
This is essential for intercellular membrane adhesion for lymphocyte interaction such as 
that which occurs during inflammation. Therefore, NF-kB activation is the central 
indicator of cellular responses to inflammation. Similarly, this scenario involves 
facilitating melanoma cell migration/invasion and survival. 
NF -kB is a genetic intracellular transcription factor which regulates the pre-
synthesis of genes involved in the inflammatory and immune response. If NF-kB is 
inactivated it is located in the cell cytoplasm, however it can be rapidly activated if 
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exposed to inflammatory cytokines such as TNF-a, lipopolysacharide (LPS), ultraviolet 
light or viral infection. The activity of NF -kB is tightly regulated by its interaction with 
inhibitory IkB proteins. This interaction blocks the ability ofNF-kB to bind to DNA and 
results in the NF-kB complex being primarily localized in the cytoplasm due to strong 
nuclear export signal in IkBa. Therefore following exposure to the inflammatory 
cytokines, the NF -kB signaling cascade is activated, leading to the complete 
degradation of the IkB. This allows the translocation of unmasked NF-kB to the nucleus 
where it binds to the enhancer genes and regulates their transcription. 
In this study, a major pro-inflammatory cytokine TNF-a was used to activate 
NF-kB in melanoma cells either in a 2D (Zhu et al., 2002; Katerinaki et a!., 2006) 
wound model of migration and in a 3D tissue engineered skin model. Measurement of 
NF-kB activity was possible in tissue engineered skin as an extremely sensitive 
indicator of inflammatory stress (Tao et al., 2004). As mentioned before in the 
Introduction Chapter, TNF-a is a major mediator of inflammation that orchestrates a 
series of immune and stromal cell responses necessary for the destruction of damaged 
cells but also for the repair of tissues during wound healing. Its production has been 
demonstrated in a number of human epithelial and haematological malignancies and it 
appears that both the protein itself and its receptor can be expressed in both the 
malignant and/or the stromal cells, suggesting potential autocrine and paracrine actions. 
In this study, melanoma cells were expos"ed to TNF-a for I to 2 hours and this 
also showed NF -kB activation by the inflammatory stress. The transcription factor NF-
kB is known to be activated within minutes after stimulation with TNF -a cytokine. The 
ability of NF -kB to be activated by inflammatory cytokines and to regulate genes 
involved in inflammatory function links the idea of inflammation to disease progression. 
Evidence from previous studies suggests that TNF -a may be acting via up-
regulation of NF-KB and integrin expression (Zhu et al., 2002; Canton et al., 2003: 
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Katerinaki et al., 2006~ Banno et aI., 2004~ Pikarsky et al., 2004). Both nonnal and 
tumour cells express integrins, which are cell surface molecules that are involved in 
attachment to the extracellular matrix, motility and degradative enzyme production in 
malignant cells (van Kemper et al., 2006). 
NSAIDs or glucocorticoids block NF-kB activation and they can be used for 
long tenn administration. Thus, the long-term use ofNF-kB inhibitors is a valid strategy 
for a variety of human disease (Baldwin, 2001). 
Although the inflammatory cytokine TNF -a was used for the expression of the 
transcription factor NF -kB as the basis of the experiments on the effects of melanoma 
cell migration, invasion and viability, this tinal part of the discussion is focused on the 
link between the cytokine TNF-a in facilitating melanoma cell survival. 
Studies point to a correlation between the activation of cellular gene expression 
by RellNF-kB factors and their participation in the malignant process (Rayet and 
Gelinas, 1999). Successful efforts in the development of small molecule inhibitors of 
NF-kB (Conner et aI., 1997) provide a logical basis for an adjuvant approach in cancer 
therapy to inhibit NF -kB and its associated anti-apoptotic function (Wang et at., 1999; 
Sarkar et al., 2008; Sanchez-Duffhues et al., 2009). 
Some studies reported that TNF-a can mediate either apoptotic or anti-apoptotic 
effects (Aggarwal, 2003; Aggarwal et ai, 2004; Pikarski and Ben-Neriah, 2006; Lin and 
Karin, 2007). However, a clinical study already suggests TNF-a blockade as an 
intervention to improve chemotherapy in cancer patients (Monk et al., 2006) and for 
eradication of the primary causes of cancer and NF -kB inhibition to halt tumour 
progression (Naugler and Karin, 2008 Yun et al., 2009). 
A review study reported that NF-kB activation is known to suppress cancer cell 
apoptosis (Balkwill and Coussens, 2004). Continuous nuclear NF-kB acti\'ity protects 
cancer cells from apoptosis and enhances their growth actiyity. 
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In Chapter 3 it was demonstrated that TNF-a enhanced melanoma cell migration 
and that ibuprofen reduced melanoma cell migration and viability in TNF-a stimulated 
HBL cells. This is in accordance with other studies (Zhu et at., 2002; Katerinaki et at., 
2003; Eves et al., 2003; Katerinaki et aI., 2006) which demonstrated that NSAIDs 
attenuated the migration and invasion of melanoma cells. 
Therefore, this study supports the hypothesis that NSAIDs may be blocking the 
effect of TNF-a induced activation of NF-kB transcription factor and hence, make 
melanoma cells more susceptible to apoptosis. 
In conclusion, this study supports the hypothesis that a pro-inflammatory 
cytokine TNF-a activates the transcription nuclear factor NF-kB creating an 
inflammatory condition which facilitated melanoma cell migration, invasion and 
survival and the fact that NF -kB activation is linked to apoptosis inhibition in melanoma 
cells. 
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CHAPTER 7 
COMBINED CAPSACIN AND HA14-1 IN INDUCING APOPTOSIS 
IN MELANOMA CELLS 
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7.1. EFFECTS OF IBUPROFEN, CAPSAICIN AND HA14-1 IN I~DUCI~G 
APOPTOSIS IN MELANOMA CELLS 
In previous results (Chapter 3) it was demonstrated that ibuprofen and capsaicin 
reduced melanoma cell migration and viability in TNF-a stimulated cells. In the next 
experiments the mechanism of the effects of TNF -a and the NSAID ibuprofen on 
melanoma cell survival and apoptosis were assessed. This also included the 
investigation of capsaicin or HA 14-1 and a combination of capsaicin and HA 14-1 to 
observe any additive or synergistic effect in inducing melanoma cell apoptosis. In these 
experiments cell viability was determined by phosphatidylserinc (PS) externalisation on 
cell membranes (Annexin-V) and cell membrane integrity, using a Guava ViaCount 
assay. 
7.2. EFFECTS OF TNF-a AND IBUPROFEN IN INDUCING APOPTOSIS IN 
MELANOMA CELLS 
In order to observe the effects of ibuprofen sodium salt affecting melanoma cell 
migration and survival, cells were 24 hours pre-incubated with 300U/ml TNF-a. After 
this incubation period, media was removed and media containing 10-3M or 10-4M Nalbu 
was added to the cells and incubated for a further 24 hours. Viability was detennined 
using a Guava ViaCount assay (see Figure 7.1). 
HBL late apoptotic cells were significantly increased when exposed to 300U/ml 
TNF-a on its own (p<O.Ol) and 10-3 M NaIbu «0.001). Livc HBL cells werc 
significantly reduced by TNF-a on its own (p<0.05). 10-4M Nalbu (p<0.05) and 10-3M 
Nalbu (p<O.OOl) relative to media, see Figure 7.1 A. 
On the other hand, TNF-a on its own and Nalbu did not induce apoptosis in 
C8161 melanoma cells. All aspects of apoptosis were unchanged and live viable cdls 
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were slightly increased at 300U/ml TNF-a (p>0.05). Slight reductions in live C8161 
cells occurred at 10-4M and 10-3 M Nalbu (p>0.05 respectively). 20~M camptothecin 
showed a significant increase in nuclear debris and late apoptosis whilst a significant 
reduction in cell viability was observed (p<0.05), relative to control media, see Figure 
7.1 B. 
In summary, TNF-a on its own and 10-3M NaIbu had a marked effect on HBL 
cells in inducing cell apoptosis and reducing live cells. However, TNF-a on its own and 
lOAM and 10-3M NaIbu did not affect C8161 cell viability and neither induced 
apoptosis. See Figure 7.1 and Table 7.1 for an illustration of these results. 
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Figure 7.1. Influence of TNF-a and NaIbu on melanoma cell viability. (A) = HBL cells, (B) 
= C8161 cells. D = Nuclear debris, D = Late apoptotic, D = Live viable, = Early 
apoptotic. Values expressed as Mean+SEM. N=2 in duplicates. * = p<0.05; ** = P < 0.01 ; 
*** = P < 0.001, relative to media. 
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Table 7.1. Influence ofTNF-a and Nalbu on C8161 and HBL melanoma cell viability. 
Percentage of cells are expressed as Mean+SD. N=2. 
HBL Cells Media 300U/mITNF-a Nalbu 104 M Nalbu 10-~M Cam~tothecin 
Nuclear debris 3.9 3.8 4.7 10.4 38.5 (1.5) (0.6) (1.4) (1.5) (6.8) 
Late apoptotic 7.1 27.5 20.2 52.7 20.6 (0.7) (2.1 ) (4.4) (4.2) (3.4) 
Live viable 86.8 68.3 73.6 34.1 21.8 (2.4) (2.5) (3.2) (2.5) (1 ) 
Earlyapoptotic 2.2 0.40 1.5 3.0 7.9 (0.8) (0.1 ) (0.4) (0.7) (3.2) 
C8161 Cells Media 300U/mITNF-a Nalbu 10-4M Nalbu 10-3M Cam~tothecin 
Nuclear debris 3.9 2.9 7.6 3.4 45.1 (0.8) (0.4) (4.5) (1.2) (3.5) 
Late apoptotic 6.6 3.73 7.1 5.3 26.5 (2.4) (0.3) (2.8) (1.8) (7) 
Live viable 88.1 92.1 83.7 89.8 26.9 (3.9) (0.2) (8.5) (4.2) (6) 
Earlyapoptotic 1.4 1.2 1.6 1.7 8.2 ~0.8~ ~0.5~ ~1.21 ~1.2~ ~31 
7.3. EFFECTS OF CAPSAICIN AND HA14-1 ON MELANOMA CELLS, 
MELANOCYTES AND FIBROBLASTS VIABILITY 
Initially, a dose-response curve for each drug and the combination of both was 
tested using MTT assays to assess cell viability and to determine appropriate 
concentrations for investigation of the effects of both drugs in inducing apoptosis in 
these cells. 
Figures 7.2 A, Band C show the effects of capsaicin and Figures 7.2 D, E and F 
show the effects of HA14-1 on melanoma cells, melanocytes and fibroblast viability 
respectively. Overall, capsaicin reduced melanoma cell viability. For HBLs the IC50 
value was 100~M. (Capsaicin significantly reduced HBL cell viability to 16.5% at 
300~M (p<O.OOl), and to 5% at 400llM (p<O.OOl). No viable cells were found at 
500~M capsaicin). 
For A375SM cell the IC50 value was 133~M capsaicin. (Capsaicin significantly 
reduced cell viability at concentrations of 200~M up to 400~M and no viable cells were 
found by 500~M). 
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For C8161 cells the IC50 value was 1661lM capSaICIn. (Cell viability was 
significantly reduced to 35% at 200llM (p<O.05) and to 6.5% at 500llM capsaicin 
(p<O.O 1) 
For melanocytes the IC50 value was 150llM capsaicin (p<O.OOl) and 
concentrations of 50-200/lM significantly reduced cell viability. For fibroblasts the 
IC50 value was 350llM capsaicin and cell viability was significantly reduced by 400llM 
and 500llM (p<O.OO 1). 
In summary, the three melanoma cell lines and melanocytes showed a similar 
sensitivity to capsaicin with capsaicin concentrations above 200llM becoming 
cytotoxic. However, fibroblasts tolerated capsaicin up to 300llM without any effect with 
an IC50 of around 350IlM, showing these cells were more resistant to the metabolic 
inhibitory effects of capsaicin. 
HA14-1 also reduced melanoma cell viability. The IC50 value for HA14-1 m 
HBL cells was around 60llM HA14-1 (p<O.05). For A375SM cells the IC50 value was 
around lOOIlM HA14-1. For C8161 cells the IC50 value was greater than IOOIlM 
HA14-1. For melanocytes the IC50 value was around IOOIlM HA14-1 (see Figure 7.2 
E). Fibroblasts were relatively resistant to HA 14-1 up to concentrations of 150llM but 
200llM reduced viability to only 1.3% (see Figure 7.2 F). 
In summary, the HA14-1 IC50 "alues for melanoma cells, fibroblasts and 
melanocytes were: HBL (55/lM) followed by melanocytes (80IlM), A375SM (95 IlM ). 
C8161 (higher than 100/lM) and fibroblasts (l80/lM). 
In conclusion, these results suggest that melanoma cells and melanocytes had 
similar sensitivities to HA 14-1 whilst fibroblasts were more resistant to HA 14-1 (by a 
factor of two-fold). 
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Figure 7.2. Effects of Capsaicin or HA14-1 on melanoma cells, melanocytes and fibroblasts 
viability (MTT assays). (A) = Capsaicin on melanoma cells, N= 2. (B) = Capsaicin on 
melanocytes, N= 2. (C) = Capsaicin on fibroblasts, N=2. (D) = HA14-1 on melanoma cells, 
N= 2. (E) = HA14-1 on melanocytes, N= 4. (F) = HA14-1 on fibroblasts. D = HBL, -
A375SM, • = C8161, D = Melanocytes, = Fibroblasts Values expressed as Mean+SD. 
N= 3 in duplicates * = p<O.05; ** = p<O.Ol; *** = p<O.OOl, related to media. 
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••• 
200 
7.3.1. Effects of Combined HA14-1 and Capsaicin on Melanoma Cell Viability 
Based on the IC50 values a combination of both drugs was then used to 
investigate their combined effect on melanoma cells, melanocytes and fibroblasts 
viability. The predicted values from an additive effect of using both agents were 
calculated. Capsaicin and HA14-1 treated cell were compared to control media treated 
cells. 
Figure 7.3 illustrates the effects of HA 14-1 and capsalClll alone and in 
combination on melanoma cells (Figure 7.3 A, B and C), melanocytes (Figure 7.3 D) 
and fibroblasts (Figure 7.3 E). 
For HBL cells both agents significantly reduced cell viability to 50% (p<0.05). 
This was not significantly different to the predicted additive effects of these two agents 
which predicted a reduction in HBL viability to 30%. 
For A375SM cell the combined dnlgs reduced viability to 57% (p<O.OOl). This 
was not significantly different to the predicted additive value of reduction in A3 75 SM 
cell viability to 47%. 
For C8161 cells the two drugs combined reduced viability to 56% (p<0.001) 
which was exactly the predicted value for an additive effect (57%) of these agents. 
For melanocytes the combined agents reduced viability to 19% (p<0.05) which 
was exactly as predicted for an additive effect of these agents. 
For fibroblasts the combination of the two agents reduced viability to only 0.4% 
(p<O.OOI) which showed a strong synergistic effect as the predicted effect was 35% 
(p<O.OOl). However, it should be noted that higher concentrations of HA14-1 and 
capsaicin were deliberately used for these cells as they had been shown to be more 
resistant to both of these agents compared to the other melanoma cells and melanocytes. 
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Figure 7.3. Additive and synergistic effects of combined HA14-1 and Capsaicin on (A) 
HBL, (B) A375SM, (C) C8161 melanoma cells, (D) melanocytes and (E) fibroblasts 
viability. HA14-1 (f.1M), Cap=Capsaicin (f.1M). Combined agents were maintained at the 
same concentrations as used isolated. Predicted values are shown by the grey coloured 
columns. Values are expressed as percentage of viable cells. N=2 in triplicates. * = p>O.05; 
** = p<O.Ol; *** = p<O.OOl, related to media. 
7.4. EFFECTS OF CAPSAICIN AND HA14-1 ALONE AND IN COMBINATION 
IN INDUCING APOPTOSIS IN MELANOMA CELLS AND FmROBLASTS 
In the following experiments, the effects of capsaicin or HA 14-1 in inducing 
apoptosis in melanoma cells and fibroblasts were investigated. IC50 values of the 
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effects of capsaicin or HA 14-1 were observed for a further investigation of the effects of 
combined capsaicin and HA 14-1 in inducing apoptosis in melanoma cells and 
fibroblasts. 
7.4.1. EFFECTS OF CAPSAICIN IN INDUCING APOPTOSIS IN MELANO:\1A 
CELLS AND FIBROBLASTS 
Table 7.2 and Figure 7.4 show the effects of increasing capsaicin in inducing 
apoptosis in melanoma cells and in fibroblasts using the Annexin-V assay for apoptosis. 
For HBL cells (Figure 7.4 A), a significant increase in late apoptosis with 
reduced cell viability started at capsaicin concentration of 300JlM. For A375SM cells 
(Figure 7.4 B) capsaicin significantly increased late apoptotic cells and reduced cell 
viability at 400JlM. For C8161 cells (Figure 7.4 C) capsaicin increased nuclear debris 
and reduced cell viability at around 400JlM capsaicin. Overall, fibroblasts tolerated with 
capsaicin at the highest concentration tested, 500JlM, see Figure 7.4 D. 
In summary, the concentration of capsaicin which reduced cell viability to 50% 
was calculated to be 220JlM for HBL cells, 350JlM for A375SM cells and 320JlM for 
C8161 cells. Capsaicin had no effect on fibroblasts at concentrations up to 500JlM. 
20JlM camptothecin was used as a positive control and significantly induced 
apoptosis in 2 of 3 melanoma cell lines and fibroblasts. This was not significant for 
HBL cells due to sample variation. 
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Table 7.2. Effects of capsaicin in inducing apoptosis in melanoma ceUs and fibroblasts. 
Values are expressed as Mean+SD 
HBL Nuclear Late Live Early Debris Aeoetosis viable Aeoetosis 
Media 17.6 ± 13.7 20.8 ± 11.9 58.3 ± 22.4 3.4 ± 1.7 
50 9.3 ± 4.8 28.2 ± 2.4 59.2 ± 7.1 3.4 ± 1.6 
100 13.5 ± 6.8 41.8±8.1 36.3 ± 12.3 8.5 ± 2.7 
200 13.3 ± 9.8 18.6 ± 3.5 61.2±7 7.1 ± 4.5 
300 26.9 ± 17.6 62.5 ± 13.2 9.0 ± 3.5 1.6 ± 1.4 
400 10.5 ± 6.5 84.9 ± 5.9 2.8 ± 1.1 1.9±1.1 
500 3.3 ± 3.1 93.4 ± 3.1 1.2 ± 0.5 2.1 ± 0.7 
Camj!tothecin 20.6 ± 12.7 38.5 ± 10.9 33.1 ± 13.7 7.9 ± 6 
A375SM Nuclear Late Live Early Debris Apoptotic viable Apoptotic 
Media 0.3 ± 0.3 7.5±13.4 88.9 ± 10 3.2 ± 6.8 
50 0.5 ± 0.3 2.7 ± 0.9 96.2 ± 1.1 0.7 ± 0.4 
100 0.6 ± 0.3 2.8 ± 0.3 95.4 ± 0.7 1.2 ± 0.4 
200 0.7 ± 0.5 6.0 ± 2.9 90.3 ± 4.5 2.9 ± 2.1 
300 1.1 ± 1.1 15.1 ± 2.1 82.6 ± 2.3 1.3 ± 0.8 
400 0.4 ± 0.1 76.4 ± 5.4 21.9 ± 5.9 1.3 ± 0.5 
500 0.4 ± 0.2 68.8 ± 9.9 27.8 ± 10.4 2.9 ± 0.5 
Camptothecin 2.6 ± 2.6 36.2 ± 16.5 53.9 ± 19.3 7.3 ± 8.2 
C8161 Nuclear Late Live Early Debris Apoetotic viable Aeoetotic 
Media 15.9 ± 2.6 9.4 ± 5.2 68.4 ± 9.1 6.6 ± 6.6 
50 14.2 ± 4.9 12.3 ± 2.4 66.7 ± 1.9 7.0 ± 4.4 
100 12.2 ± 3.8 11.4±3.7 67.6 ± 7.2 7.7 ± 5.4 
200 11.7 ± 2.3 7.9 ± 4.0 75.7 ± 7 4.9± 5.3 
300 25.2 ± 12.7 11.8 ± 1.3 60.4 ± 8 2.8 ± 3.5 
400 49.7 ± 20.4 23.4 ± 16.4 24.8 ± 1.1 2.3 ± 3.1 
500 53.3 ± 12.9 16.5± 9.4 29.9 ± 2.9 0.5 ± 0.6 
Camptothecin 43.6 ± 12.2 26.7 ± 4.7 26.9 ± 8.1 1.6 ± 1.9 
Nuclear Late Live Early 
Fibroblasts Debris Aeoptotic viable Apoptotic 
.. 
. ~~---~~------
Media 5.0 ± 1.4 5.6 ± 3.7 87.1 ±5.5 2.4 ± 1 
50 4.7 ± 2.9 11.8 ± 8.5 78.5 ± 13.2 5.1 ±2.4 
100 12.4 ± 3 23.1±1.4 59.9 ± 4 4.6 ± 2.1 
200 6.2 ± 2.7 15.9±14.2 74.8 ± 18.6 3.1±1.8 
300 5.3 ±4.5 15.5 ± 15.9 77.1 ± 22 2.1 ± 1.7 
400 8.4 ± 4.1 19.6 ± 18.3 69.8 ± 22.5 2.2 ± 1.2 
500 6.3 ± 5.7 15.7 ± 15.9 74.2 ± 22.2 3.9 ± 1.5 
Campothecin 8.8 + 3 40.0 ± 4.2 44.3 + 5.7 6.9 ± 1 
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Figure 7.4. Effects of capsaicin in inducing apoptosis in (A) HBL, (B) A375SM, (C) C8161 
melanoma cells and (D) fibroblasts. 0 = Nuclear debris, = Late apoptotic, D = Live 
viable, • = Early apoptotic. Values are expressed as Mean+SD. N=2 in duplicates. * = 
p<O.05; ** = p<O.Ol; *** = p<O.OOl, relative to media. Camptoth = 20J.1M camptothecin. 
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Figure 7.S shows the effects of capsaicin in inducing apoptosis in melanoma cells and 
fibroblasts. For this analysis, it was calculated a sum of all aspects of apoptosis (nuclear 
debris, late and early apoptosis) in relation to live viable cells. In this simpler way it was 
estimated at which capsaicin concentration increased apoptotic cells and crosses-over 
with the reduced live viable cells. 
For HBL cells (Figure 7.S A) the cross-over of increased apoptotic cells and 
reduced live cells occurred at a lower capsaicin concentration of 220)lM. Figures 7.S (B 
and C) illustrate an increase in apoptotic cells and a simultaneous reduction in live cells 
that occurred at 3S0)lM capsaicin for C8161 and A37SSM cells. 
Increasing capsaicin concentrations showed no effects on fibroblasts (Figure 7.S 
D). 
These cross-over values confmn the ICSO values demonstrated above (see 
Figures 7.4 and 7.S). 
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7.4.1.1 EFFECTS OF CAPSAICIN IN INDUCING APOPTOSIS IN MELA~O:\1A 
CELLS ASSESSED BY DNA DAMAGE ASSAY 
The effects of capsaicin in inducing apoptosis in melanoma cells were also 
investigated using a DNA Damage assay (see Figure 7.6). Capsaicin treated cells were 
compared to control media treated cells. 
For HBL cells capsaicin concentrations of 300IlM, 400IlM, and 500llM 
significantly reduced HBL cells viability to 57.8%, 57.1% and 48% (p<O.OOl in all 
cases). The IC50 value was around 480llM capsaicin. 
A375SM cell viability was significantly reduced to 68.7% at 300llM capsaicin 
concentrations (p<O.O I) and the IC50 value was 440IlM. The IC50 value for C8161 
cells was 500llM capsaicin (p<O.05). 
Fibroblasts were not affected by the effects of capsaicin up to 500llM (p>O.05). 
20llM camptothecin, which was used as a positive controL significantly reduced 
viability of HBL and A375SM cells (p<O.OOl) whilst not significantly reducing C8161 
cell viability (p>O.05). 20llM camptothecin had no effect on fibroblasts viability. 
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Figure 7.6. Effects of capsaicin (1lM) in inducing apoptosis in melanoma cells and 
fibroblasts - DNA damage assay . • = HBL cells, = A375SM cells, • = C8161 cells, • = 
Fibroblasts. Values express percentage of cells ± SD. N=2 in duplicates. IC50 values are 
indicated by a black dotted line. * = p<0.05; ** = P < 0.01; *** = P < 0.001, relative to 
media. Campth = 20llM camptothecin. 
7.4.2. EFFECTS OF HA14-1 IN INDUCING APOPTOSIS IN MELANOMA 
CELLS AND FmROBLASTS 
Table 7.3 and Figure 7.7 show the effects of increasing HA 14-1 concentrations in 
inducing apoptosis in melanoma cells and fibroblasts, compared to control media. For 
HA14-1 the concentration which reduced cell viability to 50% was 102~M for 
fibroblasts. This is higher than the concentration required to demonstrate the same 
effects on HBL cells which was 48~M and 85~M for A375SM and C8161 cells 
respectively. Fibroblasts were more resistant to higher HA14-1 concentrations 
compared to melanoma cells. The IC50 value was 112~M HAI4-1 . 
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Table 7.3. Effects of HA14-1 in inducing apoptosis in melanoma cells and fibroblasts. 
Values are expressed as Mean+SD. 
HBl Nuclear Late Live Early Debris A~o~totic viable Apoptotic 
Media 0.85 ± 0.1 5.3 ± 1.8 90.0 ± 5.48 3.9 ± 3.5 
20 1.3 ± 0 12.1 ±8.5 84.5 ± 9.6 2.3 ± 1 
30 1.8 ± 0.6 24.3 ± 9.9 70.9 ± 11.3 3.1 ± 0.9 
40 2.9 ± 0.3 36.2 ± 8.8 58.8 ± 8.3 2.2 ± 0.9 
50 3.6 ± 2.0 45.2 ± 46.9 48.1 ± 45.9 3.1 ± 3 
60 4.4 ± 1.2 60.4 ± 29.2 33.2 ± 29.1 2.0 ± 1.6 
A375SM Nuclear Late Live 
Early 
Debris A~o~totic viable Apoptotic 
Media 1.8 ± 1.5 11.9 ± 11.5 81.7±18.1 4.6 ± 5.2 
50 1.7±0.7 11.5 ± 0.8 81.1 ± 6.6 5.8 ± 6.5 
75 1.7 ± 0.2 15.9±0.1 76.7 ± 5.4 5.7 ± 5.6 
100 1.2±0.4 65.9 ± 11.9 25.8 ± 18.2 7.2 ± 6.8 
125 0.9 ± 0.1 80.3 ± 6.6 13.0 ± 0.1 5.8 ± 6.9 
150 1.8 ± 1.9 66.7 ± 27.6 22.7 ± 14.6 8.8 ± 11 
Nuclear Late Live Early 
C8161 Debris A~o~totic viable Aeoetotic 
Media 3.5 ± 1.9 15.2 ± 11.9 . 80.3 ± 14.5 1.0 ± 0.7 
50 3.3 ± 1.1 18.5 ± 9.3 77.3 ± 10.7 0.9 ± 0.4 
75 4.5 ± 1.3 22.8 ± 3.1 71.6±1A 1.2 ± 0.3 
100 5.3 ± 2.9 64.9 ± 28.5 28.5 ± 32.4 1.3 ± 1 
125 5.2 ± 2.9 84.1 ± 2.4 9.5 ± 6.8 1.1 ±0.4 
150 3.9 ± 1.1 56.1 ± 45.4 37.6±41 2.4 ± 3.4 
Nuclear Late Live Late 
Fibroblasts Debris Aeoetotic viable A[loetotic 
Media 3.8 ± 2.2 16.3 ± 004 76.5 ± 2.9 3.6 ± 0.4 
50 2.5 ± 0.4 12A±2.1 82.9 ± 1.9 2.3 ± 0.6 
75 3.9 ± 0.7 22.1 ± 4.3 70.7 ± 3.6 3.3±1.1 
100 1.4 ± 0.3 8.8 ± 2.3 85.9 ± 2.9 3.9 ± 0.5 
125 5.3 ± 0.1 8004 ± 2.7 12.8 ± 3.1 1.5 ± 0.6 
150 2.9 + 0.9 82.8 + 0.4 12.1 ± 0.2 2.2 ± 1.2 
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Figure 7.7. Effects of HA14-1 in inducing apoptosis in (A) HBL, (B) A375SM, (C) C8161 
melanoma cells and (D) fibroblasts viability. Values are expressed as Mean+SD. D = 
Nuclear debris, 0 = Late apoptotic, D = Live viable, = Early apoptotic. Values are 
expressed as Mean+SD. N=2 in duplicates. Fibroblasts N=l in duplicates. * = p<O.05; ** = 
p<O.Ol; *** = p<O.OOl, relative to media. 
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Figure 7.8 illustrates the effects of HAI4-l on all aspects of apoptosis and live 
viable melanoma cells. For HBL cells (Figure 7.8 A), a cross-over of reduced liYe and 
increased apoptotic cells occurred at a HA 14-1 concentration just below 50IlM. 
For A375SM (Figure 7.8 B), the cross-over of reduced live cell to increased 
apoptotic cells was estimated at HA 14-1 concentration just below 90IlM. 
Similarly, for C8l6l cells (Figure 7.8 C) the cross-over of reduced live cells and 
increased apoptotic cells was also estimated at an HA 14-1 concentration just below 
90IlM. 
For fibroblasts (see Figure 7.8 D), a cross-over for live and apoptotic cells 
occurred at an estimated HA 14-1 concentration just above 11 OIlM. This HA 14-1 
concentration is slightly higher than the estimated HA 14-1 concentrations of 50llM and 
90llM to demonstrate the same effect on HBL, A375SM and C8161 cells respectively. 
This shows that fibroblasts were slightly more resistant to HA 14-1 than melanoma cells. 
The cross-over values confirmed the IC50 values as shown above (sec Figures 
7.7 and 7.8). 
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Figure 7.8. Effects of HA14-1 in inducing apoptosis in (A) BBL, (B) A375SM, (C) C8161 
melanoma cells and (D) fibroblasts. = Live viable, • = Apoptotic. Values are expressed 
as Mean. N=2 in duplicates. For fibroblasts N=1. 
7.4.3. EFFECTS OF COMBINED CAPSAICIN AND HA14-1 IN INDUCING 
APOPTOSIS IN MELANOMA CELLS 
In previous experiments, capsaicin and HA 14-1 added individually were shown 
to reduce live cells and induce apoptosis in melanoma cells. In the next experiments 
capsaicin and HA 14-1 were combined to investigate whether these agents would show a 
synergistic or additive effect in inducing apoptosis in melanoma cells. Figure 7.9 shows 
micrographs of A375SM melanoma cells to which were added capsaicin and HA14-1 
individually and combined. Figure 7.9 (A) shows A375SM cells in media only as a 
control. The cells have a long or irregular shape and a fairly central nucleus. These cells 
are flattened to the culture well indicating that they are attached to the bottom of the 
well. There are a few dead cells shown by the bright round-shaped cells floating in the 
media. This is expected after incubating A375SM cells in media for 24h. Figure 7.9 (B) 
shows A375SM cells to which were added 300/lM capsaicin. This capsaicin 
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concentration was delTIonstrated to be toxic to the A375SM cells. The majority of cells 
were floating in media however, there were also some cells still attached to the well. 
Figure 7.9 (C) shows A375SM cells to which 751lM HA14-1 was added to the cells. 
This HA 14-1 concentration became toxic as there were floating cells in media with only 
a few cells remained attached to the well. Figure 7.9 (D) shows A375SM cells to which 
were added 300/lM capsaicin combined with 751lM HA14-1 in media. The cells were 
detached from the well, indicating a toxic effect on A375SM cells. Figure 7.9 (E) shows 
A375SM cells to which was added 20llM camptothecin as a positive control and this 
was also toxic to the cells. 
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Figure 7.9. Micrographs of A37SSM melanoma cells at 24 h incubation in different 
treatments (A) Control; (B) Capsaicin 300,...M, (C) HA14-1 7S,...M; (D) Capsaicin 300,...M+ 
HA14-1 7S,...M; (E) Camptothecin 20,...M. Scale bars=lOO,...m, 20 x magnification. 
Figure 7.10 shows the apoptotic effects of HA 14-1 and capsaicin alone and 
combined compared to the predicted values for the additive effects of these agents in 
inducing apoptosis. 
Figure 7.10 (A) shows that the individual treatments with 30JlM HA14-1 and 
200JlM capsaicin had little effect on live and apoptotic cells (p>O.05). Combined HA14-
1 and capsaicin showed an additive effect on HBL cells which significantly reduced live 
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HBL cells from 76% of control to 40% (p>0.05) and increased late apoptotic cells from 
18% in control cells to 52% (p<0.05). These res.ults were as predicted for an additive 
effect. 
For A375SM cells (Figure 7.10 B), 75~M HA14-1 on its own had little effect. 
300~M capsaicin on its own reduced live cells to 44% and increased apoptotic cells to 
550/0, but this was not significant (p>0.05). However, the combined agents significantly 
reduced live A375SM cells to 18% (p<0.001) and significantly increased late apoptotic 
cells to 80% (p<O.O 1), showing an additive effect of these combined agents as 
predicted. 
For C8161 cells, HA 14-1 and capsaicin individually had no effect. However the 
combined agents significantly reduced live C8161 cells from 84% in control cultures to 
50% (p<0.05) and significantly increased late apoptotic cells from 12% in control cells 
to 44% (p<O.O 1). This outcome clearly shows a synergistic effect (p<0.05) of these 
combined agents compared to the predicted additive values, (see Figure 7.10 C). 
For fibroblasts (see Figure 7.10 D), 75~M HA14-1 and 200~M capsaicin 
individually had no effect on cell viability, neither did a combination of the two. 
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Figure 7.10. Effects of combined HA14-1 and Capsaicin on (A) HBL, (B) A375SM, (C) 
C8161 melanoma cells and (D) fibroblasts. D = Nuclear debris, = Late apoptotic, D = 
Live viable, = Early apoptotic. Values are expressed as Mean+SD. N=2 in duplicates. 
For fibroblasts N=1. * = p<0.05; ** = p<O.OI; *** = p<O.OOI, relative to control media. 
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Table 7.4 summarises the etTects of capsaicin and HA14-1 on melanoma cells , 
melanocytes and fibroblasts in reducing cell viability and inducing apoptosis comparing 
the three different methods used. The main findings of this study were that: 
I. 10-3 JlM ibuprofen induced apoptosis in HBL cells but had no effect on C8161 cells. 
2. Capsaicin at around 150JlM reduces the total metabolic activity of the three 
melanoma cell lines and melanocytes by around 50% (HBL cells are slightly more 
sensitive than A375SM and C8161) while fibroblasts are able to tolerate 
approximately twice as much capsaicin before any significant loss of viability. 
3. Capsaicin induces apoptosis (assessed by the Annexin-V assay) with an IC50 range 
from 220JlM to 320JlM for the melanoma cells but greater than 500JlM for 
fibroblasts. 
4. Higher concentrations were required to induce DNA damage: 440llM to 500llM for 
the melanoma cells but greater than 500JlM for the fibroblasts. 
5. HA14-1 induced a 50% loss of viability at concentrations ranging from 60JlM to 
greater than 100JlM for melanoma cells and melanocytes For f1hf()hl~"t" the TC50 
was 175 JlM. Similar concentrations of HA 14-1 induced apoptosis in these cells. 
6. Capsaicin and HA 14-1 in combination showed additive inhibitory effects on 
melanoma and melanocyte viability. (Synergistic effects were observed on 
fibroblasts but this was at much higher concentrations of both drugs than were 
tested on melanoma cells or melanocytes). 
7. Capsaicin and HA14-1 in combination also showed additive effects in inducing 
HBL and A375SM apoptosis and, surprisingly, a synergistic effect on C8161 cells. 
These combined agents (at similar concentrations) showed no effect in inducing 
fibroblast apoptosis. 
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Table 7.4 also shows that fibroblasts were sensitive to the combined effects of 
capSaICIn and HA 14-1 when used at concentrations that were sufficient to reduce 
viability by 50% (350JlM) and induce 50% apoptosis (1 OOJlM), at which point a 
synergistic effect was seen. 
Table 7.4. Summary of the effects of capsaicin and HA14-1 viability and apoptosis 
in melanoma cells and normal skin cells. (lC50 values). 
Capsaicin (J.l'1) HA 14-1 (J.lM) Combined 
MTT Annexin DNA MTT Annexin MTT Annexin V 
V Damage V 
HBL 100 220 480 60 48 100IJM Capsaicin 200IJM Capsaicin 30IJM HA14-1 30IJM HA14-1 
ADDITI\·E ADDITIVE 
A375SM 150 350 440 70 85 150IJM Capsaicin 300JlM Capsaicin 50IJM HA14-1 75IJM HA14-1 
ADDITIYE ADDITIVE 
ISO 320 500 >100 85 150IJM Capsaicin 300IJM Capsaicin C8161 50IJM HA14-1 75IJM HA14-1 
ADDITIVE SYNERGISTIC 
150 Not done Not done 100 Not done 150IJM Capsaicin Melanocytes 50JlM HA 14-1 Not donc 
ADDITIVE 
>500 175 II~ 350IJM Capsaicin 250IJM Capsaicin Fibroblasts 350 >500 100IJM HAI4-J 75IJM HAI4-1 
SYNERGISTIC NO EFFECT 
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7.5. DISCUSSION 
The aim of this study was to examme 1) the mechanisms of ibuprofen in 
reducing melanoma cell migration by inducing apoptosis and, 2) whether a combination 
of capsaicin and HA 14-1 would have a useful pro-apoptotic effect on melanoma cells. 
To do this, the effects of both drugs were examined on melanoma cells, melanocytes 
and fibroblasts looking at their effect on cell viability and apoptosis. Viability was 
assessed using a simple metabolic assay (MTT test) and two methods for examining 
apoptosis were used, Annexin V binding to PS on the cell membrane and DNA damage. 
Initial experiments with ibuprofen showed that C8161 were not affected by 
TNF -u and ibuprofen at any concentration used. However 10-3M ibuprofen had a 
marked effect in inducing apoptosis in HBL cells. The anti-inflammatory effects of 
ibuprofen on melanoma cells are linked to the inhibition of cyclooxygenase synthesis 
and the inhibition of prostaglandin production and hence an anti-inflammatory effect. 
However, ibuprofen has been reported only once as an apoptotic inducer in murine 
melanoma and in a human cell line of colon carcinoma (L6nnroth et at., 2001). How 
ibuprofen induces apoptosis in the less aggressive melanoma cells remains to be 
clarified. 
The main findings of this study were that capsaicin at around 15011M reduces the 
total metabolic activity of the three melanoma cell lines and melanocytes by around 
50% (HBL cells are slightly more sensitive than A375SM and C8161) while fibroblasts 
are able to tolerate approximately twice as much capsaicin before any significant loss of 
viability. Capsaicin induces apoptosis (assessed by the Annexin-V assay) with an IC50 
range from 220llM to 320llM for the melanoma cells but greater than 500llM for 
fibroblasts. Higher concentrations were required to induce DNA damage: 440llM to 
500llM for the melanoma cells but greater than 500llM for the fibroblasts. 
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HA 14-1 induced a 50% loss of viability at concentrations ranging from 60llM to 
greater than lOOIlM for melanoma cells and melanocytes. For fibroblasts the IC50 was 
1751lM. Similar concentrations ofHA14-1 induced apoptosis in these cells. 
Capsaicin and HA14-1 in combination showed additive inhibitory effects on 
melanoma and melanocyte viability. (Synergistic effects were observed on fibroblasts 
but this was at much higher concentrations of both drugs than were tested on melanoma 
cells or melanocytes). 
Capsaicin and HA14-1 in combination also showed additive effects in inducing 
HBL and A375SM apoptosis and, surprisingly, a synergistic effect on C8161 cells. 
These combined agents (at similar concentrations) showed no effect in inducing 
fibroblast apoptosis. Fibroblasts were also sensitive to the combined effects of capsaicin 
and HA 14-1 when used at concentrations that were sufficient to reduce viability by 50% 
(350JlM) and induce 50% apoptosis (1 OOJlM), at which point a synergistic effect was 
seen. 
Capsaicin is a well known inducer of apoptosis in cancer cells (Dasgupta et al., 
1998; MornS et at.. 1997; Mori et aI., 1996) and in melanoma cells (Patel et al., 2002a 
Patel et aI., 2002b; Gong et al., 2005). In this study, experiments using a DNA damage 
profile demonstrated that capsaicin induced apoptosis in HBL and A375SM cells at 
300JlM. C8l61 cells were affected only at a higher capsaicin concentration of 500JlM. 
At 500JlM capsaicin all three melanoma cells had more than a 50% reduction in cell 
viability. Fibroblasts were not affected by capsaicin at up to 500JlM. These results 
suggest that capsaicin may cause DNA breakage more readily in melanoma cells than in 
normal skin cells sueh as fibroblasts. The selective apoptosis inducing effect of 
capsaicin has been previously reported (Macho et al., 1999; Kang et al.~ 2003). 
There are many reports suggesting mechanisms of action of capsaicin inducing 
apoptosis. For example. extra production of ROS by mitochondrial NADH oxidase 
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(Morn:~ et al., 1997; Surh, 2002), ras activation inducing apoptosis in transfonned cells 
(Gong et aI., 2005), Bcl-2 down-regulation and caspase 3 activation (lun et at., 2007; 
Jung et at., 2001) and inhibition of IL-6-induced STAT3 activation (Bhutani et at., 
2007). In this study, the effects of capsaicin on inducing DNA damage are very clear 
suggesting that this is one mechanism for explaining apoptosis. 
What are the molecular mechanisms by which capsaicin selectively induces 
apoptosis in transformed cells without affecting nonnal skin cells? One report from 
Bodo et al. (2004) demonstrated that functional VRI (Vanilloid Receptor -1) which 
capsaicin interacts with, was present on human epidennal cells, specifically 
keratinocytes and Langerhans cells, but not on' melanocytes; it was also present in 
dermal cells, mast cells, sweat gland epithelium, sebocytes, endothelial cells and smooth 
muscle cells but not, interestingly, in fibroblasts. The lack of response of fibroblasts to 
capsaicin may be based on their lack of receptors but on the other hand, Kim et al. 
(2004) reported the existence of VRI receptors on fibroblasts. Clearly this is an area 
that requires further investigation. 
As summarised in Table 7.4 capsaicin and HA 14-1 each reduced cell viability 
and induced apoptosis in the melanoma cells, melanocytes and fibroblasts but at 
different concentrations. With respect to metabolic activity of the cells (which is what 
the MTT assay measures) this was reduced by capsaicin with the melanO'll(1 cells and 
melanocytes showing a similar sensitivity. Fibroblast viability was also reduced by 
capsaicin (arguing for the presence of VRI receptors on these cells) but it required 
approximately twice the concentration of capsaicin compared to that which reduced 
viability in melanocytes and melanoma cells. For all cells higher concentrations of 
capsaicin (approximately twice as high) were required to show induction of apoptosis as 
evidenced by using the Annexin-V assay and still higher concentrations as measured by 
the assay for DNA damage. 
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The differences found using these different assays are much as expected. The 
MTT assay detects a reduction in cell viability and as such is quite sensitive. Not all 
cells with a reduced viability will necessarily go' on to become apoptotic or die. Many 
cells may recover. 
For the apoptotic assessment (Annex in-V and DNA damage assays), higher 
capsaicin concentrations were needed to demonstrate a similar result, showing the same 
sensitivity pattern as HBL were more sensitive followed by A375SM and C8161 cells 
and fibroblasts. 
Annexin-V binds specifically to phospholipids at early stage of the apoptotic 
process (a disruption of membrane phospholipids asymmetry exposes PS on the outer 
cytoplasmatic membrane). In contrast the DNA damage assay is based on breaks in 
doubled-stranded DNA resulting in the phosphorylation of the histone variant H2AX at 
serine 139. This measures late apoptosis (by which time physical breaks in the DNA 
have occurred) so it is entirely as expected that the IC50 values for capsaicin assessed 
using this assay were higher than when using Annexin-V. 
With respect to HA 14-1, its mechanism of action was identified by Wang et al., 
(2000). These authors verified that HA 14-1 interacts with Bcl-2 in vitro. This protein 
induces apoptosis in a variety of tumour cell lines and cooperates with other drugs 
(Campas et at., 2006~ Mena et al., 2007). 
Melanoma cells and melanocytes had a roughly similar sensitivity to HA 14-1 as 
assessed by a loss of cell viability with IC50 values ranging from 60~M to over 100~M. 
For tibroblasts the lC50 was 175~M, again suggesting that these cells are more resistant 
than melanocytes and melanoma cells. 
With respect to induction of apoptosis slightly lower concentrations of HA 14-1 
were required to produce apoptosis (compared to reducing cell viability) as assessed by 
Annexin-V (DNA damage was not undertaken in these experiments). The 1(50 values 
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were 48-85~M for the three melanoma cells and 112~M for fibroblasts. This again is 
much as expected as this drug is known to interact directly with Bc1-2 to induce 
apoptosis directly. 
The two agents were then tested together to see if agents thought to act by 
different mechanisms would show any useful additivity or synergy in their actions on 
melanoma cells. Combination therapies have been reported by others (Namkoong et al., 
2006; Mena et al., 2007; Dal Lago et al., 2008). 
For both HBL and A375SM cells the effects of combining both were additiye 
rather than synergistic, but interestingly for C8161 cells there was evidence of some 
synergy when Annexin-V was measured as an early indicator of apoptosis. This was 
encouraging as C8161 melanoma cells are particularly aggressive with respect to 
metastases. Concerning loss of viability the effects of combining the two were additive 
rather than synergistic. 
For melanocytes combining the two gave a loss of viability that was additive 
(effects on apoptosis were not studied in these cells). For fibroblasts the results appear 
contradictory at first glance (Table 7.4) in that there is apparent synergy with respect to 
loss of viability but no effect when these two agents were combined on apoptosis. 
However this is explained by the concentrations used. 
The concentrations of capsaicin and HA 14-1 that were used in measuring early 
stage apoptosis in fibroblasts were similar to those used for the melanoma cells. 
However, in studying viability, as the fibroblasts had proven relatively resistant to 
CapSaIClll and HA 14-1, higher concentrations of both were studied and then a 
combination of the two was found to be synergistic. This argues strongly for fibroblasts 
having a lower expression of the VRI receptor rather than being entirely lacking in it. 
Capsaicin and HA 14-1 showed a synergistic effect on C8161 cells. This study 
suggests that these agents may have different mechanisms of action in inducing 
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apoptosis in melanoma cells. As previously reported capsaicin induces oxidative stress 
(Morn~ et al., 1996; Brar et al., 2001), regulates activation of NF -kB and IL-8 (Patel et 
al., 2002a) and hypoxia inducing factor-I-alpha in human melanoma (Patel et al., 
2002b), but also inhibits Bcl-2 anti-apoptotic activity (lung et al., 2001; lun et al., 
2007), whilst HA14-1 blocks the anti-apoptotic Bcl-2 protein (Tian et al., 2007; Wang 
.... 
et al., 2000) inducing melanoma cell apoptosis. Thus there is some overlap in their 
activity in that both are reported to inhibit Bcl-2 anti-apoptotic protein. 
In conclusion this comparative study has shown that melanoma cells and 
melanocytes have a similar sensitivity to capsaicin while fibroblasts are more resistant 
to this agent. HA 14-1 induces apoptosis at relatively low concentrations and a 
combination of the two agents produces a useful additive affect for 2 out of 3 of the 
melanoma cancer lines studied and encouragingly for the most metastatically aggressive 
cancer cell line (C8l6l), a combination of the two showed some evidence of synergy. 
The results suggest that a natural agent (which is perhaps common in one's diet) 
such as capsaicin can be used in combination with another organic compound, HA 14-1, 
as a pro-apoptotic agent. The advantages of a combined therapy include using the two 
drugs at lower concentrations which reduces toxicity and side effects for the patient 
while promoting improved cell apoptosis. This may be a promising alternative therapy 
for those patients with malignant melanoma for whom at present there are few 
chemotherapy approaches. 
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8.1. GENERAL DISCUSSION 
Melanoma is the most dangerous type of skin cancer and affects millions of 
people worldwide. Its incidence is increasing every year and therefore prevention and 
treatment of melanoma has become a major health issue. Treatment of melanoma is 
difficult as it spreads quickly in the body if no treatment is undertaken or if treatment of 
a primary melanoma is not successful. 
Treatments for malignant melanoma do exist and are successful in thin and 
superficial melanoma which can be surgically removed. However, melanoma thicker 
than I mm indicates a poor prognosis as melanoma cells invade and spread quickly in 
the body. As these cells travel in the body, the next stage for melanoma is their 
installation in the lymph nodes. At this stage, the treatments available are the surgical 
removal of melanoma from the lymph nodes followed by chemotherapy. Unfortunately 
the drugs available so far are not as effective for melanoma as for other types of cancer, 
making it difficult to maintain a good quality of life and improved survival for patients. 
This study was based on the growing realisation of the role played by 
inflammation in cancer and on the phenomenon of local recurrence after surgical 
excision of primary melanoma. In the latter there is always a wound environment and 
inflammation associated with wound healing. 
Accordingly this study investigated how inflammation accelerates melanoma 
cell migration and invasion and to what extent anti-inflammatories may be useful in 
blocking migration and invasion and inducing apoptosis. More specifically, it 
investigated whether anti-inflammatories can block or reduce 1) melanoma cell 
migration, 2) melanoma cell invasion in a wounded and inflamed tissue engineered 
human skin model and 3) melanoma cell survival. 
Initially in this study the role of the NSAIDs (ibuprofcn and capsaicin) in 
opposing the effect of the pro-inflammatory cytokine TNF-a on human melanoma cell 
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migration were examined. Either ibuprofen or capSaICIn reduced melanoma cell 
migration in unstimulated and TNF -a-stimulated cells at concentrations which were not 
toxic to the cells. The melanoma cell lines were previously described to haye different 
levels of migration. Although this was a simple model of cell migration, the effects of 
ibuprofen and capsaicin were seen to be more effective in the 2 least aggressive 
melanoma cell lines. This study supports the hypothesis that a pro-inflammatory 
cytokine TNF-a stimulates melanoma cell migration as demonstrated by (Katerinaki et 
aI., 2003; Katerinaki et aI., 2006 Lejeune et al., 2007; Bachmann et aI., 2008) and many 
type of tumour development (Lin et al., 2010) and that NSAIDs such as ibuprofen and 
aspirin is effective for cancer prevention and therapy (Harris, 2007). 
Following the studies on migration the work next progressed to studying 
invasion of melanoma cells in 3D models. Two models were studied - a simple model of 
cell migration through fibrin and a more complex physiologically relevant model of cell 
invasion through 3D tissue engineered skin. 
In the 3D model of melanoma cell invasion in a fibrin scaffold some of the cell 
lines (HBL and A375SM cells) destroyed the scaffold after being incubated with it for 
24 hours. Therefore it was not possible to study melanoma cell invasion in this model. 
Observations by eye were that the melanoma cells showed different patterns of 
interaction with the fibrin clot. For this reason, it was decided to investigate the 
degradative capability of melanoma cells cultures in a fibrin scaffold using a protein 
assay. 
Surprisingly, the two least aggressive melanoma cells were the ones which most 
degraded the fibrin scaffold. On the other hand, C8161, the most aggressive cell line did 
not. This suggests that these more aggressive cells quickly invaded the fibrin without 
degrading the fibrin scaffold. 
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Degradation of fibrin clot scaffold, probably occurred by the action of T\1MPs 
produced by melanoma cells. Accordingly, Hofmann et al., (2000) reported that 
members of the MMP family with their natural tissue inhibitor (TIMP) are not only 
over-expressed in tumours cells but also by stromal fibroblasts. However, in this 3D 
fibrin model, only melanoma cells were present suggesting that MMPs were active in 
the least aggressive melanoma cell lines. 
One possible way to reduce melanoma cell invasion and degradation of a fibrin 
clot scaffold is NSAIDs treatment, as reported by Tsai et al. (2009). An interesting 
finding was that capsaicin reduced the degradative capability of the two (the least 
aggressive) melanoma cell lines which most degraded the fibrin scaffold. The reasons 
for this may be an anti-inflammatory effect of capsaicin (Zegarska et al., 2006; Southall 
et al., 2003) in reducing integrin-binding to fibrin or down-regulating the membrane-
bound enzymes (MMP-2 and MMP-9), attenuating the degradative capability of these 
cells. Another explanation for this is the apoptotic effects of capsaicin in reducing 
melanoma cell survival (Patel et al., 2002a; Patel et al., 2002b; Mori et aI., 1996; Morre 
et al., 2003; Gong et al., 2005; lun et al., 2007). However, the exact mechanisms by 
which the melanoma cells degraded the 3D fibrin scaffold remains to be clarified. 
Degradation and remodelling of extracellular matrix by proteolytic enzymes are 
indispensable for melanoma cell invasion. This is well described by Hofmann et al. 
(2000) and Hoffmann et al. (2005). Other studies showed that NSAIDs suppressed the 
expression of MMP-2 (Pan et al., 2001) and MMP-9 (Murono et ai., 2000) reducing 
cancer cell invasion. 
In conclusion, the 3 melanoma cell lines studied were found to degrade the fibrin 
scaffold differently. The least aggressive ones (HBL and A375SM cells) were capable 
of degrading the fibrin scaffold whilst the m~st aggressive C8161 cells were not. 
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Capsaicin reduced the degradative capability of HBL and A375SM cells and had no 
effect on C8161 cells. 
These results were very interesting, however, it was decided to develop a more 
challenging model of tissue engineered skin in which a wound was made and an 
inflammatory microenvironment was created to investigate melanoma cell invasion. 
There are many types of scaffolds used in tissue engineered skin models (Price 
et al., 2008). Tissue engineered skin models showed more consistent outcomes and 
imitate more closely the structural and physiological conditions of skin (Chakrabarty et 
al., 1999; Eves et al., 2000; Eves, 2001). Accordingly, this model proved to be a good 
model of tissue engineered human skin for studies of inflammation and melanoma cell 
. . 
InVaSIOn. 
Following the experiments in tissue engineered skin with addition of melanoma 
cells, confirm that melanoma cell interact with keratinocytes and fibroblasts in the 
extent to which they invade into the skin composite but this relationship appears to be 
dictated by the melanoma cells. Different patterns of cell invasion were confirmed in 
which HBL and A375SM cells were less invasive and C8161 cells were the most 
invasive cells. This has been previously reported by Eves et al. (2000). Initial attempts 
to add ibuprofen or capsaicin to tissue engineered skin showed poor skin composites 
because the melanoma cells did not survive in higher concentrations of ibuprofen or 
capsaicin. Lower concentrations were used in future experiments. 
Cutaneous melanoma cells are well known for their invasiveness and rapid 
metastatic capacity and this IS regulated by adhesion molecules, matrix 
metalloproteinases, chemokines and growth factors (Zbytek et al., 2008). The 
expression of adhesion molecules and proteases can be associated with inflammation 
(Eves et aI., 2003; Zhu et aI., 2002). 
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In terms of melanoma cell invasion in tissue engineered skin, one important 
result was that when fibroblasts were added with melanoma cells, cell invasion stopped 
(no keratinocytes were present in these tissue engineered skin). This is clearly seen 
when one compares melanoma cell invasion on their own and when melanoma cells are 
added together with the other skin cells (fibroblasts and keratinocytes). It may be that 
fibroblasts maintain a stronger dermis by producing more or better organised collagen 
making it difficult for the two least aggressive melanoma cells to invade, as reported by 
Quintanilla-Dieck et al. (2009) who suggested that a possible upregulation of skin 
conditions (such as scarring and inflammation) in which the prominent matrix 
degrading properties of cathepsin K in fibroblasts are thought to require tight regulation 
to maintain the homeostasis of the extracellular matrix. 
Melanoma cells and fibroblasts activate MMPs to facilitate melanoma cell 
invasion as demonstrated by Hofmann et al. (2000). Conversely, in this study, a 
different result was found as fibroblasts blocked melanoma cell invasion. However, it 
was suggested by (Ntayi et aI., (2003) that fibroblasts may influence melanoma cell 
invasion after the beginning of tumour progression through the dermis. Therefore, it 
may be possible that fibroblasts did not facilitate melanoma cell invasion as there was 
no previous invasion by melanoma cells in the reconstructed skin. 
The presence of keratinocytes influenced melanoma cells to invade in the 
dermis, as seen for A375SM cells. Therefore equilibrium between the beneficial work 
of fibroblasts in blocking or stopping melanoma cell invasion and the encouragement of 
cell invasion by kcratinocytes should be investigated further. 
Once the pattern of melanoma cell invasion in tissue engineered skin was 
cstablished, shldies progressed on to the development of wounded tissue engineered 
skin with the aim of using these to carry out studies of the impact of wounding and of 
inflammation on melanoma invasion. 
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Initial attempts of mechanical wounding with a synnge needle were 
unsuccessful as the wounds were not visible. However a single cut with a scalpel blade 
showed a clear visible full thickness wound and this was used for experiments. 
For a better understanding of wound healing, simple experiments were 
conducted in which there was a gradual addition of fibrin clots and cells to the tissue 
engineered skin. The addition of fibrin clots and fibroblasts in acellular DED 
demonstrated that fibroblasts are essential for healing and keeping the dermis in good 
condition. This is explained by the synthesis of extracellular matrix by dermal 
fibroblasts. 
Mechanical wounding increased invasion of the two least aggressive melanoma 
cell lines in tissue engineered skin. 
Wounded tissue engineered human skin was found to '"heal" after mechanical 
wounding, even without any innate immune cells or vasculature. One process that may 
have helped healing in this skin model was contraction, a common process in skin 
wound healing. During tissue repair, fibroblasts Can be transformed into a proliferative 
and contractile type of cells called myofibroblasts. These cells show the same 
characteristic of smooth muscle cells and take part in skin wound contraction (Nedelec 
et al., 2000; Darby and Hewitson, 2007). Basically, by contraction, myofibroblasts pull 
in the edges of the wound resulting in a scar. 
Addition of fibrin clots and TNF-u helped to heal the wounds and reduced 
melanoma cell invasion in 2 out of 3 cell lines. This paradox may be explained by the 
quick healing hclpcd by the fibrin clots plus TNF-u which are both normally present in 
a wounded and inflamed healing bed. 
Evidence from previous studies suggests that TNF -u may be acting via up-
regulation of NF-KB and integrin expression. Both normal and tumour cells express 
integrins, which are cell surface molecules that are involved in attachment to the 
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extracellular matrix, motility and degradative enzyme production in malignant cells. 
Malignancy of melanoma cells has been shown to be related to integrin expression, and 
therefore TNF-a stimulation of these molecules may playa pivotal role in malignant 
cell migration and invasion (Zhu et at., 2002). MMPs are described as being crucial in 
the invasion of malignant cells, in many cancer cells types including melanoma 
(Katerinaki et al., 2003). However, there was little to suggest that melanoma cells used 
their own degradative enzymes for invasion, rather the results were consistent with the 
melanoma cells invading through a dennal matrix' in which keratinocytes and fibroblasts 
were expressing activated levels of MMP2 and 9. This leads one to suggest that 
melanoma cells in a wounded bed may easily invade in the dermis in which the matrix 
is already being modelled as part of the wound healing programme. 
Another important result in this work was that mechanical wounding increased 
melanoma cell invasion and this was associated with significant breakage or damage in 
the dennis in 2 out of 3 melanoma cell lines added to the tissue engineered skin. If this 
is related to the phenomenon of local recurrence of a primary melanoma excision, this is 
a demonstration that residual cells or "circulating" cells would invade further into the 
dennis and, facilitate further local or proximal melanoma recurrence. 
In tenns of melanoma cell invasion, wound healing and dennal integrity, the 
results varied. HBL cells, the least aggressive melanoma cell lines did not facilitate 
healing the wounds and damaged the dermis. A375SM cells had an intermediate level of 
invasion and were demonstrated to heal the wounds, with less damage to the dermis. 
C8l6l cells, the most aggressive of the three cell lines, invaded the dermis 
independently of the other cells added to the skin composites and treatment used. 
Surprisingly C8l6l cells promoted complete wound healing with a good dermal 
integrity. The different patterns of melanoma cell invasion in this model may be 
. .' f MMP has 
explained by the MMPs activation. Increased expreSSIOn and actIvatIOn 0 s 
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been associated with melanoma progression (Hormann et al., 2005). MMP-2 was onl\' 
observed in highly invasive cell lines and MMP-9 was expressed in cell lines derived 
from advanced primary melanomas (MacDougall et al., 1995: Hoffmann et al., 2000) 
whereas TIMP-I and TIMP-2 reduced murine melanoma cell metastatic potential 
(Khokha, 1994). There are some studies suggesting that a proteolyitc balance between 
MMPs and TIMPs (Tissue Inhibitor of Metalloproteinases) determines melanoma 
progression (Henriet et al., 1999, MacDougall et al., 1999, Cruz-Munoz and Khokha, 
2008). However, there is still some evidence that tumour growth and metastasis may be 
also directed by surrounding fibroblasts (Kurihara et al., 2009). Another possible 
contributor for tumour cell invasion and growth is EMMPRIN (Extracellular Membrane 
Metalloproteinase Inducer) which is highly expressed in tumour cells (Nabeshima et al., 
2005) and stimulates MMPs production in surrounding fibroblasts (Gabiscon et al., 
2005) and may contribute for melanoma cell invasion. 
The tissue engineered skin model which was mechanically wounded to study 
inflammation and melanoma cell invasion prove to be very complex. Therefore it was 
decided to choose one melanoma cell type for a complete study of the effects of 
inflammation and melanoma invasion in this model. For this, A375SM cells were 
chosen as they were known to have intennediate levels of invasion, wound healing and 
dermal integrity in tissue engineered skin models. 
In tissue engineered skin, A375SM melanoma cells were showed to invade and 
damage the dennis. Wound healing in these composites occurred at an intermediate 
level. Wounds were healed with the addition of a hydrogel carrier but there was still 
considerable damage to the dermis. Ibuprofen however reduced these deleterious effects 
of melanoma cell invasion when delivered as a topical treatment from a hydrogel. 
One explanation for this is the anti-inflammatory effects of ibuprofen being 
released at a slow rate on the inflamed and wounded site of a tissue engineered skin. 
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The exact mechanism of ibuprofen which caused this effect remains to be clarified. 
However, the rationale behind this is that ibuprofen blocks COX activation in the cells 
which inhibits the production of prostaglandins and therefore inflammation is stopped 
or reduced. 
In tissue engineered skin, the addition of ibuprofen may also inhibit the 
inflammatory condition stimulated by the addition of TNF-a to the cells. Hence, it may 
down-regulate integrins and metalloproteinase enzyme activation which are responsible 
for melanoma cell attachment and degradation, facilitating melanoma cell invasion. This 
is in fair agreement with MacDougall et al. (1995) who reported that MMP-9 
production in melanoma cells was induced by either IL-IJ3 or TNF -a. Therefore 
NSAIDs could reduce melanoma cell invasion by suppressing the effects of 
inflammatory cytokines. 
This wounded and inflamed tissue engineered skin model for melanoma cell 
invasion was found to be a useful model which supports the hypothesis of the link 
between inflammation and melanoma invasion. 
Macroscopic observations of inflammation around solid tumours have been 
reported for a long time ago (Balkwill and Mantovani, 2001; Thompson et al., 2004). 
However nowadays, it is possible to observe the micro-inflammatory condition in cells 
and tissues which is made possible by advances in molecular biology. The 
microenvironment around the tumours contains pro inflammatory cytokines such as 
TNF-a which is known to be responsible for the activation ofNF-kB transcription factor 
(Zhu et al., 2002; Canton et al., 2003: Katerinaki et at.. 2006; Banno et al., 2004; 
Pikarsky et al., 2004). 
NF-kB activation induced by TNF-a is becoming another "hallmark" of 
inflammation and cancer development. It is known that the switch-off of NF-kB activity 
. h'b' . t' . At" "'f: '1 sai'e" mechanism to keep tumor prevents III 1 Ihon 0 apoptosls. pop OSIS IS a at - 11 
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formation at its lowest by the natural process of self-destruction of transformed cells. 
avoiding their proliferation and metastasis. 
Finally, the last part of the study examined apoptosis in these melanoma cells 
and to what extent inflammation (induced by TNF-a) or the use of anti-inflammatories 
affected this. 
Experiments conducted to observe the effects of ibuprofen on TNF -(1 stimulated 
cells showed that HBL cells were very sensitive to TNF-a on its own and the maximum 
concentration of 10-3M ibuprofen induced significant apoptosis in these cells and 
reduced HBL survival. On the other hand, C8161 cells did not respond to the effects of 
TNF -a alone or TNF -a stimulated with ibuprofen. This was expected as C8161 are the 
most aggressive cell line. These cells proved resistant to the induction of apoptosis by 
pro or anti-inflammatory agents. 
The different sensitiveness of melanoma cells to the same drug was 
demonstrated in this study. One intriguing result is how TNF-a on its own induced HBL 
cell apoptosis as TNF-a is known as a pro-inflammatory cytokine which promotes 
melanoma cell survival. The important result in these experiments is that prior 
stimulation with TNF-a and ibuprofen induced HBL cell apoptosis. 
F or the next set of experiments, capsaicin or HA 14-1 were administered 
individually or combined and cell viability assessed. 
There are some suggestions that combined therapies are better approach for 
melanoma treatment (Namkoong et al., 2006; Mena et a/., 2007; Dal Lago et a/., 2008; 
Valero et a/., 2009). A combined therapy containing capsaicin as a natural component 
and HA 14-1 a small molecule organic compound showing pro-apoptotic properties \\'as 
used. 
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These results showed that melanoma cells and melanocytes a had similar 
sensitivity to capsaicin or HA 14-1 (used individually or combined) and that fibroblasts 
were shown resistant to these dnlgS. 
For apoptosis, different methods were used to observe the effects of capsaicin 
and HA14-1 on melanoma cells and fibroblasts. The first method was Annexin V which 
showed early events of apoptosis and the second method was the DNA damage assay 
which shows later events of apoptosis. Comparison of these two methods showed that 
higher concentrations of capsaicin and HA14-1 were required to observe induced 
apoptosis in these. 
Combined administration of capsaicin and HA 14-1 in inducing apoptosis in 
melanoma cells showed an additive effect on th~ least aggressive melanoma cells and 
fibroblasts at similar concentrations. Surprisingly and importantly, a synergistic effect 
of combined capsaicin and HA 14-1 in inducing apoptosis was shown in the most 
aggressive cell line C8161 cells. 
Similar results on the apoptotic effects of capsaicin (Morn~ et al., 1996; Gong et 
al., 2005; lun et al., 2007); and synergistic effect ofHA14-1 and a epidermal growth 
factor receptor ErbB tyrosine kinase inhibitor (lapatinib) in human breast cancer cells 
(Witters et at., 2007) were previously reported. The synergistic effects of capsaicin and 
HA 14-1 on the most aggressively melanoma cell line may be due to the different 
mechanisms of action of capsaicin and HA 14-1 and the overlap effects of both drugs. 
However, this needs further investigation. 
Isolated or combined therapies of capsaicin and HA14-1 demonstrated that 
fibroblasts tolerated higher concentrations of these agents. This seems to be an 
important result for melanoma target therapies, in which normal cells would remain less 
affected. 
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In conclusion, this comparative study of apoptosis showed 1) how melanoma 
cells and melanocytes have a similar sensitivity to capsaicin while fibroblasts cope with 
higher concentrations; 2) how HA 14-1 induces apoptosis at relatiyely low 
concentrations; and 3) that a combination of the two in the main produces the expected 
results of an additive affect for 2 of 3 melanoma cancers but encouragingly for one 
particularly metastatic aggressive cancer, a combination of the two shows synergy. 
8.2. FINAL CONCLUSIONS 
In conclusion the NSAIDs ibuprofen reduced melanoma cell migration and 
invasion, and accelerated repair to the dermis and wound healing in tissue engineered 
human skin. This suggests that NSAIDs could be used as a topical treatment to reduce 
melanoma metastatic spread following initial excision of primary melanoma. 
Also combined therapy of a natural NSAID (capsaicin) and a pro-apoptotic agent 
(HA 14-1) reduced melanoma cell survival without extensive cytotoxicity suggesting a 
promising alternative chemotherapy for advanced melanoma. 
8.3. LIMITATIONS OF THIS STUDY 
Clearly, the interpretation of these results must be with caution as in the 2D 
model for melanoma cell migration there was no assessment of melanoma cell 
proliferation or density. Cell proliferation is an important aspect in a migration modeL 
in particular, for melanoma cells, as they can proliferate faster than normal cells. 
The 3D fibrin clot model proved impossible to observe melanoma cell invasion. 
Therefore an investigation of melanoma cell degradative capability in a fibrin clot 
scaffold was carried out. This was a simple 3D model of melanoma cell invasion and 
there was no interaction between melanoma cells, fibroblasts, keratinocytes or a 
complex extracellular matrix. 
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The 3D tissue engineered human skin model for melanoma cell invasion result 
must be also interpreted with caution. These models of tissue engineered human skin 
did not have either innervation or vascularity. In addition to this, there were no innate 
immune cells to interact and to result in a more complex immunological system of 
melanoma cell invasion and wound healing. In addition to this, although the inflamed 
and wound skin model "healed" in the presence of ibuprofen delivered from a hydrogel. 
the extension and depth of the wound were not considered for a controlled wound 
healing. However, the evidence presented from this 3D reconstructed skin suggests that 
mechanical wounding is associated with increased invasion of melanoma cells but that 
this can be attenuated by the addition of ibuprofen (either as free drug or released from a 
hydrogel). If one relates these findings to the phenomenon of local recurrence of 
melanoma then there is an argument to be made for reducing inflammation at the site of 
melanoma excision following excision of a primary melanoma. This could be achieved 
by the addition of ibuprofen either systemically or possibly, more effectively released 
from a hydrogel preparation and placed on the wound bed post surgery. Interestingly the 
results also indicated that there was less damage to the dermis following wounding 
when ibuprofen was administered in this model. 
There was a comparative study on the effects of a natural component (capsaicin) 
or a pro-apoptotic agent (HA 14-1) on melanoma cells, melanocytes and fibroblasts 
viability and, the induction of apoptosis in melanoma cells and fibroblasts after 
treatment with capsaicin or HA14-l alone or the combination of these agents. Different 
methods were used to evaluate viability and apoptosis in melanoma and control cells 
(melanocytes and fibroblasts). However, it could be investigated the possible 
. . d' t sis in melanoma 
mechanisms of action of capsaicin and HA 14-1 m m ucmg apop 0 
cells. 
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The results suggest that the advantages of a combined therapy include using the 
two drugs at lower concentrations which reduces toxicity and side effects for patients 
with malignant melanoma as an alternative therapy. 
8.4. FUTURE WORK 
After this work, it would be worthwhile to continue the investigation of 
melanoma cell invasion in an inflamed and wounded tissue engineered skin. Some of 
these aspects that could be look at are: 
1 To investigate the mechanisms of NSAIDs on melanoma cell migration, invasion and 
survival, looking at MMPs expression/production and the role of EMMPRIN. 
2. To carry out more work on the reconstructed skin model to carry out the effects of 
ibuprofen released from a hydrogel and other NSAIDs on migration of other 
melanoma cell lines in a wounded and inflamed bed. 
3. To create a computational model of melanoma cell migration and invasion in 2D and 
wounded 3D skin model respectively and, consequently, simulate the effects of 
NSAIDs and pro-inflammatory cytokines in a wounded tissue engineered model. 
It would also be very interesting: 
1. To investigate closely the apoptotic mechanisms of capsaicin and HA 14-1 looking at 
Bcl-2 levels in melanoma cells. Also it would be interesting to look at the effect of 
other natural agents with pro-apoptotic properties in melanoma cells. 
2. To further investigate the effects of combined new drugs and identify targets for 
metastatic melanoma looking at pro-apoptotic agents. 
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You are about to undergo surgery (abdominal reduction~ breast 
reduction or body lift) that involves the removal of excess skin from 
your body. This skin would nonnaHy be discarded at the end of the 
operation. However, I would like to ask you whether you would be 
wiHing to donate this skin to our research laboratories at the Kroto 
Research Institute, Sheffield. You will not have to undergo any extra 
tests or procedures as a result of donating your skin and no extra skin 
wiIJ be removed as a result of your participation in this study. 
Please take time to read the {()Howing information and discuss it with 
others if you wish. Ask, ifthere is anytlling that is not clear~ or if you 
would like more infom1ation. Take time to decide whether or not you 
w ish to donate the skin that will be rem 0 ved in your operation. 
All patients undergoing breast, abdominal reduction surgery or body 
lift will be approached regardillg the donation of their skin to the 
research laboratories. However, it is up to you to decide whether you 
would like to donate your skin for this purpose. If you do decide to 
donate your skin. you will be given this information sheet to keep and 
will be asked to sign a consent fi.)!"tn. If you decide not to donate your 
skin. yotirtreatmcnt will not be in any way affected by your decision. 
B'lcl\b.rro!'!Jl4Jni9nn1,lJ,i,g!1 
Over the last 15 years, my research group has been developing a skin-
~;ubstitute for patients with bums or chronic wounds. Eventually we 
hope to be able to offer this skin substitute to patients with severe 
bums who do not have enough of their own skin to use for skin grafts. 
We also use this skin substitute to simulate the behaviour ofnOlma.l 
skin under laboratory conditions. 
The laboratory-based component of this research involves obtaining 
sk in from patients such as yourself who are having skin removed, and 
isolati1lg and growing skin cells frollllhese samples. We also sterilise 
samples of skin to remove all the cells from them and use these 
sterilised samples to make new skin. If you agree to donate your skin, 
it will only be used in the laboratory to help us with our research. It 
willllot be used on any patients or animals. 
Skin donation 
If you donate your skin, it will be treated as a freely donated gift trom 
you to the Tissue Engineering Group. HO\:vever. the know' ledge gained 
from the gift of skin samples such as yours will hopefully be used to 
benefit many patients in the future. 
Once you have donated your skin sample. it will be given an 
anonymous reference number. The only records kept by the research 
group are a record of your hospital number, the date of your operation 
and the anonymous number of your skin sample. No other personal 
details are kept on record. The skin will be used for experiments within 
the Tissue Engineering Group, University of Sheffield and will he 
stored in the Kroto Research Instituic Labtxatorics, Sheffield. Once 
the ex.periments using your skin sample have been conlplded, it wiH 
be dj~p()sed of properly. 
My research group \vill only use your skin to isolate cells and to make 
nev.: i>kin in the laboratot"y. \Ve will twt do any tests 011 the skin that 
have anyre)evance to your current or future health. 
My resean ... "h group \-'lill aim to publish the results of our research in 
medical journals and present the result~ at national and international 
conferences related to plastic surgery and skin. If you would like to 
receive details of the results of our research, please write to me at the 
address on the front 0 fthis in formation sheet. 
Thank you for taking the time to read this infcmnation sheet 
Professor Sheila MacNeil 
Sheffield Teaching Hospitals 
Consent form for using samples of human skin for research 
Thank you for reading the information about our research. 
If you would like to take part, please read and sign this form, 
a copy of which will be retained in your medical records. 
Centre: 
Department of Plastic Surgery, Northern Genera! Hospital. Sheffield 
Title of project: 
Patient Ij~nlIficati()n sticker 
Development of tissue engineered wound models for wound healing research for patients with burns 
and chronic wounds. 
Name of researcher: Professor Sheila MacNeil 
Contact details for research team: Professor Sheila MacNeil, Tissue Engineering Group. The Kroto 
Research Institute. North Campus. University of Sheffield. Broad Lane. Sheffield. 83 7HQ. Tel (0114) 
2225995 
Please initial boxes 
1. I have read the attached information sheet on this project, (Dated July 2006. version 3) and have been 
given a copy to keep. I have been able to ask questions about the project and I understand why the research is 
being done and any risks involved. 
2 I agree to give a sample of skin for research in this project. I understand how the sample will be collected, 
that giving a sample for this research is voluntary and that I am free to withdraw my approval for the use of the 
sample at any time without giving a reason and without my medical treatment or legal rights being affected. 
3. I understand that I will not benefit financially, or othervvise, if this research leads to the development of a 
new treatment or medical test. 
4. I know how to contact the research team if ! need to, and how to get information about the results of the 
research. 
273 
Please initial boxes 
5. Consent for storage and use in possible future research projects 
I agree that the sample I have given can be stored at the University of Sheffield for possible use in future 
prOjects to tackle some of problems which occur following burns injuries as described in the attached 
information sheet. 
All donated skin samples will be stored anonymously and used only for laboratory research to benefit patients 
supervised by Professor MacNeiL All skin samples will be destroyed at the end of the experiments. 
Name of patient 
(BLOCK CAPITALS) 
Name of person taking consent 
(if different from researcher) 
Professor Sheila Mae Neil 
Name of researcher 
Dale Signature 
Date Signature 
Date Signature 
Would you like to be sent information about the progress ofthis project? Please circle once. 
YES f NO 
Thank you for agreeing to participate in this research 
Professor Sheila MacNeil 
Professor of Cell and Tissue Engineering 
Consent form version 3. June 16th, 2006 
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